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ABSTRACT
Molecular Dynamics Simulations of Self-Assemblies in Nature & Nanotechnology
by
Phu Khanh Tang

Nature usually divides complex systems into smaller building blocks specializing in a few
tasks since one entity cannot achieve everything. Therefore, self-assembly is a robust tool
exploited by Nature to build hierarchical systems that accomplish unique functions. The cell
membrane distinguishes itself as an example of Nature’s self-assembly, defining and protecting
the cell. By mimicking Nature’s designs using synthetically designed self-assemblies, researchers
with advanced nanotechnological comprehension can manipulate these synthetic self-assemblies
to improve many aspects of modern medicine and materials science. Understanding the
competing underlying molecular interactions in self-assembly is always of interest to the
academic scientific community and industry. This dissertation uses molecular dynamics (MD)
simulations with free energy techniques, such as the Adaptive Biasing Force (ABF) methodology
as well as Metadynamics (METAD), to elucidate the molecular interactions that drive selfassembly in Nature and nanotechnology.
In the pharmaceutical industry, drug permeation and diffusion through the cell membrane
is recognized as one of the most challenging barriers. Thus, an effective way of predicting such
drug partitioning can provide insight how to engineer novel delivery agents. Using the ABF
method to enhance sampling of the transportation of an anticancer drug Camptothecin across
multiple interfaces (octanol bilayer, a thick octanol/water interface, and a model 1-palmitoyl-2oleoyl-sn-glycerol-3-phosphocholine (POPC)/water interface), we investigate the enthalpic and
entropic contributions to the transfer free energy profile. We also observe that membrane-drug
and drug-drug interactions affect the rotational drug entropy. We calculate a partition coefficient
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that agrees with experimental data. Furthermore, long-time MD simulations of high
concentrations of Camptothecin show crystalline drugs formed above model POPC bilayers.
Moreover, only singular drugs penetrate the head group region. There is a strong competition
between the drug-membrane and drug-drug interaction, preventing large clusters of drugs from
breaching the cell membrane simultaneously.
Switching gears to biomedical applications of nanotechnology, we characterize the longtime dynamics and interactions of peptide-based Drug Amphiphiles (DAs) with model cellular
membranes. DAs yield a better pharmacokinetic profile than free Camptothecin because DAs can
self-assemble into nanofilaments or nanotubes (diameter ~ 6-10 nm), which strongly impacts the
circulation time and the efficacy of the drug. Moreover, the self-assembled morphology is known
to be dictated by the number of conjugated drugs. We performed MD simulations (up to 25 µs) to
investigate and characterize the molecular interactions between the DAs and POPC membrane
bilayers. Our results conclude that the intrinsic filamentous design of DAs causes repulsion in
membrane-DAs interactions. However, the results also suggest hydrogen bonding density as the
modulator that promotes the DA's penetration. Altogether, these results suggest methods to
improve the rational design of peptide-based drug delivery vehicles.
Another class of peptide-based delivery agent is known as “Tubustecan.” This generation of
DA system also self-assembles into nanotubes. In mass production, these DAs' nucleation/selfassembly process is crucial in controlling their production and purity. Electrostatics and van de
Waal interactions are the main protagonists in the assembly process, yet they are difficult to
characterize experimentally. Here we utilize enhanced sampling methods in molecular dynamics
using a reaction coordinate based on drug positions to promote the structural reorganization of
these DAs into a Tubustecan droplet. Our results indicate that the polyethylene glycol tail disrupts
the intrinsic π-π stacking of Camptothecin. Moreover, we demonstrated that our choice of
reaction coordinates in conjunction with Metadynamics encourages drug rearrangement.
Ultimately, we observed high-density droplets, followed by ordered droplet formation, suggesting
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that PAs' nucleation has multiple steps and follows the “two-step mechanism” for crystalline
growth.
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Introduction
Self-assemblies are ubiquitous
Self-assembly is a process in which building blocks self-organize into periodic and
functional patterns. These building blocks are loosely 'glued' together by weak interactions rather
than permanent linkages such as covalent bonds. Interestingly, subtle changes in these building
blocks can lead to a new identity of the entire assembly. Moreover, the external environment, such
as pH, and temperature, play a crucial role in maneuvering these building blocks to self-assemble.
While oceans of mystery remain, researchers have deduced that most self-assemblies, in any form,
possess two prerequisites: Balanced mutual interactions and the proper environment.1
Without these two prerequisites, self-assembly cannot occur. However, not everything that comes
together is classified as self-assembly, as an assembly must develop a reasonable degree of
uniformity to be called as such. First, let us look at some examples that demonstrate that selfassembly is, in fact, a ubiquitous phenomenon that resonates all over the Earth.
It is not a surprise that self-assembly is a typical process in biology. If anyone can
meticulously accomplish these two prerequisites with the highest precision, that must be Mother
Nature. Moreover, Mother Nature’s accomplishments range from nanoscale to macroscale objects
and from living to non-living things. For example, fish can form "very large fish shoals, containing
tens of millions of fish and stretching for many kilometers."2 A shoal offers better protection, food
hunting, and reproductive chances. In molecular biology, the discovery of ribosomes as organelles
that self-assemble into complex machinery that translate mRNAs into protein resulted in two
Nobel Prizes, one in 1974 and one in 2009. Another fascinating example of a self-assembly in
Nature is the microtubule, with an incredibly dynamic assembly and disassembly process.3 There
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is much evidence in Nature showing that the self-assembly of simple building blocks can
accomplish miraculous tasks.

Figure 1. The universe of self-assembled Au nanoparticles by molecular interactions.
”Temperature-sensitive DNA can induce particles clustering (a, b) via H-bonding or induce
formation of two-dimensional superlattices (c), whereas light sensitive azobenzenes induce
formation of colloidal crystal (d) via molecular dipole-dipole interactions. Hydrophobic interactions
can induce assembly of nanorods into low symmetry clusters; (h) chainlike structures (i) or
spherical objects, (j) by tuning the volume fraction of the different solvents. Similarly, highly
anisotropic carbon nanotubes undergo assembly into bundles via H-bonding induced changes in
the medium polarity (k). Finally, hierarchical self-assembly can be achieved using preformed
assemblies as building blocks.” Extracted from Marek Grzelczak et al.
Although modern nanotechnology falls short of Nature’s examples, many achievements
have still been made in this field. In 1959, Richard Feynman proposed that "we could arrange
atoms one by one, just as we want them." Thus, IF we can succeed with the prerequisites, we can
harness unlimited power from these self-assemblies and scale them economically. For example,
Marek Grzelczak et al. describes the universe of molecular interactions of self-assembled Au
nanoparticles shown in Figure 1.4 Some molecular models also have the building blocks
conjugated to natural self-assembled molecules, such as DNA.5, 6 This universe applies to other
self-assemblies as well. With the appropriate molecular interactions and in the correct solvents,
self-assemblies can achieve polymorphism. For example, cryo-TEM and coarse-grained
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simulations confirm that dendrimers with different hydrophobic/hydrophilic branches from a
library form micelles or vesicles, which can take on many shapes, such as cubic (or cubosomes),
disklike, tubular, and helical ribbons.7 Since the shape dictates the function; unlimited shapes
equate to unlimited functions.
As mentioned, to control the final shapes of self-assemblies it is not a simple task because
one must thoroughly understand the molecular interactions within the self-assemblies and with
the solvents. It is still experimentally challenging to probe molecular interactions such as
hydrogen bonding, electrostatics. For example, TEM images confirm the nanotube formation of
Tubustecan but fail to provide any information on the nucleation pathway.8 Moreover, Tang et al.
shows that the hydrogen bonding interaction between the head groups of phospholipid bilayers
limits the rotation of Camptothecin at the interfacial region.9 This dissertation attempts to venture
further into that uncharted territory with molecular dynamics (MD) simulations. The following
work focuses on modeling the molecular world of self-assemblies and how that world collides with
others. To begin, let us look at the cell membrane. Bestowed by Nature, the cell membrane is a
complex entity that defines the unit of life, the cell.

Cell Membrane
A "Ghost-like" Barrier of Nature
In 1665, Robert Hooke looked at thin slices of bottle cork under a compound microscope.
He described the “honeycomb-like” structures he saw and called them "the cells" in
Micrographia.10 With such simple light microscopes, Hooke saw "cell walls" rather than "cell
membranes." From this work, the controversial "Cell Theory" emerged. However, much later,
people started to notice that each cell had an invisible semi-permeable membrane.
While the initial models failed to recognize the semi-permeability of the cell membrane, in
the late XIX to the XX century, a clearer picture of the cell membrane emerged with more
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accumulated evidence. Here are some fundamental discoveries that led to the modern membrane
model:
•

The cell membrane contains mainly lipids and cholesterols. Overton's experiment
shows that non-polar molecules permeate the cell easier than polar molecules,
regardless of their size.11

•

The cell membrane is a bilayer structure with hydrophobic tails pointing toward
each other while hydrophilic head groups point toward the water. Gorter and
Grendel, in 1925, show that the lipid-covered surface is always twice the surface
area of the cell.12

•

Integral proteins span along with the bilayer structure. In the 1960s, Brandon and
collaborators use the freeze-etching technique of Moor and Mühlethaller13 to show
that there are identical impressions of the upper and lower leaflet of the bilayers.1417

•

Molecules diffuse freely in the cell membrane. In 1970, Frye and Edidin showed
synthetic antigens on a human cell intermingle with synthetic antigens on a mouse
cell after cell fusion18.

From 1971 to 1972, Singer and Nicolson introduced the Fluid Mosaic Model, which
nowadays remains the most significant model of the cell membrane.19 The model states that the
cell membrane is a phospholipid bilayer with its hydrophobic acyl tails pointing inwards while its
hydrophilic head groups point outwards. Some proteins can anchor symmetrically or
asymmetrically on the leaflets. Moreover, integral proteins can span across both leaflets. These
molecules can diffuse laterally in the cell membrane. However, experimental data suggest
otherwise.20-22 For example, Sako and Kusumi observe that about 90% of tagging transferrin
receptors experience some degrees of restricted diffusion.23 Moreover, using single-particle
tracking and fluorescence photobleaching recovery method, Kusumi et al. propose four diffusion
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modes of E-cadherin and transferrin receptor, indicating that the meshwork model of membraneskeleton is the barrier that restricts membrane proteins from random diffusion.24 Moreover,
glycophospholipid-cholesterol raft can serve as the functional platform assisting in many cellular
phenomena such as cell signaling, membrane trafficking.25Although emerging evidence
accentuates the need for modifying the original Fluid Mosaic Model, it remains the universal
paradigm for the cell membrane.
The elusive world inside the cell membrane is very dynamic in structure and composition.
Due to the multiple possible configurations and compositions of cell membranes, life can flourish
almost everywhere on Earth. For example, S. acidocaldarius can live in a hot and acidic
environment such as the Emerald Hot Springs in Yellowstone National Park. These extremophiles
must put on a unique coat in order to survive in such extreme conditions. Interestingly, the unique
coat contains monolayer sn-1 ether-linkage lipids instead of bilayer sn-3 diester-linkage lipids,
which are usually dominant in the membranes of Bacteria and Eukarya and highly decorated by
other molecules on the outside. Among many molecules found in membranes, lipids are the most
crucial component that give membranes their unique attributes.

Phospholipids
In general, lipids are amphiphilic molecules that are insoluble in water. The chemical
diversity of lipids is archived in the LIPID MAPS® Structure Database (LMSD).26, 27 According to
the LMSD, there are eight classes: fatty acyls, glycerolipids, glycerophospholipids, sphingolipids,
sterol lipids, prenol lipids, saccharolipids, and polyketides. Among them, glycerophospholipids or
phospholipids are the foundation of membrane architecture. In addition to being the basic
building blocks of the membrane, lipids can also possess multiple functionalities, playing a critical
role in energy metabolism28, cell signaling29, and serving as a protein recruiting platform.30
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As described in Figure 2,31 phospholipids have hydrophilic head groups at the sn3 position of the
glycerol backbone, while the fatty acids are usually esterified at the sn1 and sn2 positions. As a
result, phospholipids are highly asymmetric and hydrophobic. Some common hydrophilic head
groups are choline, ethanolamine, or serine. The long tails are usually made of saturated and/or

Figure 2. Common head groups of glycerolphospholipid. Extracted from “Nelson, D. L., &
Cox, M. M. (2017). Lehninger principles of biochemistry (7th ed.). W. H. Freeman.

unsaturated fatty acids such as palmitic acid (16:0) or oleic acid (18:1n-9). Due to the multiple
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combinations of fatty acids and head groups, phospholipids are diverse. Since membrane
compositions are dynamic and complex32, researchers usually mimic the cell membrane using
synthetic phospholipids such as 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) in
biophysical studies. POPC belongs to phosphatidylcholines (PC) subclass, which was historically
called "Lecithin" (from "λεκιθος," "egg yolk") by Théodore Gobley.33, 34 POPC has a choline head
group, as shown in Figure 2; the tails of palmitic acid and oleic acid are esterified to the sn1 and
sn2 positions, respectively, on the glycerol backbone. Although the synthetic membrane is
mediocre compared to the cell membrane, it is more workable and predictable. Cell membrane
composition is extraordinarily complex and complicated due to the variety of its building blocks
and post-modifications.32 This leads to chemical diversity, which is impossible to replicate without
using the cell. Moreover, diversified chemical properties may come with unknown side effects that
interfere with the result intepretation.35 Thus, synthetic membranes replace cell membranes to
give researchers total control of the membrane composition and chemical properties.
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Figure 3. “Temperature dependence of liquid crystalline POPC bilayer thickness (black
circles represent DB, and green triangles represent 2DC) and lipid area (blue squares).
Data shown are from the analysis of ULV samples, while data denoted by the gray X
symbols (30 °C) are from the joint refinement of ULV and ORI samples.” Extracted from
N. Kučerka et al. / Biochimica et Biophysica Acta 1808 (2011) 2761–2771.

Structural characterizations of popular synthetic phospholipid membranes are presented
by Kučera et al. at different temperatures.36,

37

For example, at 30℃ POPC bilayers have a

thickness of 39.1±0.78 Å, while that of DMPC (1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine)
is 36.7±0.70 Å.37 Additionally, Figure 3 shows an anti-correlated dependence of bilayer thickness
and the area per lipid of POPC on temperature.37 These experimental parameters are the basis for
empirical force fields of common phospholipids in molecular dynamics simulations.
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When worlds collide with each other
Molecules such as water, essential nutrients, or drugs frequently interact with the cell
membrane. There is profound motivation by the pharmaceutical industry to characterize the
interactions between cell membranes and drugs. Within the self-assembly theme, let us introduce

Figure 4. Some clinical Camptothecin analogs.
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Camptothecin － a natural product that can self-assemble in solution. Figure 4 shows common
Camptothecin analogs that are in clinical trials.38

Camptothecin: From the bark of a "Happy Tree"
The story of the divine farmer Shennong (神農), who taught his people how to farm and use
herbal medicine, is well-known throughout Asia. Shennong had tasted many plants himself to
evaluate their qualities before he wrote the first Chinese pharmacopeia. Due to his love and
sacrifice for his people, he became a divine entity and was praised as the father of Traditional
Chinese Medicine (TCM). Although it is just a myth, the practice of TCM has flourished for
millennia. Thus, it is not a surprise that the bark of Camptotheca acuminate ("喜树," "Happy
tree") has been known as a medicinal plant for a long time in China.
In 1966, M. E. Wall and M. C. Wani officially registered Camptotheca acuminate as
Camptothecin (CPT), derived from the "Happy Tree" bark as a potent antitumor drug after

Figure 5. A schematic illustration of Camptothecin blocking the “cleavable complex” of
Topoisomerases I and DNA (TOP1-cc) in Replication or Transcription via “replication fork
collision” model.
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screening hundreds of natural products39. Extensive studies show that CPT increases ssDNA
(single-stranded DNA) by inhibiting human Topoisomerase I, an enzyme responsible for relaxing
the superhelical tension in DNA due to unwinding40-47, as shown in Figure 5. Such inhibition of
Topoisomerases I by CPT will ensure cell death during the S-phase of the cell cycle.43 Despite its
potential antitumor ability, CPT suffers from low solubility and bioavailability.48 Moreover,
unpredictable cytotoxicity, resulted from the pH changing, was of concern during clinical trials in
the 1970s.49 Thus, people have synthesized and used CPT derivatives to circumvent its drawbacks.
Topotecan (Hycamptin) and Irinotecan (Camptosar), as shown in Figure 4, are FDA-approved
and used in the U.S. for various cancer treatments. Clinical results of CPT analogs can be found
elsewhere.50 Despite its downsides, CPT remains a protagonist in drug development and research
because it is still superior to any clinical analogs.51 Besides using chemical modifications,
nanotechnology offers an alternative solution using self-assemblies as drug delivery systems such
as liposomes and micelles.52

Drug Delivery Systems
Unfortunately, according to the American Cancer Society,
cancer-related cases increase every year (Figure 6). Surgery
can extract visible benign tumors but fails to obliterate all of
them cellularly. Thus, we need a one-shot treatment that can
identify and annihilate all leftover tumorous cells. In the early
1900s, Paul Ehrlich envisioned the "Magic Bullet" and sparked
interest in Drug Delivery.53 Since then, innovative drug delivery
systems continue to grow exponentially.54
Figure 6. American Cancer
Usually, blood vessels are selectively permeable to small
Society: Global Cancer Facts &
Figures, Second Edition from molecules. However, the enhanced permeability and retention
Cancer.gov
(EPR) effect in cancerous cells causes hypervascularity and
imperfect

blood

vessel

formation

that

can

amass
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macromolecules in the bloodstream.55 Thanks to the EPR effect, macromolecular self-assembled
delivery systems are designed to identify such cancerous locations and increase the retention time
in the body. In 1995, one of the first self-assemblies approved by the FDA was the liposome, which
improves the delivery of Doxorubicin (Dox).56 Koshkina et al. also demonstrated that aerosol
liposome is an effective way to dispense CPT via the lungs.57 Robert Langer and his colleagues

Figure 7. “Analysis of macromolecular structure evolution in drug delivery. Nanomaterials have
had a key role in delivering active pharmaceutical agents to the diseased site. Here, we provide
a brief summary of the timeline, advantages and disadvantages of each category of nanocarriers,
ranging from early discoveries of phospholipids and linear polymers to branched and
hyperbranched macromolecules, hybrids thereof, drug-free macromolecules as therapeutics
themselves, and strategies to accelerate bench-to-bedside transition. CMC, critical micelle
concentration; PEG, poly(ethylene glycol).” Extracted from Kakkar, A., Traverso, G.,
Farokhzad, O. C., Weissleder, R. & Langer R. Evolution of macromolecular complexity in
drug delivery systems. Nat. Rev. Chem.1, 0063 (2017).
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wrote thorough reviews on self-assembled drug delivery systems.58-61 As shown in Figure 7,
polymer-based drug delivery systems can be based on various molecules such as linear polymers,
dendrimers, miktoarm polymers, and telodendrimers.60 Apart from directly killing cancer cells,
nanoparticle-based encapsulation poly(lactic-co-glycolic acid) (PLGA) can also stimulate T cells
or engage lymphocytes to non-inflamed tumors.62 Furthermore, porous poly(lactide-co-glycolide)
(PLG) scaffolds, implanted in mice, show strong recruitment and proliferation of dendritic cells.63
Another class of self-assembled drug delivery vehicles is peptide-based. The laboratory of
Samuel M. Stupp specializes in designing peptide amphiphiles (PAs) that can self-assemble into
long fibers.64-67 PAs can also self-assemble into various nanostructures, such as micelles, vesicles,
bilayers, nanotubes, and nanofilaments.68-70 In general, a PA consists of four functional chemical
components.67 The first component is the hydrophobic domain which can consist of acyl chains
of different lengths. The second component is the enhanced intermolecular hydrogen bonding
domain, such as a β-sheet forming peptide. Modifications of the chemical structure of the first
and second components vary the amphiphilicity of PAs and ultimately shift the nanostructure
shape of the PAs.65, 71 The third component is the hydrophilic domain, such as a charged peptide
sequence that is sensitive to pH and salt concentration.72 The fourth component is the antigenic
domain, consisting of epitopes to which specific cells bind. For instance, tetrapeptide RGDS are
commonly used as an epitope in PAs to stimulate cell adhesion.65,

73, 74

PAs are highly

compartmentalizable, with each domain tailored to accommodate a particular contribution to
either self-assembly or biological function; it is crucial to understand how each component works
individually and cooperatively. Emerging MD (molecular dynamics) simulation techniques, such
as all-atomistic (AA) or coarse-grained (CG) models, provide details in molecular structures and
interaction modes of PAs that are cumbersome to obtain experimentally. For example, Schatz
group simulate 144 PAs for 40 ns; the simulated results contradict the common assumption that
it is the electrostatics, and not the β-sheets,71, 72, 75 that govern the cylindrical nanofiber selfassembly.76 The group also extend their studies on the mechanism of PA self-assembly using
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Umbrella Sampling. The study again confirms the predominant solvent electrostatics as the main
driving force and suggests the two-step mechanism for the PA self-assembly. Moreover, one can

Figure 8. “Schematic illustration of the designed and synthesized drug amphiphiles (DAs) and
control molecules. (a) Self-assembled nanostructures containing the same drug fraction as
the individual DA. (b) Three key component parts of the drug amphiphiles studied in this
paper: the hydrophobic drug CPT, the Tau-β-sheet-forming peptide, and the buSS
biodegradable linker. (c) The synthesized CPT DAs with quantitative drug loadings of 23%,
31%, and 38%. (d) The two synthesized control molecules.” Extracted from J. Am. Chem.
Soc. 2013, 135, 2907−2910.

look through Manandhar et al. to have a more general view on the current state-of-art MD
simulation techniques and challenges in theoretical studies of PAs.77 For example, MD
simulations by Tsonchev et al. predict that cylindrical micelles are the most stable nanostructures
for PAs.78 Later, CG-based models simulated by Velichko and colleagues reveal that it is the
competition between the hydrophobic effect and hydrogen bonding that determines the final
shapes of the PAs.75
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Another subclass derived from the PAs is Drug-peptide Amphiphiles (DAs) developed by
the laboratory of Honggang Cui. These DAs resemble PAs in terms of sectionalization. As shown
in Figure 8, DAs have three sections.79 Instead of using hydrophobic acyl chains like PAs, the
DAs use the hydrophobic drug Camptothecin (CPT) as a functional hydrophobic replacement. The
drug is conjugated to a reducible linker (buSS),80 followed by a β-sheet forming peptide (AcCGVQIVYKK).81 This conjugation formula has shown an overall improvement, compared to drug
alone, in overcoming multidrug resistance, solubility, biodistribution, and pharmacokinetic
profiles.80, 82 It is recognized that the numbers of conjugated CPTs influence the drug efficacy and
the morphologies of the DAs. Cheetham et al. used circular dichroism (CD) and TEM imaging to
confirm that mCPTs, carrying one CPT, form long nanofilaments, while dCPT (2 CPTs) and qCPT
(4 CPTs) self-assemble into nanotubes.79 Moreover, cell viability assays show that dCPT is
superior to others in inhibiting cancer cell proliferation. A similar DA system named
“Tubustecans” also emphasizes the crucial role of CPT as the driving force of the self-assembling
process due to concrete aromatic stacking interactions.8 Theoretical works by Kang and colleagues
confirm the intrinsic 𝜋 − 𝜋 stacking of CPTs as the driving force of the self-assembly of these DAs.
By adjusting the Shinoda-DeVane-Klein (SDK) force field, usually used to simulate CG models of
surfactants83, 84, phospholipid bilayers85, and polymers, Kang et al. developed a CG model capable
of recapitulating some unique characterization of the DAs. The 𝜋 − 𝜋 stacking between CPT is well
preserved together with the clustering trend.86
Despite many successful specimens, the “Magic Bullet” of Paul Ehrlich is still nowhere to be
found. Thus, improving existing drug delivery systems or finding new ones are still the quests of
pharmaceutical research. This dissertation endeavors to use AA MD simulations with advanced
enhancing methods to confirm and extend our limited knowledge on DAs.
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Theoretical Framework
The Necessities of Classical Statistical Mechanics
Although quantum mechanics describes electronic configurations of atomic systems most
accurately, classical statistical mechanics is more practical and a better choice to describe manyparticle system. One should consult “Understanding Molecular Simulation: From
Algorithms to Applications” by Frenkel and Smit for more thorough insight.87 This
dissertation is not trying to explain all mathematical expressions, but to convey the fundamental
statistic mechanics that forms the foundations of molecular dynamics simulations.
To compute the probability of finding a thermal average of some observable 𝒜, at
temperature T, with energy ℰ! , one can use the following equation
'ℰ!

〈𝒜〉 =

∑! 𝑒 )" * ⟨𝑖|𝒜|𝑖⟩
∑+ 𝑒

'

ℰ#
)" *

[2.1.1],

where ⟨𝑖|𝒜|𝑖⟩ is the expected value of operator 𝒜 in quantum state 𝑖; 𝑘" is the Boltzmann’s
constant. Choosing 𝑖 and 𝑗 is arbitrary when the system only contains identical particles. There
are two steps to compute the thermal average 𝒜 as
1. We need to solve the Schrödinger equation for the system
2. Compute all expected values of ⟨𝑖|𝒜|𝑖⟩
Although the two steps are straightforward to “read,” the actual computation is unbearable
for many-body systems due to the mathematical complexity. Moreover, the astronomically large
%&

quantum states of 𝒜, 𝒪 810#$ ;, make them unrealistic to evaluate numerically. Nonetheless,
Classical Statistical Mechanics (CSM) offers an alternative way to compute [2.1.1. Before we can
understand how CSM intervenes, let us introduce the Hamiltonian operator =
ℋ , which is the sum
? and the potential energy operator 𝒰A, as
of kinetic energy operator 𝒦
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? =𝒦
? + 𝒰A
ℋ
=−

ℏ%
∆ + 𝒰(𝑟⃗),
2𝑚

where ℏ is the reduced Planck’s constant, m is the system's total mass and ∆ is the Laplace
operator.
? is unique because when applying to the position-space
The Hamiltonian operator ℋ
wavefunction 𝜓(𝑥, 𝑡), it will return the total energy of the system ℰ. Thus, for each quantum state
$ℰ!

? , at each quantum state 𝑖, 𝑒 &"' =
𝑖, we can calculate the corresponding energy ℰ! , by applying the ℋ
$ℋ

S𝑖T𝑒 &"' T𝑖U; because of that, we can rewrite Equation [2.1.1, as

〈𝒜〉 =

=

∑! V𝑖W𝑒 ',ℋ! 𝒜W𝑖X
∑+ V𝑗W𝑒 ',ℋ# W𝑗X
𝑇𝑟 𝑒 ',ℋ 𝒜
𝑇𝑟 𝑒 ',ℋ

,
#

where Tr is the operator's trace or the summations of all eigenvalues and 𝛽 = ) *. To be practical,
"

? =𝒦
? + 𝒰A, we can estimate
it is impossible to sum over all discrete states of the system. Since ℋ
𝑇𝑟 𝑒 ',ℋ as
𝑇𝑟 𝑒 ',ℋ ≈ 𝑇𝑟 𝑒 ',𝒦 𝑒 ',𝒰

[2.1.2].

Using the bra-ket notation, we can rewrite the Equation [2.1.2 by using the eigenvectors
of position operator, |𝓇⟩, and momentum operator, |𝓀⟩, as following
𝑇𝑟 𝑒 ',ℋ = ^

𝓇,𝓀

V𝓇W𝑒 ',𝒰 W𝑟X⟨𝓇|𝓀⟩V𝓀W𝑒 ',𝒦 W𝓀X⟨𝓀|𝓇⟩

[2.1.3].

The matrix elements in Equation [2.1.3 can be resolved as,
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3

V𝓀W𝑒

',𝒦

W𝓀X = exp b−𝛽 ^
!4#

𝑝!%
d
2𝑚!

V𝓇W𝑒 ',𝒰 W𝓇X = exp[−𝛽𝒰(𝑟 3 )]

,

where 𝑟 3 is a function of the coordinates of all N particles instead of an operator 𝒰A. For each ith
particle, 𝑝! = ℏ𝓀! is the function of momentum and 𝑚! is its mass. If its coordinates and momenta
define a particle in classical space or “phase space” with a volume V, we can write equation 2.1.3
as
𝑇𝑟 𝑒 ',ℋ ≈

1
𝑝!%
3
3
j
𝑑𝑝
𝑑𝑟
𝑒𝑥𝑝
l−𝛽
b^
+ 𝒰(𝑟 3 )dm
𝑁! 𝑉3
2𝑚!
!

≡𝒬

[2.1.4].

#

where ⟨𝓇|𝓀⟩⟨𝓀|𝓇⟩ = 5 ) , 𝑉 3 is the continuous volume in phase space, N! represents
indistinguisible particles in the system, d is the system's dimensionality since pN and rN are
functions of momentum and position which may have more than one independent variable.
#

Equation [2.1.4 defines the classical partition function 𝒬, and 𝜌tp7 , r 7 u = 𝒬 is the probability
density. Altogether, we can compute the probability density of finding the thermal average of the
observable 𝒜 as

〈𝒜〉 =

𝑝!%
+ 𝒰(𝑟 3 )yz 𝒜( 𝑝3 , 𝑟 3 )
∫ 𝑑𝑝3 𝑑𝑟 3 𝑒𝑥𝑝 w−𝛽 x∑! 2𝑚
!

𝑝!%
+ 𝒰(𝑟 3 )yz
∫ 𝑑𝑝3 𝑑𝑟 3 𝑒𝑥𝑝 w−𝛽 x∑! 2𝑚
!

[2.1.5].
Equation [2.1.5 is the most significant equation derived from the CSM. It provides an
alternative way to compute the energy at a particular state using observable quantities such as
position and momenta. Therefore, it is at the heart of all classical simulation methods of manybody systems.

Ergodicity: Ensembles vs. Time
18

Supposedly, Equation [2.1.5 means to shrink the complexity of computing 〈𝒜〉. Still, it is
not practical to calculate such an average over all discrete quantum states, 〈𝒜〉9:;9<=>9 . Thus, we
need to incorporate some assumptions that can again simplify the above. Borrowing from the
ideas of the Ergodicity hypothesis, one can achieve a more workable form of Equation [2.1.5.
Ergodicity, by definition, is a process in which a sizable sample can represent the whole thing. For
example, a big enough aquarium can roughly represent the ocean. We know that it is not identical,
but if the ocean does not have any different states than those of the aquarium, it is a good
approximation. To elucidate how using the ergodicity hypothesis can simplify Equation [2.1.5,
we need to define some terms:
1. A microscopic state is a state of the interested system, in which the state is
different atomistically or quantumly from other states.
2. The macroscopic state is usually the experimental observation.
3. An ensemble is an assembly of all possible microscopic states of collectively
identical systems in order to make macroscopic observations.
For example, a car goes from A to B. The road AB is not linear but highly tortuous. The
passengers only care about when they can get to B while the driver forces his/her eyes open so
he/she can patiently maneuver the car through the zigzag road. The “macroscopic state” of this
example is that they will get to B eventually, and the “microscopic state” is each combination of
wheel pedals that the driver must perform throughout the road. Now, for a more scientific
example, let’s compute the instantaneous density, in a fluid system, at a distance 𝑟 from the
particle 𝒾 over time 𝓉 as
𝜌! (𝑟) = 𝜌𝒾 (𝓇(𝑟), 𝑟 3 (𝒪), 𝑝3 (𝒪), 𝓉)

[2.2.1],

where 𝑟 N (𝒪) and 𝑝N (𝒪) are the initial position and momentum, respectively, of all N-particles in
the system, 𝓇(𝑟) The position function calculates the distance r from the particle 𝒾 to all (N-1)
particles.
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In MD simulation, 𝜌(𝑟) is estimated as the time-averaged }}}}}}
𝜌(𝑟), in a volume V, at a constant
energy E,
𝓉

}}}}}} = 𝑙𝑖𝑚 1 j 𝑑𝓉 C 𝜌𝒾 (𝑟̇ , 𝓉 C )
𝜌(𝑟)
𝓉→B 𝑡 𝒪

[2.2.2],

where 𝑟̇ denotes the time derivative of distance 𝑟. Note that when 𝓉 → ∞, 𝓇𝑁 (𝒪) and 𝓅𝑁 (𝒪) are
irrelevant to }}}}}}}
𝜌(𝓇). Thus, if we can average all 𝜌! (𝑟) over an infinite long trajectory of MD
}}}}}}}. As a result, from
simulations in constant N, V, E, hypothetically, they will converge to 𝜌(𝓇)
}}}}}}} as,
Equation [2.2.1 and [2.2.2, we can re-evaluate 𝜌(𝓇)
1 𝓉
∑𝒪 𝑙𝑖𝑚 ∫𝒪 𝑑𝓉 C 𝜌𝒾 (𝑟̇ , 𝑟 3 (𝒪), 𝑝3 (𝒪), 𝓉 C )
𝑡
𝓉→B
}}}}}}
𝜌(𝑟) =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛𝑠
→

∫F 𝑑𝑝3 𝑑𝑟 3 𝑓 (𝑟 3 (𝒪 ), 𝑝3 (𝒪 ))
𝛺 (𝑁, 𝑉, 𝐸 )

[2.2.3],

where f is an arbitrary function of the initial positions and momenta, Ω(N, V, E) is all the quantum
states in given N, V, E. So, Equation [2.2.3, which is a time-average denoted by a bar, can now
be rewritten using ensemble average notation 〈… … 〉35F as
𝓉

1
C
3
3
C
}}}}}}}
𝜌
G (𝑟) = 𝑙𝑖𝑚 j 𝑑𝓉 〈𝜌𝒾 (𝑟̇ , 𝑟 (𝒪), 𝑝 (𝒪), 𝓉 )〉35F
𝓉→B 𝑡 𝒪
[2.2.4].
The definition of time becomes obscure in the ensemble average of 𝜌𝒾 (𝑟) since there is a
“one-to-one correspondence between the initial phase-space coordinates of a system and those
that specify the state of the system at a later time 𝓉′ ”,87 we can simplify the time notation in
Equation [2.2.4 as
}}}}}}} = 〈𝜌𝒾 (𝓇)〉3,5,F
𝜌(𝓇)

[2.2.5].

Equation [2.2.5 assumes that there are two ways to compute the average function of
positions and momenta. While one method computes the time average using the MD simulation
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method, the other computes the ensemble average using the Monte Carlo method. In other words,
like the ergodic aquarium example, one can estimate an observable quantity of the aquarium by
looking at all the snapshots at the same time (ensemble average) or over time (time average).
Nonetheless, Equation [2.2.5 is merely an estimation to reduce the computational workload
since “ergodic systems” are rare to find in nature. The following section will focus on the role of
MD simulation as the principal methodology in this Dissertation for time averaging.

Molecular Dynamics Simulation: “A movie of life”

Figure 9. “Computational ‘microscopy’and its different levels of resolution.” Extracted from
Journal of cell science, 129(2), 257–268.
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Numerical simulations are indispensable in academia and industry to investigate many
experimentally challenging problems in many disciplines. For instance, 30 years after its first
prediction, the existence of superionic water ice is confirmed experimentally; it provides concrete
evidence for the presence of the subsurface ice under ultra-high temperature and pressure
conditions on Neptune, Uranus, and other icy giant exoplanets.88 Because there has not been a
perfect computational method yet, one must choose a suitable computational method to balance
the compromise between computational accuracy and efficiency. Figure 9 shows the multiple
levels of size and timescale in molecular simulations.89 For example, Edgar A. Engel et al. predicts
“74,963 ice structures,” using DFT calculations, proving novel insights into ice formation.90 On
the other hand, lower resolution models, such as coarse-grained models, allow researchers to
simulate large-scale events such as membrane fusion.91, 92 Juan R Perilla et al. review the progress
and necessity of using robust coarse-grained models in studying viruses, ribosomes, bioenergetic
systems.93 Molecular dynamics (MD) simulation offers time-averaged measurements which are
similar to those in experiments. Let’s look at the process of running MD simulation as stages in
life: conceiving, birth, first step, and growing up.

The Initial Configuration: “Conceiving a baby”
The first step in MD simulation generates an initial configuration analogous to the first stage
of life, conceiving a baby. As such, choosing the initial configuration is essential. Although
Equation [2.2.2 hypothesizes that the initial configurations will be irrelevant when the
simulating time is infinite, reasonable starting configurations reduce simulation time significantly
because the systems do not have to explore too many irrelevant phase spaces. Usually, in
biomolecular MD simulations, one uses crystalized structures as starting points. According to the
well-known protein data bank server, in 2019, there are 158,960 crystals derived from various
crystallographic methods.94 There are 141,570 deposits (~90%) from X-ray, 12,843 deposits
(~8%) from NMR, and the last ~2% are from other methods. Sometimes, it is hard to find a readyto-go crystal for complex biological systems, such as membrane proteins. Due to technical
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difficulties, there are only about 3,000 solved structures of membrane proteins, according to
https://blanco.biomol.uci.edu/mpstruc/. Thus, modeling, such as homology modelling95, 96, is
also a valuable tool to approximate the initial configurations based on user-defined templates. For
constructing non-biological specific geometry, such as interfaces of solvents, one can also use an
open-source tool called PACKMOL.97 Although choosing the initial configuration is essential;
they are nothing but structureless points defined in 3D Cartesian coordination. Thus, to start
simulations, we need to animate these points with something called “force fields.”

Molecular Force Field: “Giving birth to the baby”
As introduced, the initial configuration is a collection of points with Cartesian coordinates.
They are structureless and meaningless. Thus, we need to give them “living forces” to behave
similarly to natural atoms. In MD simulations, the “living forces” are the force fields that simplify
the electronic configurations of atoms. In other words, the quantum states of the atoms are
negligible to reduce the computational workload. As a result, atoms are defined as simply
particles. The parameters of a force field are derived from ab initio calculations and experimental
data to dictate the behaviors of the structureless points. Some popular force fields for
biomolecular systems are CHARMM98, AMBER99, and GROMOS.100
A force field usually has two principal terms to describe the molecular interactions of atoms.
Depending on each force field, the total potential energy, 𝑈IJIK> , can generally be expressed as
𝑈IJIK> = 𝑈"J:L9L + 𝑈3J:=J:L9L

[2.3.1].

For example, in CHARMM General Force Field (CGenFF)101, Equation [2.3.1 is written as
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𝑈IJIK> = ^ 𝑘= (𝑟 − 𝑟$ )% + ^ 𝑘M (𝜃 − 𝜃$ )%
=J:L;

K:N>9;

+

^

𝑘O (1 + 𝑐𝑜𝑠(𝑛𝜑! − 𝛿))

L!P9LQK>;

+

𝑘R (𝜙 − 𝜙$ )%

^
!<SQJS9Q;

+

%

^

𝑘T" t𝑟#,U − 𝑟#,U;$ u

TQ9W'"QKL>9W
X! X#

+ ∑! ∑+^! –YZ[

* Q!#

\!#

#%

+ 4𝜀!+ x™ Q š
!#

\!#

]

− ™ Q š y›
!#

[2.3.2],

where kb , k𝜃 , k a , k b , and k cd are the force constants for bond stretching, bending, dihedral angle,
improper angle, and Urey-Bradley 1,3-term. Moreover, 𝑟$ , 𝜃$ , ϕ$ , r1,3;0 are the equilibrium values
of bond stretching, bending, dihedral angle, improper angle, and Urey-Bradley 1,3-term,
respectively. 𝑛 and δ are the dihedral multiplicity and phase, respectively. Furthermore,
electrostatics and van der Waal interactions (vdW) also contribute to the total potential energy,
as 𝑈3J:=J:L9L , when two non-bonded atoms come together around the cut-off distance, 𝑟!+ .
Coulomb's law is used to calculate the electrostatics between two charged atoms, 𝑞! and 𝑞+ , with
𝜀$ is the electric constant of the solvent. The Lennard-Jones (LJ) 12-6 potentials effectively
approximate the vdW interactions with a repulsion term of 𝑟 '#% , and an attraction term of 𝑟 '] . 𝜀!+
is the well-depth, and 𝜎!+ is the collision diameter where the energy is zero. There are more choices
of the LJ potentials; however, 12-6 potential is a reasonable estimation, for general MD
simulations, with reasonable computational efficiency.
Equation [2.3.2 is just an estimation and cannot recapitulate all intermolecular forces.
Depending on the complexity of the systems, different force fields can produce inconsistent
results. For example, evaluating the energy profiles of 11 molecules, Markéta Paloncýová et al.
suggest CHARMM36 is suitable for hydrophilic molecules while the Slipid force field is more
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appropriate for complex systems.102 Huang and MacKerell review the benchmarks of popular
force fields for intrinsically disordered proteins.103 CHARMM36 is superior to CHARMM27 and
CHARM27r in reproducing experimental data for six lipids in a tensionless ensemble (NPT).104
Also, ff19SB with the 2D dihedral correctional map (CMAP) yields better results with the OPC
water model.105-107 Hence, the choice of force fields is crucial in assessing the qualities of the
simulated results.

Equation of Motion: “The first step of the baby”
Thanks to the force fields, the structureless points materialize themselves into particles with
atomic attributions such as molar masses and partial charges. Moreover, as described, the force
fields in MD simulations assume that the particles behave as in the ideal gas system; thus, using
classical Newton’s equation of motions substantially depicts the movements of the atoms.
Therefore, when atoms collide, the second law from the classical Newton’s laws of motions can
predict the total forces, 𝐹IJIK> , as
𝐹IJIK> = 𝑚𝑎⃗

[2.3.3],

where m is the total masses of the particles, and 𝑎⃗ are the accelerations. Base on the numbers of
atoms, this force calculation is the most time-consuming step. For example, if there are N atoms
in a system, one must compute

3(3'#)
%

paired distances to find the system’s total energy 𝑈jJIK> .

After all the paired distances are calculated, one can integrate Equation [2.3.3 and sum up the
values to calculate the total energy 𝑈jJIK> as
j 𝑚𝑎⃗ d𝑟¢¢¢¢⃗
𝑟3
3 = −𝑈IJIK> ( ¢¢¢¢⃗)

[2.3.4],

where 𝑟¢¢¢¢⃗
3 is the relative positions of the reference atom to others after an infinitesimal change of
time, 𝛿𝑡.108 Conventionally, the Verlet algorithm is involved in solving the above numerically.109,
110

Starting with the Taylor expansion of the coordinate 𝑟 of a particle, one can predict its

coordinates before and after an infinitesimal change of time Δt as
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𝑟(𝑡 + Δ𝑡) = 𝑟(𝑡) + 𝑣(𝑡)Δt +

𝑓(𝑡) % Δt U
Δt +
𝑟⃛ + 𝒪(Δ𝑡 Y )
2m
3!

𝑟(𝑡 − Δ𝑡) = 𝑟(𝑡) − 𝑣(𝑡)Δt +

𝑓(𝑡) % Δt U
Δt −
𝑟⃛ + 𝒪(Δ𝑡 Y )
2m
3!

,

where Δt is the timestep parameter in MD simulation, 𝑓(𝑡) is the force at time t, m is the mass, 𝑟⃛
is the third derivative of 𝑟. The sum of the above equations gives
𝑟(𝑡 + Δ𝑡) ≈ 2𝑟(𝑡) − 𝑟(𝑡 − Δ𝑡) +

𝑓(𝑡) %
Δ𝑡
𝑚

[2.3.5].

This approximation is called the Verlet algorithm that has an error that is of order Δ𝑡 Y . Note that
Equation [2.3.4 only involves the coordinate of the particle since the velocity (or acceleration)
can be derived as
𝑣(𝑡) =

𝑟(𝑡 + Δ𝑡) − 𝑟(𝑡 − Δ𝑡)
+ 𝒪(Δ𝑡 % )
2Δ𝑡

[2.3.6].

This approximation of velocity is accurate to order Δ𝑡 % . A shorter timestep yields better estimation
and more efficient because there is always a correction term in Equations [2.3.5 and [2.3.6. In
summary, new coordinates of particles are estimated from their initial coordinates after using the
Verlet algorithm to compute the potential energy based on their relative distances. Note that the
total energy must always be conserved.
Different MD packages use different forms of Verlet-like algorithms to achieve a better
estimation of coordinates and velocities. Among MD packages, GROMACS111, AMBER112, and
NAMD113 are popular in academia due to their low-cost, straightforward implementation and
flexible force field choice. Recently, their scalability is reasonably good for simulating large
systems such as biomolecular systems.93 With the help of CHARM++114, NAMD can also scale up
to more than 500,000 processing cores for the most extensive simulations. According to
ks.uiuc.edu, “NAMD, recipient of a 2002 Gordon Bell Award, a 2012 Sidney Fernbach Award,
and a 2020 Gordon Bell Prize, is a parallel molecular dynamics code designed for highperformance simulation of large biomolecular systems. Based on Charm++ parallel objects,
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NAMD scales to hundreds of cores for typical simulations and beyond 500,000 cores for the
largest simulations.” Computational power and coding development achieve outstanding results.
For example, NAMD 3.0 on the NVIDIA DGX-2 platform accomplishes microseconds per day
while simulating ApoA1 in water (92 224 atoms).113
Thanks to the MD method, the system is not a static picture anymore. Now the particles
know what their next coordinates are. The next step is to create a virtual environment using
thermostats and barostats, to mimic the experimental setup.

Environmental Mimicking:
Temperature and Thermostat:
In MD simulations, especially in biological systems, one usually wants to use specific
microcanonical ensembles, such as NPT or NVT, that can mimic a constant temperature (T),
pressure (P), or volume (V). In a simple all-atomistic system, the average kinetic energy is defined
as a square of momenta in 3-D space with (x, y, z) as
3

2〈𝒦〉 = 〈^
!4#

|𝑝! |%
〉
𝑚!

[2.3.7],

where 𝑝! , 𝑚! are momenta, and masses, respectively, of the i-th atom in N atoms, 𝑘" is the
Boltzmann’s constant. According to the equipartition theorem, which states that a quadratic term
contributes average energy of

#
%)"

per degree of freedom, for a system in 3-D space, the sum of all

momenta will contribute 3𝑁𝑘" 𝑇 energy to the kinetic energy. Thus, Equation [2.3.8 can be
rewritten as,
2〈𝒦〉 = 3𝑁𝑘" 𝑇

[2.3.8].

Meanwhile, we can define the instantaneous temperature at time t as
3

𝑇(𝑡) = ^
!4#

𝑚! (𝑣! )%
𝑘" 3𝑁k

[2.3.9],
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where 𝑚! , 𝑣! is the masses and velocities of the i-th atom in N atoms, 𝑘" is the Boltzmann’s
constant, 3𝑁k = 3(𝑁 − 1) is the degrees of freedom. Thus, one can derive a rescaling factor 𝜆 of
velocities at an advancing timestep 𝑡 + Δ𝑡 so that 𝑣! (𝑡 + Δ𝑡) = 𝜆𝑣! ,
3

3

!4#

!4#

1
2 𝑚! (𝜆𝑣! )% 1
2 𝑚! (𝑣! )%
∆𝑇 = ^
− ^
2
3 𝑘" 𝑁k
2
3 𝑘" 𝑁k
∆𝑇 = (𝜆% − 1) 𝑇(𝑡)
𝑇(𝑡 + Δ𝑡 )
𝜆=ª
𝑇(𝑡)

[2.3.10].

Equation [2.3.11 shows a convenient way to compute the new temperature from the
current temperature using the rescaling factor 𝜆. However, it is not corresponding to any physical
ensembles because the kinetic energy is just the average. Thus, it is imperative to use a better
thermostat that can recapitulate physical ensembles. Some of them are worth mentioning, such
as Andersen115, Berendsen116, Nosé-Hoover117, 118 thermostats.
Andersen and Berendsen thermostats are stochastic-based methods. In other words, such
methods rely on stochastic (random) collisions between the atoms in the system with the
imaginary particles in a “heat bath.” In thermodynamics, the thermal contacts of two entities will
result in thermal equilibrium between them. Thus, the Andersen algorithm will rescale the
velocities after random collisions using a thermal conductivity, 𝜆 * , to rescale the collision rate per
particle, 𝜈, with a probability ρ = 𝜈Δ𝑡 at each timestep Δ𝑡 as
+
1
𝜈 ∝ 𝜆* ª %
𝜌𝑁

[2.3.11].

This method is helpful in standard MD codes. However, the stochastic algorithms randomly
produce uncorrelated velocities over a long course of the simulation. In other words, timedependent properties cannot be sampled correctly with this method. As a result, a minor collision
rate 𝜈 already imposes little effects on the time correlation function119, and, of course, a high value
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of 𝜈 will result in an exponential decay of the velocity-time correlation function.120 For example,
the diffusion coefficient of the Lennard-Jones fluid shows low susceptibility to variations of 𝜈 with
the Andersen thermostat.121 Additionally, the “flying ice cube” caused by the Berendsen
thermostat discourages such a method.122
Other kinds of thermostats are deterministic-based, such as the Nosé-Hoover thermostat117,
118.

Instead of random collisions, Nosé expresses additional degrees of freedoms or a thermal

reservoir, called 𝕤, in the Lagrangian of a N-particle system or the “extended system”:
3

𝔏3J;é = ^
!4!

𝑚! % %
𝑄
𝐿
𝕤 𝑟̇! − 𝒰(𝑟 3 ) + 𝕤̇ % − 𝑙𝑛 𝕤
2
2
𝛽

[2.3.12],

where mi is the mass of i-th atom, Q is an effective “mass”, which the dimensions of
S

𝑒𝑛𝑒𝑟𝑔𝑦 × 𝑡𝑖𝑚𝑒 % , that is associated to 𝕤, L is a constant, 𝒰(𝑟 3 ) is the potential energy, 𝑟̇! = m! with
,

𝑝! is the momenta. Moreover, the accent dot indicates the time derivative. If we use the momenta
conjugate to 𝑟𝑖 and 𝕤, we can rewrite the momenta function as
𝑝! ≡

𝜕𝔏
= 𝑚! 𝕤% 𝑟̇!%
𝜕𝑟̇!

𝑝𝕤 ≡

𝜕𝔏
= 𝑄𝕤̇ .
𝜕𝕤̇ !

Using the momenta function, as above, we can write the Hamiltonian of the “extend system”
with the additional degrees of freedoms 𝕤 as
3

ℋ3J;é = ^
!4!

𝑝!%
𝑝𝕤% 𝐿
3)
+
𝒰(𝑟
+
− 𝑙𝑛 𝕤
2𝑚! 𝕤%
2𝑄 𝛽

[2.3.13]. 123

The magnitude of Q is the level of coupling between the existing system and the “extended
system.” The velocity of the extended system is given by vp = 𝕤

qr,
qj

and the timestep 𝛿𝑡 is also scaled

by 𝕤. Thus, MD simulations with Nosé-Hoover thermostat will suffer a slow time scaling due to
converting “extended system” positions and momenta back to physical r and p.
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Pressure and barostat:
As crucial as constant temperature, biomolecular MD simulations also need constant
pressure since the isobaric-isothermal condition is an ideal experimental environment. In the 17th
century, Boyle’s law predicted that the pressure and volume are indirectly proportional in a
constant temperature container. Thus, P, by the fluctuation of the volume of an isothermal system
at temperature T, can control the simulating pressure. The fluctuation of the volume is the
isothermal compressibility 𝜅, which is also the mean square volume displacement:
1 𝜕𝑉
1 〈𝑉 % 〉 − 〈𝑉〉%
𝜅=− ™ š =
〈𝑉 % 〉
𝑉 𝜕𝑃 * 𝑘" 𝑇

[2.3.14].

Similarly, controlling pressure can also achieve by coupling the MD system to a “bath” that
can rescale the pressure at time t,
𝑑𝑃(𝑡) 1
= t𝑃=KIP − 𝑃(𝑡)u
𝑑𝑡
𝜏S

[2.3.15],

where τs is the coupling constant, Ptujv is the pressure of the “bath,” P(t) is the instantaneous
pressure at time t, and the volume of the simulation box is also rescaled, after each timestep Δ𝑡,
xI

by a factor of λw = 1 − κ y tPtujv − P(t)u.
-

Another scheme of barostat is developed by Martyna et al.124, where the modified momenta
and position functions are written as
𝑟̇! =

𝑝! 𝑝z
+ 𝑟
𝑚! 𝒲 !

𝑝{#
𝑑 𝑝z
𝑝̇ ! = 𝐹! − ™1 +
𝑝
š 𝑝! −
𝑑𝑁 𝒲
𝑄# !

[2.3.16],

where N is the number of particles, 𝑝! is the momenta, mp is the masses. 𝑝z and 𝒲 are the
associated momenta and mass to 𝜖, which is the logarithm function of the volume
fluctuation, lnt𝑉(𝑡) − 𝑉(𝒪)u, from time t ® 𝒪.

S./
|/

is derived from the Nose-Hoover chain
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algorithm with 𝜉 is the thermodynamic friction. From Equation [2.3.17, one can derive the
volume 𝒱 in d-dimension as,
𝑑𝒱𝑝z
𝒲

𝒱̇ =

3

1
𝑝! % 𝑝{#
𝑝ż = 𝑑𝒱(𝑃!:I − 𝑃9}I ) + ^
−
𝑝
𝑁
𝑚! 𝑄# z

[2.3.17],

!4#

where 𝒱̇ and 𝑝ż are the time derivatives of box volume and the momenta of 𝜖 = lnt𝑉(𝑡) − 𝑉(𝒪)u,
𝒲 is the associated mass of 𝜖. Pp~j and P•€j are the internal (calculated from the simulation) and
external pressure (desired pressure). The Pp~j can be calculated as
3

𝑃!:I

1
𝑝! %
𝜕𝒰(𝒱)
=
b^ –
+ 𝑟! ∙ 𝐹! › − 𝑑𝒱
d
𝑑𝒱
𝑚!
𝜕𝒱

[2.3.18],

!4#

where 𝒰 is the potential. Finally, the Hamiltonian equation of the system can be modified as
•

ℋ3w*

𝑝{
𝑝z%
= ℋ(𝑝, 𝑟) +
+ ^ & + (𝑑𝑁 + 1)𝑘" 𝑇𝜉#
𝒲
𝑄)
)4#

•

+ 𝑘" 𝑇 ^ 𝜉) + 𝑃9}I 𝒱
)4#

[2.3.19].

In terms of applications, MD simulations of the cell membrane require a special barostat to
control the pressure anisotropically because the cell membrane experiences fluctuations that
variate the lateral or normal pressure profiles. Therefore, a barostat that can only control the
pressure isotropically is not an ideal approach. Membrane MD simulations require anisotropic or
a semi-isotropic barostat, such as the Langevin piston method in extended systems of Feller et
al.125, which can partially couple the pressures in different schemes as shown in Figure 10.126
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Figure 10. (a) Isotropic pressure with Px, Py, Pz are coupled prevent any surface area
fluctuation. (b) Semi-isotropic pressure with independent Pz results in small morphological
fluctuation. (c) With Px, Py, Pz are uncoupled to each other, large deformities may happen.
Extracted from Methods (San Diego, Calif.), 41(4), 475–488.

Free Energy Calculations
Perturbation Theory
The free energy profile or the potential of mean force (PMF) is always of interest to
biophysicists. It materializes a chemical process in a more visual way which is easier to interpret
and analyze. In other words, the PMF is the energetic profile along a reaction coordinate. For
example, biochemistry textbooks always use the PMF to describe ligand-enzyme binding with
activation energy as the main barrier. It will be more convenient to explain such a complicated
process when one has no clue about its physical appearance. However, calculating such a PMF
profile is a nontrivial task. One of the earliest methods to estimate the PMF is the Free Energy
Perturbation (FEP) Theory.127-130
In a system with constant P, and V the Helmholtz free energy ℱ is expressed, in term of
partition function 𝒬, as
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ℱ = −𝛽 '# 𝑙𝑛 𝒬(𝑁, 𝑉, 𝑇)
where 𝛽 = )

#
"*

[2.4.1],

with temperature T and 𝑘" is the Boltzmann’s constant. Thus, we can extrapolate

the absolute value of ℱ based on the estimation of 𝒬. However, such estimation is far from
practical in this state, and thus, one usually wants to find the Helmholtz free energy differences
∆ℱ. If the system can exist in states 0 and 1, their corresponding free energy can be estimated by
𝒬$ and 𝒬# , respectively. Therefore, the meaningful ∆ℱ will be expressed as,
ℱ# − ℱ$ = ∆ℱ = −𝛽 '# 𝑙𝑛
where 𝛽 =

#
)" *

𝒬#
𝒬$

[2.4.2],

with temperature T and 𝑘" is the Boltzmann’s constant. Since state 0, state 1, or

any “state” are microscopic states of the same system, thus any 𝒬: can be defined as an integral
over the volume, Γ𝑛 , in phase space accessible to that state 𝑛,
𝒬: =

1
j 𝑒 ', ℋ(},S0 ) 𝑑𝑥 𝑑𝑝}
𝑁! ℎU3 „1

where N is the number of particles, ℎ is the Plank’s constant, 𝛽 = )

[2.4.3],
#
"*

with temperature 𝑇 and 𝑘"

is the Boltzmann’s constant; ℋ is the Hamiltonian of the system and 𝑥, 𝑝} are the functions of
positions and momenta, respectively. Combining Equation [2.4.2 and [2.4.3, one can calculate
the energy difference ∆ℱ alternatively as
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1 ∬ exp[−𝛽 ℋ# (𝑥, 𝑝} )] 𝑑𝑥 𝑑𝑝}
∆ℱ = − 𝑙𝑛
𝛽 ∬ exp[−𝛽 ℋ$ (𝑥, 𝑝} )] 𝑑𝑥 𝑑𝑝}
1 ∬ 𝑒𝑥𝑝Ê−𝛽t ∆ℋ(𝑥, 𝑝} ) + ℋ$ (𝑥, 𝑝} )uË 𝑑𝑥 𝑑𝑝}
= − 𝑙𝑛
𝛽
∬ exp[−𝛽 ℋ$ (𝑥, 𝑝} )] 𝑑𝑥 𝑑𝑝}
1 ∬ 𝑒𝑥𝑝[−𝛽 ∆ℋ(𝑥, 𝑝} )] exp [−𝛽ℋ$ (𝑥, 𝑝} )] 𝑑𝑥 𝑑𝑝}
= − 𝑙𝑛
𝛽
∬ 𝑒𝑥𝑝[−𝛽 ℋ$ (𝑥, 𝑝} )] 𝑑𝑥 𝑑𝑝}
1
= − 𝑙𝑛 Ì 𝑒𝑥𝑝[−𝛽 ∆ℋ(𝑥, 𝑝} )] 𝒫$ (𝑥, 𝑝} ) 𝑑𝑥 𝑑𝑝}
𝛽
1
= − 𝑙𝑛〈𝑒𝑥𝑝 [−𝛽 ∆ℋ(𝑥, 𝑝} )]〉$
𝛽
where 𝒫$ (𝑥, 𝑝} ) =

•€s ℋ* (},S0 )
∬ 9}S[', ℋ* (},S0 )] L} LS0

[2.4.4],131
is the probability density function of finding the system

at the state with the positions and momenta of the particles. Note that the 〈… 〉$ indicates an
ensemble average, and thus the Equation [2.4.4 states that one can estimate ∆ℱ from sampling
only equilibrium configurations of state "0", or any reference state. Moreover, this is the essence
of the FEP method. Numerical solving Equation [2.4.4 will return the difference in the potential
#

energy between the predicted state and the reference state of the system as − , ln〈𝑒𝑥𝑝 [−𝛽 ∆𝒰]〉$ .
However, the reliability of the estimation of ∆ℱ is always a challenge because 𝒫$ (𝑥, 𝑝} ) is
not the only-and-one factor that solely influences the ∆ℱ. There are “regions” in the phase space
accessible to the system that contributes significantly to the ∆ℱ, but yield lowkey probability.
Thus, these “regions” are usually not sampled adequately to show off on the free energy profile.
As shown above, the predicted state is a different equilibrium configuration of the reference state.
Thus, the overlapped “regions” between the reference and the predicted state significantly impact
the accuracy of ∆ℱ estimation. There are four cases of overlay that might happen. Figure 11 is a
pictorial explanation for those four cases131. In Figure 11 a, the “regions” in state 0 and 1 are
distinguishable, and this is the worst scenario for ∆ℱ estimation because P1 and P0 are almost
coming from “different systems.” In the second case, Figure 11 b, we achieve an ideal overlay of
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Figure 11. “Schematic representation of the different relationships between the important regions
in phase space for the reference (0) and the target (1) systems, and their possible interpretation in
terms of probability distributions – it should be clarified that because ΔU can be distributed in a
number of different ways, there is no obvious one-to-one relation between P0(ΔU), or P1(ΔU), and
the actual level of overlap of the ensembles. (a) The two important regions do not overlap. (b) The
important region of the target system is a subset of the important region of the reference system.
(c) The important region of the reference system overlaps with only a part of the important region
of the target state. Then enhanced sampling techniques of stratification or importance sampling that
require the introduction of an intermediate ensemble should be employed (d).” Extracted from
“Free Energy Calculations” Chipot, Christophe, Pohorille, Andrew (2007).

“regions,” which results in an accurate value of ∆ℱ estimation. In the last two cases, Figure 11 c
and d, there is only a partial overlay of the two “regions” from state 0 and state 1, which happen
more often in practice, leaving out unsampled “regions” be significant to the ∆ℱ estimation. Thus,
we usually employ an enhanced sampling method to bridge the gap between “regions,” which
gains noticeable results such as Thermodynamic Integration (TI), Adaptive Biasing Force (ABF),
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and Metadynamics (METAD). Before we can go into the mathematic formalism of each present
technique, we must define a term that most of the free energy techniques revolve themself around:
collective variables or reaction coordinates.

Collective Variables
Conventional MD simulations often miss out on the high energetic areas, which usually
correspond to unstable transitional states. It is because of those energetic states that shuttle our
system to sample in another state. Thus, the free energy method is essential to facilitate the
exploration of those states. Thus, it is essential to distinguish discrete states to know if a new state
is discovered. One way to reduce the dimensionality of a complex system is using the collective
variable.
Collective variables are variables that describe a system's order at a given time using atomic
positions. Sometimes, they are called reaction coordinates 𝜉. For example, the distance between
two groups of atoms, measured from the center of masses, can be a reaction coordinate to justify
the difference between two discrete states from those two groups. Moreover, 𝜉 can be more
elaborated, such as the coordination number, dihedral angles, radial distribution function,
torsional angles. Ideally, we want to choose 𝜉 so that it can represent the progress of a chemical
reaction. A wrong choice of 𝜉 can result in slow to no convergence in PMF. While the importance
of choosing 𝜉 is indisputable, there is no rules to dictate such discretion; it instead relies on
chemical intuition and luck. Some recent works develop machine-learning models to identify
reasonable 𝜉.132-135 However, a systematical methodology to pinpoint 𝜉 is still underway.

Thermodynamic Integration
Mathematical Formalism
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As mentioned, enhanced sampling methods are artificial ways to improve the overlay of
high-energy-and-low-probability “regions” between the reference and predicted state of the
system. Amongst them, TI is the oldest and easiest method to increase the degrees of overlays.
Before going to the formalism of TI, let revisit a general PMF example131 in Figure 12 where 𝜉 is

Figure 12.An example of the potential of mean force (PMF) along the reaction coordinate 𝝃. Here,
there PMF is disjoint into multiple subintervals that corresponds to significant phenomena during
a chemical process with respect to 𝝃.

a reaction coordinate and y-axis is the free energy that changes along 𝜉. As shown in Figure 12,
the ideal chosen 𝜉 should be sensitive to the progress of the chemical reaction in such a way that
it can capture “momentous phenomena” during the chemical progress. For example, meta-stable
A and B are the energetically favorable configurations that correspond to some meaningful states
of the system, and one wishes to know about the free energy difference between state A and state
B. In other words, one must interpolate the most likely pathway on the PMF profile that can go to
B from A. A popular method is TI.
Assumingly, the potential energy 𝒰 of states A and B are 𝒰(A) and 𝒰(B), respectively.
Additionally, there is also a coupling parameter 𝜆 = (0,1) which can represent both 𝒰(A) and 𝒰(B)
as following123
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𝒰(𝜆) = (1 − 𝜆)𝒰(𝐴) + 𝜆𝒰(𝐵)

[2.4.5].

Then, the partition function 𝒬(𝑁, 𝑉, 𝑇, 𝜆) can be used to calculate the Helmholtz free energy
ℱ as a function of 𝜆,
ℱ(𝜆) = −𝛽 '# 𝑙𝑛 𝒬(𝑁, 𝑉, 𝑇, 𝜆)

[2.4.6].

Thus, the partial derivatives of ℱ(𝜆) over 𝜆 can be written as,
™

𝜕ℱ
𝜕 𝑙𝑛 𝒬(𝑁, 𝑉, 𝑇, 𝜆)
= −𝛽 '#
š
𝜕𝜆 3,5,*
𝜕𝜆
=

1
𝜕𝒬(𝑁, 𝑉, 𝑇, 𝜆)
−𝛽𝒬 (𝑁, 𝑉, 𝑇, 𝜆)
𝜕𝜆

𝜕𝒰(𝜆)
∫ 𝑑𝑟 3 ™ 𝜕𝜆 š expt−𝛽𝒰(𝜆)u
=
∫ 𝑑𝑟 3 expt−𝛽𝒰(𝜆)u
=〈
where 〈

𝜕𝒰(𝜆)
〉
𝜕𝜆 ˆ

[2.4.7],

‰𝒰(ˆ)
‰ˆ

〉ˆ is an average ensemble of the system that can be calculated using MD simulation

or other numerical methods. From Equation [2.4.7], we can now calculate the difference of free
energy ∆ℱ from state A to state B with the following integration,
∆ℱ = ℱ(𝐵) − ℱ(𝐴) = ℱ(𝜆 → 1) − ℱ(𝜆 → 0)
#
𝜕𝒰(𝜆)
〉 𝑑𝜆
=j 〈
𝜕𝜆 ˆ
$

[2.4.8].

Equation [2.4.8]. is the mathematic formalism of the TI method, and it also indicates
that we can estimate the difference of free energy between state A and B using numerical methods,
‰𝒰(ˆ)

such as MD simulations, to calculate the average ensembles, 〈

‰ˆ

〉ˆ .

Moreover, if we can define a reasonable atomic-position-based reaction coordinate 𝜉 which
can differentiate between state A and B, then we should be able to recover the PMF profile along
𝜉 as,
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{"
𝑑𝒜
𝜕ℋ
〉 𝑑𝜉
™
š=j 〈
𝑑𝜉
𝜕𝜉 {
{2

where

L𝒜
L{

[2.4.9],

is the derivative of the free energy with respect to the reaction coordinate 𝜉; ℋ is the

Hamiltonian of the system.

The Derivative of Free Energy
From the Generalized Coordinates
To numerically estimate the derivatives of free energy as in Equation [2.4.9], we need to
solve partial derivatives by defining generalized coordinates of the form (𝜉, 𝑞# , … , 𝑞3'# ) for a Nparticle system. While q is a configuration of the system at its 𝜉, a set of (𝜉, 𝑞# , … , 𝑞3'# ) describes
the order parameters of the system with respect to 𝜉, and 𝜉 can be calculated from positions and
momenta of all particles. Thus, we can define the free energy 𝒜 as a function of 𝜉, which can be
related to 𝒜(𝜉) = −𝑘" 𝑇𝑙𝑛t𝑃(𝜉)u. Since 𝑃(𝜉) is the probability density function and can be derived
from the positions and momenta of all particles, 𝒜(𝜉) can re rewrite as integration in phase space
as
𝐴(𝜉) = −𝑘" 𝑇 j

𝑒 ',ℋ
𝛿t𝜉 − 𝜉(𝑥)u 𝑑𝑥 𝑑𝑝}
𝑄

[2.4.10],

#

where −𝑘, 𝑇 = − , is the Boltzmann constant, Q is the partition function, and Dirac delta function
is a switching function that ensures the integration is only applied on all 𝑥 with the conditions of
𝜉(𝑥) = 𝜉. Assumed that the condition of 𝜉(𝑥) = 𝜉 is satisfied, the associated momenta from the
X
generalized coordination (𝜉, 𝑞# , … , 𝑞3'# ) are t𝑝{ , 𝑝#X , … , 𝑝3'#
u. Then, the Equation [2.4.10], can

be reduced to
𝐴(𝜉) = −𝑘" 𝑇 j

𝑒 ',ℋ X
X
X
𝑑# … 𝑑3'#
𝑑𝑝{ 𝑑𝑝3'#
𝑄

[2.4.11],
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X
where the generalized momenta t𝑝{ , 𝑝#X , … , 𝑝3'#
u can be defined using Lagrangian function

ℒ(𝑞, 𝑞̇ ). In mechanics, ℒ(𝑞, 𝑞̇ ) is simply the kinetic energy minus its potential energy. If there is an
arbitrary vector 𝔛 field so that 𝑞 = 𝑞(𝔛), 𝑞̇ can be written as
𝑞̇ ! = ^
+

𝜕𝑞!
𝑥̇ ≝ [𝒥'# (𝑞)𝑥̇ ]!
𝜕𝑥+ +

[2.4.12],

‰}

where 𝒥(𝑞) is the Jacobian matrix, [𝒥(𝑞)]!+ = ‰X ! . The accent dot is the time derivative function.
#

Now the kinetic energy can be expressed as
1
1
^ 𝑚! 𝑥̇ !% = 𝔛̇I ∙ 𝑀 ∙ 𝔛̇
2
2
!

1
= 𝑞̇ I ∙ [𝒥I (𝑞) 𝑀 𝒥(𝑞) ∙ 𝑞̇
2

[2.4.13],

where M is a diagonal matrix with 𝑀!! = 𝑚! , and 𝔛̇I and 𝒥I (𝑞) are the transposes of vector 𝔛̇ and
the Jacobian matrix, respectively. If we define by 𝑍 and 𝑀‹ the following matrices:
𝑍 ≝ 𝒥'# 𝑀'# (𝒥'# )I

[2.4.14]

𝑀‹ ≝ 𝑍 '#

[2.4.15],

where 𝑍{ is the first element in the matrix Z
𝑍{ = ^
!

1 𝜕𝜉 %
™ š .
𝑚! 𝜕𝑥!

After defining Z and 𝑀‹ , the generalized momenta 𝑝! can now be expressed as
𝑝! =

𝜕ℒ
𝜕 1 I '#
=
™ 𝑞̇ ∙ 𝑍 ∙ 𝑞̇ š = [𝑍 '# 𝑞̇ ]!
𝜕𝑞Œ̇
𝜕𝑞Œ̇ 2

While the Hamiltonian in generalized coordinates is defined as
1
ℋ(𝑞, 𝑝) = 𝑝I 𝑍 𝑝 + 𝑈(𝑞, 𝑝)
2
where q are configurations and p is generalized momenta, 𝑝I is the transpose of p, Z is defined in
equation 2.4.14. The equations of motion can now be derived as
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𝑑𝑞! 𝜕ℋ
=
= [𝑍 𝑝]!
𝑑𝑡
𝜕𝑝!
𝑑𝑝! 𝜕ℋ
1 𝜕𝑍
𝜕𝑈
=
= − 𝑝I
𝑝−
𝑑𝑡
𝜕𝑞!
2 𝜕𝑞!
𝜕𝑞!
After ascertaining the equations of motions using the generalized coordinates and
momenta, we can calculate the derivative of free energy with respect to a reaction coordinate
defined by generalized coordinates as
𝜕ℋ ',ℋ
X
𝑑𝑞# … 𝑑𝑞3'# 𝑑𝑝{ … 𝑑𝑝3'#
𝑑𝐴 ∫ 𝜕𝜉 𝑒
𝜕ℋ
〉
=
=〈
X
',ℋ
{
𝑑𝜉
𝜕𝜉 {
𝑑𝑞# … 𝑑𝑞3'# 𝑑𝑝 … 𝑑𝑝3'#
∫𝑒
=〈

𝜕𝑈
𝜕 ln|𝒥|
〉{
− 𝑘" 𝑇
𝜕𝜉
𝜕𝜉

[2.4.16],

where |𝒥| is the determinant of the Jacobian matrix. The angle bracket 〈… 〉{ indicates average
L•

ensembles with fixed 𝜉. The essence of Equation [2.4.16], is that it simplifies the L{ to physical
quantities that will be more comprehensible and practical to calculate, such as atomic positions.
In other words, solving

L•
L{

does not involve solving the Jacobian matrix with generalized

coordinates, which is more feasible with complex systems. For example, if 𝜉 is defined in 1DCartesian coordinates as 𝑥# , the Equation [2.4.16], will be rewritten as
−

𝑑𝐴
𝜕ℋ
𝜕𝑈
〉 }/ = − 〈
〉 = 〈𝐹# 〉}/
= −〈
𝑑𝑥#
𝜕𝑥#
𝜕𝑥# }/

[2.4.17],

where 𝐹# is the force exerted on 𝑥# . Since the angle bracket 〈𝐹# 〉}/ indicates an average value, the
L•

− L} is the “mean force” exercising on atomic positions, or 𝐴(𝑥# ) is the PMF profile of 𝑥# .
/

A More Practical Way
As mentioned in the previous section, to calculate

L•
L}/

need not explicitly define a set of

generalized coordinates. This section will discuss the convenience of defining the reaction
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coordinate 𝜉 with atomic positions instead of generalized coordinates. Given a vector field 𝑤 such
L•

that ∇𝜉 ∙ 𝑤 ≠ 0, L{ can be defined as136, 137
𝑑𝐴
𝑤
𝑤
〉
= 〈∇𝑈 ∙
− 𝑘" 𝑇 ∙
𝑑𝜉
𝑤 ∙ ∇𝜉
𝑤 ∙ ∇𝜉 {

[2.4.18],

where ∇ operator, which is the differential operator. Detailed proof can be found elsewhere.131
Now with 𝑤 = ∇𝜉, the Equation [2.4.18 can be elaborated as
𝑑𝐴
1
∇𝜉 ∙ 𝐻(𝜉) ∙ ∇𝜉
=〈
Û∇𝑈 ∙ ∇𝜉 − 𝑘" 𝑇 –∇% 𝜉 − 2
›Ý〉{
%
|∇𝜉|
|∇𝜉|%
𝑑𝜉

[2.4.19],

where 𝐻(𝜉) is the Hessian matrix of 𝜉 in such its element is defined as
𝐻(𝜉)!+ = ^
!

𝜕%𝜉
𝜕𝑥! 𝜕𝑥+

,

𝜕%𝜉
𝜕𝑥!%

.

and ∇% 𝜉 is the Laplacian of 𝜉 as
∇% 𝜉 = ^
!

If each elemental 𝑤! =

‰}!
‰{

, the condition ∇𝜉 ∙ 𝑤 ≠ 0 is satisfied
𝜕𝑥! 𝜕𝜉
=1
𝜕𝜉 𝜕𝑥!

∇𝜉 ∙ 𝑤 = ^
!

,

then the first part from Equation [2.4.18 is
∇𝑈 ∙

𝑤
𝜕𝑈 𝜕𝑥! 𝜕𝑈
=^
=
𝑤 ∙ ∇𝜉
𝜕𝑥! 𝜕𝜉
𝜕𝜉
!

and the

‰ Ž~|𝒥|
‰{

,

from Equation [2.4.16 is also equaled to

𝜕 ln|𝒥|
𝜕𝒥
= 𝑇𝑟 ™𝒥'#
š
𝜕𝜉
𝜕𝜉
=^
!+

𝜕𝑞! 𝜕 𝜕𝑥+
x y
𝜕𝑥+ 𝜕𝜉 𝜕𝑞!
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=^
!+

=^
+

𝜕𝑞! 𝜕 𝜕𝑥+
x y
𝜕𝑥+ 𝜕𝑞! 𝜕𝜉
𝜕 𝜕𝑥!
Þ ß
𝜕𝑥+ 𝜕𝜉

= ∇𝑤
.
With this, we prove that Equation [2.4.16 is identical to Equation [2.4.18 as
𝜕𝑈
𝜕 ln|𝒥|
𝑤
𝑤
− 𝑘" 𝑇
= ∇𝑈 ∙
− 𝑘" 𝑇 ∙
𝜕𝜉
𝜕𝜉
𝑤 ∙ ∇𝜉
𝑤 ∙ ∇𝜉

.

In other words, with a reasonable choice of elemental 𝑤! computing the derivative of free
energy without defining the generalized coordination of 𝜉 is superior to solving complicated
Jacobian matrices. This method of differentiation is the core of many free energy calculations.

Advantages and Limitations
The TI method is a great solution when the A－B path is not straightforward to interpret.
For example, a protein will go through an “energy funnel” with infinite configurations and
hopefully reach the final state, as shown in Figure 13. Moreover, some chaperones help folding
proteins to overcome high energy barriers. As a result, it is almost impossible to explore the A－
B path completely with conventional time-dependent MD simulations. Thus, the TI method can
boost the chance of visiting rare events along the A－B path. Moreover, this method can “split up”
the PMF profile into smaller regions or “windows” to increase accuracy and efficiency. In theory,
if one can find enough discrete states energetically closed to the interested states, the TI method
can reconstruct the PMF profile along with a chosen reaction coordinate 𝜉.
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For the TI to work as intended, we need to prioritize the system to make educated guesses
about these discrete states. However, we will miss those states that are not closed to equilibrium
because they may not resemble the equilibrium states. In other words, one must perform a series
of simulations with configurations at different reaction coordinate 𝜉 (expected to be closed to
‰ℱ

equilibrium) to obtain multiple values of 8 ‰ˆ ;

3,5,*

, so that the integration from equation 2.4.8 can

be estimated numerically and smoothly converged. Moreover, the reaction coordinate 𝜉 must be
fixed at the given state by an additional constraint force, which accidentally restraints the system
from exploring other potential pathways. This method is the “blue-moon method” developed by
Ciccotti and coworkers.136, 138, 139 Nonetheless, TI paves the way to develop more efficient methods
such as ABF.

Figure 13. Protein folding energy landscape illustrated as energy funnel. Higher positions on
the funnel indicate unstable conformations while the lower positions represent permanent
conformations of the protein. Extracted from https://jonlieffmd.com/blog/protein-foldingand-the-mind.

Adaptive Biasing Force (ABF)
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Mathematical Formalism
The TI method is one of the oldest methods to calculate the derivative of free energy.
Therefore, it requires more works to address its limitations. Many more upgraded versions of TI
are still underway. One apparent attempt is the adaptive biasing force (or ABF) algorithm.
Like any enhanced sampling techniques, the ABF method gives an external boost to the
system to overcome high activation energy and flatten the PMF curve to achieve diffusion-like
transformation between states. The ABF method calculates the PMF profile by adds an equal but
opposite force on the chosen 𝜉. By doing so, only the fluctuation of the instantaneous force on 𝜉
remains. It allows 𝜉 to be uninformedly sampled. Darve et al. derives a way to calculate the
derivative of free energy as
%

2𝑚{
𝑑𝐴
1 𝜕𝜉 𝜕𝜉 𝜕 % 𝜉
〉
= − 〈𝑚{ 𝜉̈ −
^
𝑑𝜉
𝛽
𝑚! 𝑚+ 𝜕𝑥! 𝜕𝑥+ 𝜕𝑥! 𝜕𝑥+

[2.4.20]140,

!+

141,

where 𝑚{ = 𝑍{'# , as defined in Equation [2.4.14 and Equation [2.4.15. However, since MD
simulations are time-dependent, equation 2.4.20 can be simplified to
𝒅𝑨
𝒅
𝒅𝝃
= − 〈 ™𝒎𝝃
š〉
𝒅𝝃
𝒅𝒕
𝒅𝒕 𝝃

[2.4.21].

Similarly, if 𝜉 = 𝑥# which is 1D-Cartesian coordinate, the Equation [2.4.20 can be reduced
to the mean force on 𝑥# as in Equation [2.4.17,
𝑑𝐴
𝑑
𝑑𝑥#
𝜕𝑈
〉
= − 〈 ™𝑚#
š 〉} / = 〈
𝑑𝑥#
𝑑𝑡
𝑑𝑡
𝜕𝑥# }/

[2.4.22].

Solving Equation [2.4.21 or [2.4.22 require numerical computation of time derivatives. At
half timestep 𝑡 +

xI
%

, the instantaneous force can be calculated as
t𝑚{ 𝜉̇ u(𝑡 + 𝑑𝑡) − t𝑚{ 𝜉̇ u(𝑡)
𝑑
𝑑ξ
+ 𝒪(𝑑𝑡 % )
™𝑚{ š =
𝑑𝑡
𝑑𝑡
𝑑𝑡

[2.4.23],
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where 𝑚{ 𝜉̇ = 𝑚{ ∇ξ ∙ v = 𝑚{ ∇ξ 𝑥̇ . The accent dot is the time derivative notation. The velocity v at
half-steps is defined with the same accuracy 𝒪(𝑑𝑡 % ) as
𝑣 ™𝑡 +

𝑑𝑡
𝑑𝑡
š ≝ 𝑣 ™𝑡 − š + 𝑑𝑡 𝑎(𝑡)
2
2

𝑥(𝑡 + 𝑑𝑡) = 𝑥(𝑡) + 𝑑𝑡 𝑣 ™𝑡 +
where 𝑎(𝑡) =

L3}
LI 3

𝑑𝑡
š
2

[2.4.24],

[2.4.25],

= −𝑀'# ∇𝑈, 𝑀 is a diagonal matrix with 𝑀!! = 𝑚! . Using the Verlet algorithm,

one can estimate 𝑣(𝑡) with accuracy 𝒪(𝑑𝑡 Y ):

𝑣(𝑡) =

𝑣 8𝑡 +

𝑑𝑡
𝑑𝑡
; + 𝑣 8𝑡 − ;
2
2
2
−

𝑑𝑡
t𝑎(𝑡 + 𝑑𝑡) − 𝑎(𝑡 − 𝑑𝑡) + 𝒪(𝑑𝑡 Y )u
12

[2.4.26],

where 𝑎 is the acceleration. With this Equation [2.4.26, one can now compute the estimation of
the time derivative at 𝑡 +

xI
%

as

t𝑚{ 𝜉̇ u(𝑡 + 𝑑𝑡) − t𝑚{ 𝜉̇ u(𝑡)
𝑑
𝑑𝜉
+ 𝒪(𝑑𝑡 U )
™𝑚{ š =
𝑑𝑡
𝑑𝑡
𝑑𝑡
=

𝑚{ (𝑡 + 𝑑𝑡) ∇ξ (𝑡 + 𝑑𝑡) ∙ 𝑣(𝑡 + 𝑑𝑡) − 𝑚{ (𝑡) ∇𝜉(𝑡) ∙ 𝑣(𝑡)
+ 𝒪(𝑑𝑡 U )
𝑑𝑡

“
“
'
1 𝒑{ (𝑡 + 𝑑𝑡 ) − 𝒑{ (𝑡) 𝒑'
{ (𝑡 + 𝑑𝑡) − 𝒑{ (𝑡)
= –
+
›
2
𝑑𝑡
𝑑𝑡

[2.4.27],

where
𝒑“
{ ≝ 𝑚{ (𝑡) ∇𝜉(𝑡) ∙ Þ𝑣(𝑡 + 𝑑𝑡) −

𝑑𝑡
𝑎(𝑡 + 𝑑𝑡)ß
6

𝒑'
{ ≝ 𝑚{ (𝑡) ∇𝜉(𝑡) ∙ Þ𝑣(𝑡 − 𝑑𝑡) −

𝑑𝑡
𝑎(𝑡 − 𝑑𝑡)ß
6

[2.4.28],
[2.4.29].

Again, 𝑚{ , ∇𝜉, 𝑎 can be extrapolated using only particle coordinates. To summarize, calculating
𝒅
𝒅𝒕

𝒅𝝃

8𝒎𝝃 𝒅𝒕; at half timestep advancing, the core of the ABF algorithm, requires information around

time t such as 𝑡 − Δ𝑡, 𝑡, 𝑡 + Δ𝑡, 𝑡 + 2Δ𝑡.
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Advantages and Limitations
Compared to the TI method, ABF is more efficient since the algorithm is adaptive. In other
words, the algorithm keeps updating the average acting force on the reaction coordinates so it can
have a better estimation of the force. As a result, the ABF yields uniformed sampling on the
reaction coordinate 𝜉 and achieves simple diffusion. One can calculate the running average of the
force acting on 𝜉 from collecting samples in bin 𝑘 after 𝑁 steps as
:& (3)

1
𝑑
𝑑𝜉
F{– (𝑁) = )
^
™𝑚{ š t𝑥>) u
𝑛 (𝑁)
𝑑𝑡
𝑑𝑡
>4#

[2.4.30],

where 𝑥>) is the sample 𝑙 in bin 𝑘. Thus, the biasing force is −F{– . When few samples are collected,
F{– (𝑁) cannot accurately estimate the

L•
L{

. Hence, significant fluctuation of F{– (𝑁) may lead to a

nonequilibrium effect and systematic bias of the calculation. Numerical analysis suggests that it
is the choice of 𝑁 that determines the quality of the results. Smaller 𝑁 will lead to a better sampling
of the system while large 𝑁 avoids the nonequilibrium effect. Fortunately, one can get away with
the nonequilibrium effect by a longer sampling time in a bin. Therefore, simulating at smaller 𝑁
with longer time provides good sampling along with the reaction coordinate 𝜉. Moreover, low
samples in a bin can be recovered by using good statistics in the surrounding bins.

Metadynamics
Mathematical Formalism
The TI method requires a careful choice of the reaction coordinate 𝜉, and it usually limits
the sampling on a broader range of configurations due to a fixed 𝜉. To sampling on a more coarsegrained reaction coordinate 𝜉, Laio and Parrinello et al. developed the Metadynamics technique
(METAD).142-144
METAD calculate the reaction coordinate 𝜉 following the steepest-descendent algorithm to
find the next possible value of 𝜉, which has lower free energy, as
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𝑑𝒜(𝜉)
𝜉:“# = 𝜉: − ℎΔ𝜉𝑠𝑖𝑔𝑛 –
›
𝑑𝜉
L𝒜({)

where 𝑠𝑖𝑔𝑛 8

L{

; = 1 if

L𝒜({)
L{

[2.4.31],

≥ 0, −1 otherwise; h is a fixed stepping parameter, Δ𝜉 is the

estimated width of the free energy well at the current 𝜉. The new calculated 𝜉 will corresponding
to the lower free energy state. Moreover, this method also employs Gaussian-like biasing force to
prevent the system from re-visiting sampled area,
|𝜉 − 𝜉) |%
𝒜(𝜉)=!K; = 𝒜(𝜉) + 𝜔(𝑘𝜏) ^ exp (
)
2𝜎 %
)—:

[2.4.32],

where 𝜔 is the Gaussian height, 𝑘𝜏 is the rate of adding biasing force, 𝜎 = ℎΔ𝜉 is the estimated
width of the free energy well. The Gaussian-formed biasing force was enhancing sampling over
rare events and prevented the system from revisiting sampled minima. For a standard METAD
run, 𝜔(𝑘𝜏), and 𝜎 must be defined before the run. After a while, the added Gaussian biasing
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Figure 14. “Upper panel: trajectory of a one-dimensional system evolved by a Langevin
equation on the three-minima potential represented in the lower panel. The dynamics is
biased with a metadynamics potential VG as defined by Eq. 2. The parameters are δs =
0.4, w = 0.3, and τG = 300. Middle panel: time evolution of the metadynamics bias
potential VG. Blue line, VG as when the first minimum is filled and the system escapes to
the second minimum; red line, VG as when also the second minimum is filled; orange
line, VG when the entire profile is filled and the dynamics becomes diffusive. Lower panel:
time evolution of the sum of the metadynamics potential VG and of the external potential,
represented as a thick black line.” Extracted from Alessandro Laio and Francesco L
Gervasio 2008 Rep. Prog. Phys. 71 126601.

potential will fill up the current free energy well. At this point, the system will transform to another
minimum, and the process will repeat until all minima are filled. The total added Gaussian biasing
force for each energy well is a negative image of the well. Thus, if we can sample the system for a
long time, we can reconstruct the free energy wells from their negative images as
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|𝜉 − 𝜉) |%
lim b𝜔(𝑘𝜏) ^ exp –
›d = 𝒜(𝜉)
I→B
2𝜎 %
)—:

[2.4.33].

An illustration of the METAD algorithm is shown as in Figure 14. As more Gaussians
being added on 𝜉, the system can explore more hidden regions and ultimately achieve uniform
sampling. In the lower panel, the time evolution of the bias force 𝒜(𝜉)=!K; explore the basins as
more Gaussians being added. After 120 Gaussians, the third basin is sampled.

Advantages and Limitations
While this is still far from being a perfect free energy technique, METAD is still suitable for
sampling coarse-grained reaction coordinates without prior knowledge from the system. It is also
an effective way to sample high-dimensional reaction coordinates. According to Laio et al., the
accuracy of METAD heavily depends on the chosen parameters of 𝜔, 𝑘𝜏, 𝜎.145 The paper also
suggests optimum choices of those parameters so the accuracy of METAD can be estimate prior
to the run.

PLUMED
Free Energy methodology is undoubtedly an essential tool in MD simulation to explore rare
events that are unpractical to simulate in conventional MD simulations. Each MD package has its
way of implementation in its source code. Some are more usable than others. For example, the
NAMD package has an extensive collective variable (CV) (colvar) library, written in C++, that
offers flexible designs of reaction coordinates. For instance, Jeffrey Comer et al. explore the
hidden regions on the reversible folding pathway of a short peptide by the novel multiple-walker
Meanwhile, AMBEM’s colvar module is not as flexible as NAMD’s. Given the benefits of using
enhanced sampling in MD simulations, it is urgent to develop an additional code coupled to
popular MD engines such as “ACEMD, Amber, DL_POLY, GROMACS, LAMMPS, NAMD,
OpenMM, DFTB+, ABIN, CP2K, i-PI, PINY-MD, and Quantum Espresso.” In 2009, PLUMED was
introduced to the MD simulation community as a C++-based module that provides a flexible way
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to compose complicated or complex reaction coordinates in enhanced sampling. Following its
welcome from the ever-growing community, PLUMED 2.0 is a “complete rewrite” of the old code
introducing “greater flexibility and greater modularity”; it expands the usability of implementing
new CVs or methods.135, 146-149 Many successful demonstrations use PLUMED in biomolecular
simulations, such as amino synthesis150, protein conformation151-153, ligand binding154, 155, helicase
unwinding156, and polymers157, water134, 158, crystals159, 160 simulations. Those publications indicate
PLUMED is a highly adaptable package that aids or develops current free energy methods to yield
more reliable results with less computing time.
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The Interaction of Camptothecin with Model
Cellular Membranes
Modified from “Tang, P. K.; Chakraborty, K.; Hu, W.; Kang, M.; Loverde, S. M., Interaction
of Camptothecin with Model Cellular Membranes. Journal of Chemical Theory and Computation
2020, 16 (5), 3373-3384.”

Abstract

Accurate and efficient prediction of drug partitioning in model membranes is of significant
interest to the pharmaceutical industry. Herein we utilize advanced sampling methods, precisely,
the Adaptive Biasing Force methodology to calculate the potential of mean force for a model
hydrophobic anti-cancer drug, Camptothecin (CPT), across three model interfaces. We consider
an octanol bilayer, a thick octanol/water interface, and a model 1-palmitoyl-2-oleoyl-sn-glycerol3-phosphocholine (POPC)/water interface.

We characterize the enthalpic and entropic

contributions of the drug to the potential of mean force. We show that the rotational entropy of
the drug is inversely related to the probability of hydrogen bond formation of the drug with the
POPC membrane. Also, in long-time microsecond simulations of a high concentration of CPT
above the POPC membrane, we show that strong drug-drug aromatic interactions shift the spatial

52

orientation of the drug with the membrane. Stacks of hydrophobic drugs form, allowing
penetration of the drug just under the POPC head groups. These results imply that
inhomogeneous membrane models need to consider the effect of drug aggregation on the
membrane environment.

Background
Biopharmaceutical investments cost about $90 billion, surpassing other industrial
investments in 2016161. However, Phase I162, II163, and III164 trials are mostly inadequate due to
poor bioavailability and the efficacy of current R&D models.165 Knowing how to fine-tune the
permeability of small compounds across the membrane is of significant interest to the
pharmaceutical industry. Over one century ago, Overton’s rule166 first established a quantitative
relationship between membrane permeability and the partition coefficient of small compounds.
Using the 1-octanol (octanol) partition coefficient in pharmacology is an efficient means to predict
the permeability of hundreds of small molecular compounds quickly. Indeed, this becomes a daily
routine in most drug discovery labs. Quantitative structure-property relationship (QSPR)
models167 and quantitative structure-activity relationship (QSAR) models168 have also proved
their potential as quantitative methods to assess the permeability of small molecules based on
their physicochemical properties such as oral bioavailability169, intestinal absorption170, as well as
ability to cross the blood-brain barrier171. Notably, there has been an increasing interest in the
computational chemistry field to harness the power of statistical methods such as machine
learning approaches to predict small drug permeability in membranes172-174.
At the most superficial level, a membrane can be considered a homogenous slab, where the
permeability of a solute through the membrane is inversely proportional to the thickness of the
membrane. The membrane permeability, P, can be expressed in terms of the bulk properties such
that 𝑃 =

˜™
%š

where D is the diffusion coefficient of the solute in the membrane, K,

membrane/water partition coefficient, and 2L is the thickness of the membrane.175, 176 However,
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the solute, or drug, can possess multiple degrees of freedom. The effect of the drug configuration
on the free energy profile across a membrane interface can be explored with advanced sampling
methods in molecular dynamics.177 Likewise, the solubility-diﬀusion model can be expanded in
terms of the translational and rotational degrees of freedom of the solute.175, 178 Furthermore,
inhomogeneous membrane models that consider various phospholipid compositions in realistic
membranes must also be considered.179-181
With the increase in current state-of-art computational power, molecular dynamics (MD)
simulations offer a powerful tool to probe the multitudes of length-scales86, 182, and time-scales183185,

especially in biological phenomena such as membrane permeability and transport across

membrane interfaces. Enhanced sampling methods in molecular dynamics offer emerging and
powerful tools to probe the membrane permeability of small molecular compounds177,

186-191.

Several enhanced sampling methods that characterize the free energy profile across the
membrane interface are thermodynamic integration128,

192,

metadynamics143,

193-195,

umbrella

sampling196, and the adaptive biasing forces (ABF) method190, 197-200. In the ABF method, an onthe-fly force to counter the internal system force is continuously updated, requiring no prior
knowledge of the free energy profile.
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Camptothecin39 (CPT), a model hydrophobic anti-cancer drug, is a Topoisomerase I
inhibitor201, 202. CPT possesses a planar pentacyclic ring structure. A molecular diagram of CPT is
shown in Figure 15.

12.99

C

C16

O2

N
3.07

11.69

O

Figure 15. Diagram of CPT showing pKa of hydroxyl oxygen. The C16-O2 29
vector is used to calculate the CPT vector.
Notably, the pKa of the hydroxyl oxygen is 11.69; thus, the hydroxyl oxygen will remain
deprotonated across the interfaces unless there are significant shifts in the pKa value203. A unique
property of CPT is that it is known to self-assemble in solution into filamentous assemblies204, 205.
Herein, we characterize in the free energy profile of this model hydrophobic anticancer drug, CPT,
across three model interfaces of varying thickness: an octanol bilayer/water interface (~ 20 Å)
(Interface I), a thick octanol slab/water interface (~ 80 Å) (Interface II), and a model phospholipid
bilayer

membrane

composed

by

1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine

(POPC)/water interface (~ 40 Å) (Interface III). Together with hydrogen bonds, the rotational
angle of the drug, and drug enthalpy, we characterize this model hydrophobic drug interaction
with these three model interfaces using advanced sampling methods, precisely the ABF method.
Moreover, based on the Schlitter method206-208, we also characterize the rotational entropy
of the drug across each model interface. The Schlitter method estimates the upper value of
configurational entropy by diagonalizing the covariance matrix of the Cartesian positional
fluctuations of atoms obtained from MD simulation. Here we apply a modified version of this
method, described in further detail in the methods section, to characterize the rotational entropy
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of the hydrophobic cancer drug, CPT. We next suggest that the strength of hydrogen bonding of
this model drug with a model phospholipid bilayer is inversely correlated with the rotational
entropy of the drug. Finally, we show that CPT can form strong aromatic interactions at high
concentrations above this model phospholipid bilayer. The strong aromatic interactions lead to
the formation of stacks of drugs above the membrane interface, modulating the interaction of the
drug with the phospholipid bilayer. This shift allows penetration of the drug just under the POPC
head groups. We suggest that this mechanism of membrane permeation may apply to other
hydrophobic compounds with strong aromatic interactions.

Methodology
Initial Configurations Set-up
Interface I: Bilayer of 1-octanol
A 20-Å bilayer of 1-octanol was preassembled using Packmol97, as shown in Figure 16.

Figure 16. (A) A snapshot of the octanol bilayer and CPT (Interface I). The oxygen atoms are
highlighted in red and the CPT is shown in magenta licorice representation. Waters are
transparent. (B) The electron density profile. The thickness of the octanol bilayer is 20 Å.
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The 1-octanol was parameterized using CHARMM36101, 104, 209, 210. The hydrophobic cancer
drug CPT was based on the General Automated Atomic Model Parameterization (GAAMP)
method developed by Huang and Roux211. This automated parameterization server optimizes
electrostatic potential and "soft" dihedrals (conformational changes) via quantum mechanical
results (as used in AMBER) and water interactions (as used in CHARMM). Overall, this system
contained 20,350 atoms, including 200 1-octanols, 4,954 TIP3P waters; and one CPT molecule
placed 35 Å above the center of mass (COM) of the octanol bilayer. An additional 150 mM NaCl
was added to the simulation box. The final box, after 40 ns of equilibration, was 56 Å × 56 Å × 65
Å.

Interface II: Bilayer of 1-octanol
A layer of 1-octanol with a thickness of 100 Å was preassembled using Packmol97. The 1octanol and the CPT parameters were the same as Interface I. Overall, this system contained
31,719 atoms, including 620 1-octanols and 4,963 TIP3P waters. We set up the initial
concentration of ~ 0.26 mol fraction of water; however, after ~ 80 ns, the system equilibrated
with a mol fraction of ~ 0.23. The system reached stable dimensions of 46 Å × 38 Å × 172 Å. Also,
150 mM NaCl was added to the simulation box. One CPT was placed at the center of mass (COM)
of the bulk octanol.

Interface III: Bilayer of 1-octanol
A pure 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (POPC) membrane bilayer was
set up using Packmol97. The CHARMM36 membrane force field was used for POPC104. The CPT
parameters were the same for Interface I and II. The membrane bilayer system contained 23,782
atoms, which contained 59 POPCs and 5,268 TIP3P waters. Also, 150 mM of NaCl was added to
the system. The area per lipid was approximately 59.9 ± 1.8 Å2, and its thickness was
approximately 40 Å at 310 K. The area per lipid was calculated with a block averaging approach
with 9 blocks of 1.9 ns. These characteristics agree well with experimental measurements for
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Figure 17. (A) A snapshot of the POPC membrane bilayer and CPT (in magenta) - Interface III, .
(B) The thickness of the POPC bilayer is around 40 Å based on electron density.

POPC bilayer37. Our simulations are at 310 K, far above the gel transition temperature for POPC,
which is 271 K. After 80 ns of equilibration, the box dimensions were stable at 43 Å × 40 Å × 133
Å. One molecule of CPT was placed 35 Å above the COM of the POPC bilayer membrane and the
electron density profile are shown in Figure 17.

High CPT Concentration with POPC membrane
The system contained 84 CPT molecules, 163 POPCs, 13097 TIP3P waters, and 37 NaCl
molecules. In total, the system had 65,743 atoms. The box dimensions were 92 Å x 92 Å x 125 Å.
The simulation time was 1.6 microseconds at 310 K with anisotropic pressure. A summary of MD
configuration parameters with various CPT concentrations is shown in Table 1. Bilayer thickness
was approximately 40 Å at 310 K.
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Table 1. Initial configurations of high CPT concentrations
System
Number of atoms
CPT count
Box dimensions, Å

3.8 mM CPT

23.8 mM

94.4 mM

411 mM

65,679

70,954

70,032

65,743

1

7

27

108

72 × 75 × 117

74 × 73 × 128 73 × 74 × 127 71 × 77 × 117

Ion concentration
Total run time, ns
Area per lipid

0.15 M
171
66.9

1,668.5
66.1

POPC count

65.8

66.9

163

Water count

14,571

16,242

15,670

13,097

NaCl count

82

92

88

74

Membrane thickness

37.4

37.8

38.6

37.0

Membrane area, Å2

5453.5

5359.8

5359.8

5457.3
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Free Energy Calculations
Table 2. Initial configurations and ABF set-up of all interfaces
Octanol bilayer Thick octanol layer POPC bilayer
(Interface II)
(Interface II)
(Interface III)

System
Box dimensions, Å

56 × 56 × 65

46 × 38 × 175

43 × 40 × 133

20,350

31,719

23,782

Water, molecules

4,954

4,967

5,268

Other, molecules

200 Octanol

620 Octanol

59 POPC

Atoms

Number of Replica
Temperature, K
Pressure
Constant Area

3

2

298

310

Isotropic

Anisotropic

N/A

Partially
(Constant ratio)

Yes

Window width, Å

2

Numbers of windows

15

35

12

Distance (dz), Å

30

75

36

35 (rep1)
40 (rep2,3)

60 (rep1,2)

142 (rep1)
145 (rep2)

0

~0.23

0

Total run time, ns
Mole fraction of water

3

The converged free energy profiles, or the potential of mean force (PMF), across the three
model interfaces were calculated using the Adaptive Biasing Force or the ABF method190, 197-200. In
ABF calculations, an external force is continuously estimated and imposed along the chosen
reaction coordinates, 𝜉 ∗ , to cancel out the total average of the acting mean force on the system,
•

V𝐹{ W𝜉 ∗ X = − L{ (𝜉 ∗ ).
Here, 𝐹{ is the total acting force, and 𝐴 is the free energy along 𝜉 ∗ . The standard deviation
in the PMF profiles, 𝑆𝐷Ê∆𝐴(K=k)Ë, were approximated using the method by Rodriguez-Gomez et
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al.

141,

where 𝜅 is the correlation length212, 𝜉= − 𝜉K is the width of each window or bin, 𝜎 % is

Variance[𝐹{ ], and K is the number of steps:
𝑆𝐷Ê∆𝐴(K=k)Ë ≈ (𝜉= − 𝜉K )

\
/
˜3

/

(1 + 2𝜅)3 .

To increase the efficiency, the reaction coordinate, 𝜉, was truncated into smaller distances,
(𝜉= − 𝜉K ). The octanol bilayer, bulk octanol, and membrane bilayer were divided evenly into 15,
35, and 12 windows with widths of 2 Å, 3.5 Å, and 3 Å, respectively. The initial configurations of
each window were selected from trajectories obtained from steered molecular dynamics (SMD)
simulations213. During SMD simulations, a harmonic constraint was placed on the COM of the
POPC phospholipid bilayer with a spring constant of 50.0 kcal/mol/Å2 to minimize the movement
of the bilayer throughout the trajectory. Three replicas of the PMF were calculated across an
octanol bilayer/water interface (Interface I), two replicas of the PMF were calculated across a
thick octanol slab/water interface (Interface II), and two replicas of the PMF were calculated
across a model phospholipid bilayer membrane (POPC/water) interface (Interface III). The first
replica of each of the free energy profiles of the CPT with the octanol bilayer, bulk octanol, and
membrane bilayer were converged after 35 ns, 60 ns, and 142 ns, respectively. A summary of
system setup and sizes is in Table 2.
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Orientation Angle
The angle

𝜃

between the CPT and the interface in question was calculated using the

following (Figure 18),
𝐴⃗ . 𝑧⃗ = cos 𝜃 . W𝐴⃗W. |𝑧⃗|.
Here, 𝜃 is the angle between the vector 𝐴⃗ on CPT, which was defined by C16-O2 (numbering
was solely based on PDB, see Figure 12), and the unit vector 𝑧⃗ of the box. All physical fluctuations

Figure 18. Theta is the angle between the membrane normal vector with the C16-O2 or CPT
vector

of the bilayer or the thick octanol were disregarded to simplify the angle calculations.

Partition Coefficient
The partition coefficient was calculated with two different methodologies. The first method
of calculating the partition coefficient, logP, of CPT in each system was extrapolated using the free
energy profile from ABF calculation,
log 𝑃 =

:→<
'Δ‹45617895

œ*>:(#$)

=

'(Δ‹=>461<? ' Δ‹@6495)
œ*>:(#$)

=

Δ‹@6495 ' Δ‹=>461<?
œ*>:(#$)

,
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where R is the gas constant, and T is the temperature. In the second method, the partition
coefficient of CPT in each system was calculated from the center of mass of the POPC bilayers (0)
to one leaflet (L/2) as
$

𝐾 = 2 ∫š/% 𝑒 '∆‹(ž)/œ* 𝑑𝑧,
where L is the width of the interface.214 Here, log P is the same as log K.
Rotational Entropy. The rotational entropy of the CPT drug is estimated from the principal
root-mean-square (RMS) fluctuations of Euler angles. We utilize the method from Carlsson, and
Aqvist et al.215 Rotational entropy of any molecule can be written as
Sr

j

¡

= − v+ ∫ p(p, r)ln(p, r)dpdr,

where 𝑝(𝒑, 𝒓) is the position and momentum in rotational phase space. The above equation can
also be written as
#

𝑆 QJI = 𝑅 𝑙𝑛 ö\ 8
7

%Z9)" *
P3

U¢
%

;

(𝐼K 𝐼= 𝐼£ )

#¢
%ø

− R ∫ 𝑃QJI (𝛳)𝑙𝑛𝑃QJI (𝛳)𝑑𝛳,

where R is the gas constant, 𝑘" is Boltzmann’s constant, e is Euler’s number, T is the temperature,
𝜎; is the symmetry number, 𝐼K , 𝐼= , 𝐼£ are the time average moment of inertia along the three
principal axes, and, 𝑃QJI (𝛳) is the probability density of positions in rotational phase space. It is
challenging to obtain the correct 𝑃QJI (𝛳) from molecular dynamics simulation trajectories,
especially for complex systems. Thus, we use a Gaussian distribution to calculate 𝑃QJI (𝛳). 208 The
Gaussian probability distribution can be written as 𝑃QJI (𝛳) =
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where R is the gas constant, 𝑒 is the Euler number, 𝜎; is the symmetry number which normalizes
the number of different molecular conformations by rotation216, 𝑘= is the Boltzmann's constant, ℎ
is the Planck's constant; 𝐼K , 𝐼= , 𝐼£ are the principal moments of inertia, and 𝜃̅ is the average value
for 𝜃 from 0 ≤ 𝜃 ≤ 𝜋. Here 0 ≤ φ ≤ 2π, 0 ≤ ψ≤ 2π, 0 ≤ θ ≤ π, are the Euler angles. The formula
includes deformation of the drug structure accounted for in the principal moments of inertia.

Drug Enthalpy
The average drug enthalpy, Δ𝐻LQ¤N for each window was calculated as the following,
𝐻LQ¤N = 𝐸¦K: L9Q §KK>; + 𝐸F>9£IQJ;IKI!£;
For 𝐻LQ¤N we include the interactions between CPT and its surrounding species, such as
CPT-water, CPT-POPC, CPT-octanol, and CPT-ion. All other interactions between non-CPT
molecules were excluded. These interactions between non-CPT molecules should be included in
the total enthalpy 𝐻IJIK> = 𝐻LQ¤N + 𝐻9:¦!QJ:<9:I where 𝐻9:¦!QJ:<9:I includes the surrounding
molecules such as phospholipid, octanol, and water.

Hydrogen Bonds
The hydrogen bond analysis was performed using the Cpptraj package217 from AmberTools.
The cut-off angle was 120°, and the cut-off distance was 3 Å, as shown in Figure 19. Since CPT

Figure 19. Definition of calculated hydrogen bond
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and octanol can both be hydrogen donors and acceptors, we consider both cases. The atoms used
to calculate the H bonds are the oxygen from the hydroxyl on the CPT, the oxygen from the
hydroxyl on the octanol, and either the oxygen from the phosphate or nitrogen from the choline
group on the POPC.

Results and Discussion
In the present work, we characterize the free energy profiles of a model hydrophobic
anticancer drug, CPT, across three different interfaces—an octanol bilayer/water interface
(Interface I), a thick octanol slab/water interface (Interface II), and a model phospholipid bilayer
membrane composed by 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (POPC)/water
interface (Interface III)—using the ABF methodology. We next characterize the enthalpic and
entropic energetic contributions of CPT with these three interfaces (Interface I, II, and III).

Calculation of Free Energy Profiles
First, we calculate the potential of mean force profile, 𝛥𝐺, in kcal/mol, across three replicas
of Interface I. As shown in Figure 21, the octanol bilayer exhibits significant fluctuations, but
the octanol is still fairly ordered at the interface. Moreover, the octanol bilayer is significantly
thinner (~ 20 Å) than a model phospholipid membrane bilayer (~ 40 Å). See Figure 16, for a

Figure 20. Time evolution of (A) PMF profile for the CPT across the octanol bilayer (Interface I)
for the first replica. (B) Force gradient, and (C) Counts per window.
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snapshot of the system setup and the electron density. To address the convergence of the free
energy profiles, we show the time evolution of the first replica of the free energy profile, the
variations in the gradient forces, as well as the total counts in Figure 20.
The Δ𝐺IQK:;k9Q , as indicated in Figure 21, calculated is 5.5 kcal/mol. At the hydrophobic
center of the octanol bilayer, CPT experiences a minimal energy barrier, ∆𝐺=KQQ!9Q , 0.5 kcal/mol.
The corresponded partition coefficient, log P, was calculated from the Δ𝐺IQK:;k9Q to be 4.0. The
second method of calculating the partition coefficient, from ∫ 𝑒 w•¨/œ* gives log K = 1.8. In
comparison, the octanol/water partition coefficient of CPT is known to be 1.74218. The second
method, integrating the values of the local partition coefficients across the interface, gives very
close agreement with experimentally reported results, even though we are simulating a very thin
octanol bilayer.

Figure 21. (A) Interface I: A snapshot of the octanol bilayer and CPT interface. The oxygen
atoms are highlighted in red, and the CPT is shown in magenta licorice representation.
Waters are shown in blue. (B) The PMF profile, 𝛥𝐺, in kcal/mol, of transferring the CPT along
the z-direction of the octanol bilayer averaging over three separate replicas, where dz is the
distance from the center of mass of the octanol bilayer in Angstroms. Error bars (based on
the 95% confidence interval) are shown in light blue. The shaded area indicates the thickness
of the bilayer based on electron density.
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Figure 22. (A) Interface II: A snapshot of the octanol layer and CPT (in
magenta) placed about 70 Å away from the center of mass of the
octanols. Notice the hydrophilic path created from the hydroxyl groups
and some, waters are found inside those paths. (B) A snapshot shows
the “overlapping elongated inverse micelles” region (circled). (C) The
PMF of the CPT along the z-direction of the octanol bilayers after 60 ns.
Error bars (based on the 95% confidence interval) are shown in light
purple. The electron density shows the thickness of the bulk octanol layer.
The shaded area indicates the thickness of the bilayers based on their
electron density.

Next, we construct a thick layer of octanol (~ 80 Å) to characterize the effect of increased
thickness on the free energy profile across Interface II. We calculate the potential of mean force
profile, 𝛥𝐺, in kcal/mol, across two replicas of this interface. We start the free energy calculation
at the COM of the bulk octanol layer. The octanol slab exhibits tail and head enriched regions,
which are scattered throughout the bulk octanol layer (see Figure 22 A), first described as
“overlapping elongated inverse micelle” regions by Tieleman et al. 219 (see Figure 22 B).
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Figure 23. Time evolution of A. PMF profile for CPT across the thicker octanol (Interface II) for
the first replica, B. Force gradient, and C. Counts per window.

The hydroxyl groups line up to form hydrophilic paths so that water molecules penetrate
the bulk phase from both sides of the octanol layer. According to the electron density profile (see
figure 18 C), at ~55 Å away from the COM of the octanol, we see the effects of the neighboring
bulk water on the ordering of the octanol at the interface, with the 1-octanol at the surface forming
an ordered monolayer. To address the convergence of the free energy profiles, we show the time
evolution of the first replica of the free energy profile, the variations in the gradient forces, as well
as the total counts in Figure 23.
After 60 ns, the PMF profile converges. We calculate the potential of mean force profile, 𝛥𝐺,
in kcal/mol, across three replicas of the thick octanol interface (Figure 21 B). The ∆𝐺IQK:;k9Q
calculated at 70 Å from the COM of the slab with a value of 6.2 kcal /mol. This corresponds to an
overestimated partition coefficient of 4.6. The second method of calculating the partition
coefficient, from ∫ 𝑒 w•¨/œ* gives log K = 2.2, it is much closer to the experimentally reported
partition coefficient of 1.74218. We note that the ordering of the 1-octanol across the interface
corresponds to multiple barriers within the free energy profile. Here, the influence of the
thickness of the octanol layer plays multiple roles. To begin with, the interface is wider by a factor
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of 4. Moreover, the ordering of the octanol across the interface in both cases, the octanol bilayer,
and the thick octanol layer is substantially different.
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Figure 25. (A) Interface III: A snapshot of the POPC membrane bilayer and CPT (in magenta).
(B) The PMF profile, 𝛥𝐺, in kcal/mol, of transferring the CPT along the z-direction of the POPC
bilayer averaged over two replicas, where dz is the distance from the center of mass of the POPC
bilayer in Angstroms. Error bars (based on the 95% confidence interval) are shown in light pink.
The shaded area indicates the thickness of the bilayer based on electron density.

We next calculate the potential of mean force profile, 𝛥𝐺, in kcal/mol, across two replicas

Figure 24. Time evolution of (A) PMF profile for CPT across the POPC bilayer (Interface III) for
the first replica. (B) Force gradient, and (C) Counts per window.
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of

the

POPC

bilayer/water

interface (Figure 25). The CPT
was initially placed 35 Å away
from the COM of a model POPC
phospholipid membrane bilayer
(see Figure 25 A). See also figure
21 for additional snapshots of the
system setup and electron density.
We show the time evolution of the
first replica of the free energy
profile, the variations in the
gradient forces, as well as the total
counts in Figure 24. The timedependent violin plot of the
orientation

angles

for

both

replicas in Figure 26 and Figure
27 shows the convergence of theta
angle.
The free energy to transfer
CPT across Interface III is 5.8
kcal/mol (see Figure 25 B) after
nearly 166 ns ABF calculations.
From the ∆𝐺IQK:;k9Q , the partition
Figure 26. Time-dependent violin plot of the orientation
angles of the CPT with respect to the POPC bilayer for the
first replica. From top to bottom, the orientation angle at 0,
25, 50, 75, and 142 ns.
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coefficient was calculated to be
4.05. To our knowledge, there is
no

available

experimental

partition coefficient for CPT
with POPC. However, a value of
1.67

was

reported

with

DOPC220. The second method of
calculating

the

partition

coefficient,

from

∫ 𝑒 w•¨/œ*

gives log K = 1.9.

This is a

difference of 13% from the
reported value for the partition
coefficient with DOPC, which
seems reasonable. The barrier
free energy for CPT to cross the
hydrophobic core from one
leaflet

to

another

is

approximately 3 kcal/mol. To
summarize, here, we calculate
the partition coefficient for a
model hydrophobic drug across
three

different

model

hydrophobic interfaces with
increasing degrees of thickness
Figure 27. Time-dependent violin plot of the orientation angles
heterogeneities
in
of the CPT with respect to the POPC bilayer for the second and
replica. From top to bottom, the orientation angle at 0, 25, 50,
composition. Slow convergence
75, and 145 ns.
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of the free energy profiles across the model POPC phospholipid bilayer suggests multiple hidden
reaction coordinates.

Spatial Orientation of Drug
To characterize one of the first most probable hidden reaction coordinates, we characterize
the spatial orientation of CPT with respect to the normal vector of the model interfaces, along the
reaction coordinate, dz. We consider the interfaces to be rigid and neglect vertical fluctuations of
the layers. Thus, the calculated angle of the drug reflects its relative orientation to each respective
layer. In Figure 25, violin plots show the distribution of angles between the three interfaces and
CPT. Figure 25 A, for the octanol bilayer (Interface I) CPT, is slightly tilted parallel to the acyl
chains shown by a higher population of angles around 25° and 130°. Most likely, this is to
minimize the local steric hindrances within the hydrophobic core. However, when CPT is in the
interfacial region, approximately from 5 Å away from the COM of the octanol bilayer, interactions
between the CPT and the octanol bilayer, such as hydrogen bonds, shifts the distribution of the
angles to around 80° to 110°. This implies that the CPT is almost parallel to the octanol bilayer,
with the only hydroxyl group of the CPT pointing toward the hydroxyl groups of the octanols. In
Figure 25 B, for the thick octanol layer (Interface II), the angle distribution is quite different
from the ordered octanol bilayer. As expected, the "overlapping elongated inverse micelles"
influence the orientation of CPT. Until about 40 Å away from the COM, CPT rotates freely.
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However, at 42-46 Å and 60-63 Å, strong interactions correspond to the minima in the PMF (see
Figure 25 B).

Figure 28. Violin plots showing the distribution of θ angles between CPT and the normal
vector of (A) the octanol bilayer (Interface I) (B) the thick octanol (Interface II) (C) the
POPC bilayer (Interface III). Only the first replica of each interface is ploted here. Each
plot is calculated on each window. The white dots are averaged angles. The black bars
indicate the 95% confidence interval.
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The distribution of angles of CPT with respect to the phospholipid membrane bilayer
(Interface III) suggests strong interactions of the CPT with the phospholipids in the interfacial
region (Figure 28 C). Compared to the other two systems, the POPC head groups have more
pronounced effects on the orientation of the CPT. CPT is slightly tilted parallel to the acyl chains
in the center of the membrane indicated by the higher population of angles around 25° and 150°,
with a distinct lack of CPT oriented at an angle of 90°. However, we find that CPT can make a
nearly 180° flip as a rare event in the simulation trajectory. Indeed, the strong orientational
dependence of the CPT in the membrane causes slow convergence of the PMF profile in this region
(Figure 25). It is possible that spatial orientation can be used as the second reaction coordinate
for the free energy surface across the phospholipid membrane bilayer in future studies. Figure
28 also demonstrates that within the interfacial region, CPT is not as parallel to the membrane as
in the other two model interfaces. Instead, the CPT points its hydroxyl group towards the POPC
head groups. Since the POPC is zwitterionic, electrostatic interactions can also play a role. For
example, the drug can exhibit multiple electrostatic interactions with the dipole layer of the POPC
membrane. Next, we further explore the relationship between the strength of hydrogen bonds
between the drug and the interfaces (I, II, and III) and how this affects the rotational entropy of
the drug. In addition, we characterize the van der Waals and electrostatic contributions to the
enthalpy.

Hydrogen Bonds, Rotational Entropy, and Enthalpy
Next, from the ABF trajectories, we quantify the average numbers of hydrogen bonds,
〈𝐻 𝐵𝑜𝑛𝑑𝑠〉, and the rotational entropy of the CPT, 𝑆QJIKI!J:K> , for all three interfaces, averaging
over the first replica. One should note that both CPT and octanol molecules can be hydrogen bond
donors and acceptors. As mentioned above, to be consistent and compare all three systems, CPT
and octanols were both analyzed as a donor and acceptor while POPC was only considered as a
donor. With the octanol bilayer (Interface I), there are two minima of the 𝑆QJIKI!J:K> (see Figure
29) as the CPT approaches the membrane. One of them matches the minimum in the PMF profile,
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while the other is close to the interfacial region. As shown in Figure 30, which includes a detailed
cross correlation coefficient matrix between the electrostatic energy, H-bonding, the PMF, the
rotational entropy, and the van der Waals energy for the thin octanol bilayer, the PMF is very
weakly anti-correlated with the rotational entropy.

Figure 29. The shaded area indicated the thickness of the octanol bilayer based
on its electron density. Interface I: (A) The averaged numbers of hydrogen bonds
in both situations where CPT can be a donor (blue) or acceptor (black). The bars
show standard deviation. (B) The rotational entropy of CPT, the enthalpy, which
is made of van der Waals, and electrostatics, are plotted along the distance
between the center of mass of CPT and the octanol bilayer. The left axis is for the
rotational entropy of CPT only. (C) The PMF of the CPT along the z-direction of
the octanol bilayer after 35 ns. Error bars are in light blue. The electron density
showed the thickness of the bulk octanol layer.
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Figure 30. Matrix of cross-correlation coefficients between the electrostatic energy, H-bonding,
the PMF, the rotational entropy, and the van der Waals energy for the thin octanol bilayer.

With the thick octanol layer (Interface II), H bonds consistently form everywhere,
especially in the interfacial region as well as inside the thick octanol phase. One might suspect
that CPT is then locked into a specific spatial orientation. However, the angle analysis and the
𝑆QJIKI!J:K> indicate otherwise. CPT rotates freely in the bulk octanol phase (See Figure 28 B and
Figure 31 B). Whereas there are three minima in the PMF profile, the 𝑆QJIKI!J:K> profile
possesses multiple minima with a maximum in the water. We find that the lower free energy
within the thick octanol layer is favorable from electrostatic, enthalpic, and entropic contributions
due to the rotational entropy of the drug. As shown in Figure 32, which includes a detailed cross
correlation coefficient matrix between the electrostatic energy, H-bonding, the PMF, the
rotational entropy, and the van der Waals energy for the thick octanol bilayer, the PMF is also
very weakly anti-correlated with the rotational entropy, which is similar to the thin octanol
bilayer.
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Figure 31. Interface II: (A) The average number of hydrogen bonds for each window of the thick
octanol slab in both situations where CPT can be a donor (purple) or acceptor (black). The bars
indicate standard deviation. (B) The rotational entropy of CPT (TSrotational), the enthalpy, which
has contributions due to the van de Waals (vdW), and the electrostatics, are plotted along the
distance between the center of mass of CPT and the thick octanol slab. The left axis is for the
rotational entropy of CPT only. (C) The ΔG in kcal/mol of the CPT along the z-direction of the
thick octanol layer after 60 ns. Error bars are in light purple. The shaded area indicates the
thickness of the thick octanol layer based on its electron density.

With the POPC membrane bilayer (Interface III), the average number of hydrogen bonds is
lower than the other two systems (see Figure 33 A). Interestingly, similar to the octanol bilayer,

78

Figure 32. Matrix of cross-correlation coefficients between the electrostatic energy, H-bonding,
the PMF, the rotational entropy, and the van der Waals energy for the thick octanol layer.

the two minima of 𝑆QJIKI!J:K> were similar to those in the PMF profile (see Figure 33 B C).
Importantly, when the CPT loses its rotational entropy, the average number of hydrogen bonds
increases, with the corresponding minima in the PMF. However, in the inner hydrophobic core of
the membrane, CPT regains its rotational entropy due to the spontaneous breaking of CHCPT···OPOPC hydrogen bonds. As the CPT crosses the phospholipid membrane interface, the
dominant hydrogen bond for each position based on its lifetime is shown in Figure 34. At 6-9 Å
the dominant hydrogen bond is C-HCPT···OGlycerol/POPC hydrogen bonds. At 12-15 Å the dominant
hydrogen bond is O-HCPT···OPhosphate/POPC hydrogen bonds. At 21-24 Å the dominant hydrogen bond
is O-HCPT···OGlycerol/POPC hydrogen bonds. In contrast to the thick octanol layer, we find that the
lower free energy within the POPC membrane bilayer is unfavorable from electrostatic and
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Figure 33. Interface III: (A) The average numbers of hydrogen bonds bonds for each window of
the along the POPC interface in both situations where CPT can be a donor (Magenta). The bars
indicate standard deviation. (B) The rotational entropy of CPT (TSrotational), the enthalpy, which
has contributions due to the van de Waals (vdW), and the electrostatics, are plotted along the
distance between the center of mass of CPT and the POPC bilayer. The left axis is for the
rotational entropy of CPT only. (C) The The ΔG in kcal/mol along the z-direction of the POPC
bilayer after 166 ns. Error bars are in light magenta. The shaded area indicates the thickness of
the POPC bilayer based on its electron density.

enthalpic contributions, however the rotational entropy of the drug corresponds with the location
of the free energy minimum. Thus, we infer that with more complex and ordered interfaces the
rotational entropy of the drug can play a significant role in the location of the free energy
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minimum. In particular, the rotational entropy of the drug is inversely related to the average
numbers of hydrogen bonds of the drug with the phospholipid headgroups. The cross-correlation
coefficient for the rotational entropy of the drug with respect to the average number of hydrogen
bonds is -0.48. A detailed cross correlation coefficient matrix between the electrostatic energy,
H-bonding, the PMF, the rotational entropy, and the van der Waals energy for the POPC bilayer
is shown in Figure 35. We calculate the difference in rotational entropy, van der Waals, and

Figure 34. (A-C) The relative position and orientation of CPT with respect to the POPC membrane
bilayer (Interface III) at a distance of 6-9 Å, 12-15 Å, and 21-24 Å. (D-F) the dominant hydrogen
bond at a distance of 6-9 Å, 1215 Å, and 21-24 Å based on its lifetime.
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Figure 35. Matrix of cross-correlation coefficients between the electrostatic energy, H-bonding,
the PMF, the rotational entropy, and the van der Waals energy for the POPC bilayer.

electrostatic interactions in the bulk vs. the minimum in the POPC bilayer. The relative difference
in rotational entropy is 31.0 kcal/mol, while the difference in van der Waals and electrostatic
interactions are -18.9 kcal/mol and 17.4 kcal/mol respectively. Notably, the rotational entropy
contribution is nearly twice the van der Waals and electrostatic contributions and is playing a
critical role. Thus, at the cost of decreasing rotational entropy, the minimum in the PMF profile
is still within the bilayer and the transfer free energy is 5.8 kcal/mol. This suggests that additional
environmental contributions to the enthalpy (and entropy) are the determining factors in setting
the relative minimum for the drug in the interface and the overall magnitude of the transfer free
energy.

Higher Concentration of CPTs
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Figure 36. (A) A snapshot of the CPTs at high concentration, starting configuration at 0
µs. POPC is shown in Licorice representation. CPT is shown in blue. (B) A snapshot of
the CPTs at high concentration ordering above the membrane, after starting to insert into
the POPC bilayer 1at 1.044 µs. The drug forms stacks along the surface of the
membrane. Several drugs start to insert just under the phospholipid headgroups. POPC
is shown in Licorice representation. (C) CPT’s above the membrane with few remaining
CPT’s inside the membrane at 1.688 µs CPT (D-F) CPT is shown in Paperchain
presentation and the POPC is shown as a transparent slab. The drug forms stacks along
the surface of the membrane. Several drugs start to insert just under the phospholipid
headgroups.
We next hypothesize that the calculated partition coefficient may neglect cooperative CPT-CPT
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interactions and how this CPT drug stacking will affect the hydrophobic environment of the
membrane204, 221. To test the degree of CPT—CPT stacking and how the stacking will disrupt the
membrane interface, we ran a long-time 1.6 microsecond simulation of multiple CPTs above a
slightly larger POPC bilayer at a concentration of approximately 400 mM (411 mM), as shown in
Figure 36 A. The initial positions of the drug molecules are completely randomly distributed on
both sides of the membrane. We find that the drug forms long chains of drug molecules above
the membrane surface that gradually push down and permeate the bilayer after approximately 1
µs shown in Figure 36 B. A fraction of this drug population breaks off and remains in the bilayer
while the rest of the long chains form a filament above the membrane surface at 1.8 Figure 36
C. These long chains locally distort the interfacial concentration of the POPC chains.
In Figure 37, the electron density profile shows the CPT molecules distributed randomly in
solution above the membrane about 40 Å away from the COM of the POPC bilayer. As shown,
after 1.6 µs, the CPT peak on the electron density profile becomes sharper and shifts 50-65 Å away
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Figure 37. The electron density profile along z-direction. Magenta lines show the distribution of
CPT molecules for the high concentration CPT ~ 411 mM system. Green lines show the position
of membrane head groups (phosphates and cholines). The transparent lines indicates the
beginning timepoint. The opaque lines are after 1.6 microseconds.

from the COM of the POPC bilayer (location of filament), with a secondary peak due to drugs that
break off and insert themselves into the hydrophobic membrane just under the POPC headgroups.
The sharper peak of CPT in Figure 37 is due to well-organized CPT-CPT stacking. As Kang
et. al suggests, a dominant feature of CPT in solution is π-π stacking204. With this highly
concentrated system, the CPT-CPT stacking via π-π interactions significantly impacts CPT
orientation and also its permeation pathway into the membrane. Hence, it is interesting to
compare the orientation of multiple CPTs interacting with the membrane against the singular CPT
system. We calculate the θ angles between every CPT and the membrane normal vector, as shown
in Figure 38.
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Figure 38. A violin plot showing the distribution of θ angles between CPT and the normal vector
of the POPC bilayer (Interface III). The white dots are averaged angles. The black bars indicate
the 95% confidence interval. The shaded areas highlight the peaks of distribution. Arrows show
schematic spatial orientation of CPT with respect to the membrane.

Interestingly, with the CPT-CPT stacking, the violin plot of θ angles shifts its shape
significantly from the singular CPT θ angle. In Figure 38, contrary to expectation where CPTs
should rotate freely at 50-65 Å away from the COM of the POPC bilayer, the higher concentration
of CPTs is given by three populations that correspond to three orientations of CPTs with respect
to the membrane normal vector: parallel (~ 6°), perpendicular (~ 75°-100°), and anti-parallel (~
175°). These three orientations are caused by pronounced CPT-CPT stacking and are absent in the
singular CPT systems. To test if the formation of filamentous assemblies depends on the initial
concentration of the drug, we next ran three additional concentrations. All simulation runs of
varying CPT concentrations above the membrane are summarized in Table 1. We ran two
additional high concentration systems at 24 mM and 94 mM. In addition, one additional replica
containing a single CPT was run, to test passive diffusion for one drug only. All three systems at
high concentrations (24, 94, and 411 mM) show the formation of filamentous assemblies. The

86

Figure 39. For the high concentration ~ 411 mM CPT system, electron density profile as a
function of distance, dz, from the center of mass of the membrane showing CPT electron density
(magenta) and P1 phosphate atom density (black) at 0 ns B. 1044 ns C 1668 ns. Order Parameter
of the D) sn-1 POPC tails E) sn-2 POPC tails.

additional replica containing a single CPT the drug enters the membrane after 16 ns. The electron
density over time and the order parameter of the phospholipid tails are shown in Figure 39,
Figure 40, Figure 41, and Figure 42. We note that the trend in these systems is that the
drugs penetrate the membrane in groups of 2-3, but longer chains of drugs do not insert.
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Figure 40. For the high concentration ~ 94 mM CPT system, electron density profile as a function
of distance, dz, from the center of mass of the membrane showing CPT electron density
(magenta) and P1 phosphate atom density (black) at 0 ns B. 1044 ns C 1668 ns. Order Parameter
of the D) sn-1 POPC tails E) sn-2 POPC tails.

Thus, the presence of additional surrounding drugs greatly modifies the orientation of each
CPT with the membrane as the drugs form stacks that lay on top of the phospholipid bilayer but
do not directly interact. We note that the formation of the drugs into these long stacks above the
membrane effectively reduces the drug's rotational entropy, shifting its contribution to the free
energy profile across the bilayer and significantly affect the membrane permeation pathway. In
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addition, the hydroxyl group of the CPT cannot quickly form H bonds with the membrane surface.
In comparison with experiments, the experimentally reported partition coefficients from Selvi et
al.220 are at the 0.11 µgram/mL or around approximately 30 µM concentration. Furthermore, the

Figure 41. For the high concentration ~ 24 mM CPT system, electron density profile as a function
of distance, dz, from the center of mass of the membrane showing CPT electron density
(magenta) and P1 phosphate atom density (black) at 0 ns B. 1044 ns C 1668 ns. Order Parameter
of the D) sn-1 POPC tails E) sn-2 POPC tails.
experimental concentrations by Cheetham et al.205 are in the 50 µM range, however
supramolecular aggregates as reported by Cheetham et al.205 expect that a high concentration of
CPT is stable in supramolecular aggregate form at 20 µM. While the lowest concentration we
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simulate is ~ 4 mM is 50 nearly times more concentrated than this concentration, the local
concentration of CPT’s may be increased if interactions with the membrane destabilize individual
supramolecular aggregates. Effectively, the membrane may serve as a surface that is nucleating

Figure 42. For the single CPT system, electron density profile as a function of distance, dz, from
the center of mass of the membrane showing CPT electron density (magenta) and P1 phosphate
atom density (black) at 0 ns B. 84 ns C 171 ns. Order Parameter of the D) sn-1 POPC tails E)
sn-2 POPC tails.
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and growing unidimensional drug crystals.

The membrane itself may lower the critical

concentration for the growth of these supramolecular aggregates.

Conclusion
We summarize the calculated partition coefficient results for the three model systems
calculated with the Adaptive Biasing Force (ABF) methodology in Table 3 .In comparison with
experimentally reported partition coefficients, the value for log Poctanol/water that we calculate from
the transfer free energy is off by a factor of 2. However, calculation via the second methodology,
from integration over the potential of mean force, gives a closer agreement (2.2) with the
experimentally reported value (1.74). Surprisingly, calculating the partition coefficient using the
second methodology, integrating over a thin octanol bilayer, gives excellent agreement (1.8) with
an experimental partition coefficient (1.74218). For the POPC membrane, we find that the value of
the partition coefficient calculated from the transfer free energy (4.1) is exceptionally high
compared to the experimentally reported value for a model DOPC membrane (1.65220). However,
recalculation via the second methodology (1.9) gives closer agreement. The closer agreement of
the calculated partition coefficient, log K, with experimentally reported values for the partition
efficiency implies that interfacial structure plays a critical role in all three interfaces. Indeed, the
minima in the PMFs for the first and third interface are five Å or less from the thickness of the
interface as defined by the density profile. For the second interface, the minimum in the PMF is
~ 20 Å from the bulk octanol surface. Therefore, in all three cases, one can infer that the drug will
be interfacial active, with more drug partitioning close to the interface than the bulk.
We note that the lack of polarization in the TIP3P water model may provide the wrong
baseline for partitioning, and the lack of polarization may impact transfer free energies. While
force fields that include polarizability may lead to higher accuracy for the transfer of free energies,
this would increase computational cost.

Including polarizability of the water, or else the

phospholipids could impact the permeation pathways222, 223. Herein we attempt to correlate the
strength of hydrogen bonding of this model hydrophobic cancer drug, CPT, with a model
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phospholipid bilayer with the rotational entropy of the drug. We show that the two are inversely
correlated, with an anti-correlation coefficient of -0.47. In particular, the orientation of the drug
with respect to each model interface is determined to some degree due to the strength of hydrogen
bonding at each respective interface. Most notably, due to the planar pentacyclic structure of CPT,
it can form strong aromatic interactions with itself. We show that these strong aromatic
interactions lead to stacks of drugs across the membrane at higher concentrations. The formation
of CPT drug stacks modulates the interaction of the drug with the phospholipid bilayer, shifting
the orientation of the drug with respect to the membrane, changing the membrane permeation
pathway.
Table 3. ∆𝑮𝒃𝒂𝒓𝒓𝒊𝒆𝒓 , ∆𝑮𝒕𝒓𝒂𝒏𝒔𝒇𝒆𝒓 and partition coefficients (log P and log K) as defined in the
methods section based on average overall replicas for each interface.
Simulation
∆𝑮𝒃𝒂𝒓𝒓𝒊𝒆𝒓
kcal/mol
Octanol bilayer
0.27 ± 0.15
(Interface I)
Thick octanol layer
N/A
(Interface II)
POPC membrane bilayer
3.8 ± 0.8
(Interface III)

Experiment
∆𝑮𝑻𝒓𝒂𝒏𝒔𝒇𝒆𝒓
kcal/mol

log P log K

log P

5.5

4.0

1.8

N/A

6.2

4.6

2.2

1.74

5.8

4.1

1.9

1.65
(in DOPC)

With the increasing computational power available, in addition to recent increased interest in
the power of machine learning approaches to predict small drug permeability in membranes172174,

we note that further characterization of variables and/or hidden reaction coordinates that

determine small drug permeability in membranes is urgent.224, 225 However, we note that these
models have not accounted for the strength of drug-drug interactions on the modulation of the
permeability into the membrane. This may be an additional consideration that needs to be
considered in these models. A methodology uniquely suitable for exploring the contribution of
drug-drug interactions on membrane permeability is rational coarse-grained methods.225, 226
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The Interaction of Supramolecular
Anticancer Drug Amphiphiles with Phospholipid
Membranes
Modified from “Tang, P. K.; Manandhar, A.; Hu, W.; Kang, M.; Loverde, S. M., The
interaction of supramolecular anticancer drug amphiphiles with phospholipid membranes.
Nanoscale Advances 2020.”

Abstract
The shape of drug delivery vehicles impacts both the circulation time and the effectiveness
of the vehicle. Peptide-based drug amphiphiles (DAs) promise new candidates as drug delivery
vehicles that can self-assemble into shapes such as nanofilament and nanotube (diameter ~ 6-10
nm). The number of conjugated drugs affects the IC50 of these DAs, which is correlated to the
effective cellular uptake. Characterizing and optimizing the interaction of these DAs and their
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assemblies with the cellular membrane is experimentally challenging. Long-time molecular
dynamics can determine if the DA molecular structure affects the translocation across and
interaction with the cellular membrane. Here, we report long-time atomistic simulation on Anton
2 (up to 25 µs) of these DAs with model cellular membranes. Results indicate that the interaction
of these DAs with model cellular membranes is dependent on the number of conjugated drugs.
We find that with increased drug loading, the hydrophobic drug (Camptothecin, CPT) builds up
in the outer hydrophobic core of the membrane, pulling in positively charged peptide groups.
Next, we computationally probe the interaction of different shapes of these model drug delivery
vehicles—nanofilament and nanotube—with the same model membranes, finding that the
interaction of these nanostructures with the membrane is strongly repulsive. Results suggest that
the hydrogen bond density between the nanostructure and the membrane may play a key role in
modulating the interaction between the nanostructure and the membrane. Taken together, these
results offer important insights into the rational design of peptide-based drug delivery vehicles.

Introduction
There are many challenges in the design of an effective drug delivery vehicle, including a
controlled and high drug loading capacity, extending the circulation time in blood-stream227,
eliminating non-specific cell uptake228, tunability of the vehicle morphology/shape at the
nanoscale229, and ultimately control of the vehicle interaction with the cellular membrane—either
through active targeting of cellular receptors and/or control of the membrane response via
morphology230 and/or surface patterning231, 232. Small molecules such as ions, peptides, and sugars
(< 1 kDa), dependent on their size and polarity, can cross the membrane via passive diffusion or
an active transport mechanism221. In contrast, large molecules such as proteins and viruses (>=10
kDa) traverse the membrane barrier either through pore formation or endocytosis233. The relative
contributions to the free energy of interaction between the particle (large molecule such as protein
or virus) and the membrane include the bending energy of the membrane, the membrane tension,
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Figure 43. “(A) Chemical structure of ‘mCPT-buSS-Tau’, which has one-drug loaded per peptide. In
solution, ‘mCPT-buSS-Tau’ can self-assemble into a nanofilament. Camptothecin (CPT), Linker, and
Peptide are highlighted in magenta, yellow, and green, respectively. (B) Chemical structure of ‘qCPTbuSS-Tau’. In solution ‘qCPT-buSS-Tau’ can self-assemble into a nanotube. CPT, Linker, and Peptide
are highlighted in magenta, blue, and green, respectively. (C) Random initial configurations of ‘mCPTbuSS-Tau’ and ‘qCPT-buSS-Tau’ interact with a model membrane using unbiased molecular dynamics
simulations (or simple diffusion). CPT (in magenta) and peptide (in yellow) are shown in ‘Licorice’ and
‘New Cartoon’ representation, respectively. The zoomed-in view shows a insertion of CPT into the model
POPC membrane. Pre-assembled initial configurations of the nanofilament and the nanotube interact
with the membrane using Umbrella Sampling.”
and any adhesive contact between the particle and membrane234. Particle-based simulation
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methods such as molecular dynamics offer an emerging tool to probe nanoparticle-membrane
interactions235, 236, characterizing, for example, the effect of size,237 shape,226 surface charge,238 and
chemistry of the nanoparticle239. For example, molecular simulations can uniquely capture
deformations and rearrangements of the nanoparticle itself at the molecular level, such as
molecular ‘snorkeling’239, which cannot be well-described with continuum models. Ultimately, an
effective drug delivery vehicle design entails engineering the vehicle's shape and interaction with
the cellular membrane.
Peptide amphiphiles (PAs) are a class of peptide-based molecules composed of a
hydrophilic head and hydrophobic tail240-242 that self-assemble into ordered nanostructures of
various morphologies, such as ribbons, bilayers, tubes, and fibers.65, 67, 68, 70 The morphology of the
self-assembled nanostructure is driven at the molecular level by balancing hydrophobicity and
hydrophilicity, which the peptide sequence can further tune. Peptide sequence can be tailored for
various biomedical purposes such as stabilizing membrane proteins243,

244,

facilitating cell

differentiation245, and serving as drug delivery vehicles.246, 247 Indeed, peptides, such as ‘cellpenetrating peptides’ or CPPs, are classic examples of molecules that can be tailored via sequence
to affect their membrane interaction. For example, specific functional domains248 control the
translocation activity249. As a result, these findings also act as general guidelines for rational
designs of CPPs as potent drug delivery tools250-252.
Additionally, CPPs, such as a non β-sheet forming peptide from the Tat protein transduction
domain, HIV protein253, can also be coupled to hydrophobic drugs to improve their delivery
effectiveness254. For example, Cui et al.79 designed peptide-based drug amphiphiles (DAs),
consisting of a short modified Tau peptide sequence (CGVQIVYKK)—the β -sheet forming a
segment of Tau (a protein that stabilizes microtubules255)— and hydrophobic anticancer drug
Camptothecin (CPT), conjugated via a biodegradable disulfide linker (buSS) as shown in Figure
43 A and B. CPT is a model hydrophobic anticancer drug39 with a known octanol/water partition
coefficient9, 218 that can p-p stack in solution due to its planar aromatic structure204, driving the
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self-assembly process. Dependent on the molecular structure of the DAs, such as the number of
conjugated drugs (‘mCPT’ or ‘mCPT-buSS-Tau,’ which has one drug attached, vs. ‘qCPT’ or ‘qCPTbuSS-Tau,’ which has four drugs linked), the shape of the self-assembly in solution ranges from
nanofilament (diameter ~ 6.5 nm) to nanotube (diameter ~ 9.5 nm)79. Essentially, varying the
drug loading varies the relative balance of hydrophobic to hydrophilic interactions, determining
the compact shape and diameter of these unidimensional self-assemblies.
Here, we report long-time molecular dynamics simulations (up to 25 µs) to characterize
how the DA structure affects the translocation across and interaction with the cellular membrane.
Briefly, we find that DAs with lower drug loading (one drug attached per peptide) do not interact
with or penetrate the membrane after very long timescales (18 µs). The results for a slightly
different DA structure, four hydrophobic drugs attached per peptide, are strikingly different
instead of only one drug-linked. In this case, due to the increased relative accessibility of the CPT,
the hydrophobic cancer drug starts to interact with and penetrate the membrane after only 0.5 µs
(Figure 43 C). After 25 µs, we see that the drug builds up in a stacking configuration in the outer
hydrophobic core of the membrane, starting to bend the membrane, pulling the positively charged
peptide groups towards the membrane surface. Thus, single DAs are suggested to interact with
the membrane via a simple diffusive mechanism at a shorter timescale (< 1 microsecond).
However, at longer timescales (>= 10 µs), we expect the DAs to permeate the membrane following
an active mechanism. Next, using advanced sampling methods in molecular dynamics, we
determine the potential energy of interaction of varying DA nanostructures—nanofilament and
nanotube—with the cell membrane. Here we find that both nanostructures repel the membrane
due to their high positive surface charge density; however, the nanotube, with its increased
diameter, is more repulsive. The membrane thins and bends as both nanostructures approach the
membrane surface, as shown in Figure 1 C. Moreover, we find that hydrogen bonds between the
nanostructure and the membrane may display a critical role in mediating membrane permeation.
These results suggest that the interaction of engineered peptide sequences with model cellular
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membranes can be tailored by increasing the relative hydrophobicity of the molecule and
controlling the hydrogen bond density between the nanostructure and membrane.

Computational Methods
System Setups
The phospholipid bilayers were preassembled and minimized using CHARMM-GUI256. The
1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholines or POPC phospholipids were parameterized
using the Amber Lipid14257 force field. Next, the bilayer was further equilibrated, in NAMD 2.13258,
with an anisotropic Langevin barostat124, 125 using an oscillation period and decay time of 100 fs
and 50 fs, respectively, for ~100ns. A damping coefficient of γ =1 ps-1, at a pressure of 1 atm, was
used together with the Langevin barostat to allow fluctuations of the membrane. ‘mCPT-buSSTaau’ and ‘qCPT-buSS-Tau’ were parameterized with the General Amber Force Field (GAFF)259.
TIP3P water was used. Packmol97 set up the initial configuration where the DAs were placed
randomly above and below the POPC bilayer membrane. The ‘mCPT-buSS-Tau’ and ‘qCPT-buSSTau’ with POPC membrane systems were equilibrated for 80 ns and 88 ns, respectively. The
nanofilament/nanotube systems were constructed by combining a pre-equilibrated POPC
membrane and the ‘mCPT-buSS-Tau’ nanofilament or the ‘qCPT-buSS-Tau’ nanotube. The
nanofilament was constructed in the same way as demonstrated in Kang et al.,260 specifically the
nanotube where all four CPT drugs are parallel. All systems used tleap from AmberTools112 to
neutralize the overall charge with Cl- ions. All system details/sizes are listed in Table 4.
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Table 4. System details/sizes.
Random
System name
Box Size, Å

mCPT

qCPT

Nanofilament

Nanotube

127 × 131 × 177

128×126 ×143

160 × 158 × 207

123 × 196 × 210

POPC count
Water count
Cl- count

500

505

72,929

46,000

90,916

87,089

54

108

336

144

168

72

DA count
[DA], mM

Preassembled

54
39.3

54.7

N/A

MD Simulation Parameters
All systems used the NPT ensemble with Langevin dynamics124, 125 with a temperature of 310
K. A damping coefficient of γ =1 ps-1, at a pressure of 1 atm, was used together with an anisotropic
barostat to allow fluctuations of the membrane with a piston period of 100 fs and a damping time
scale of 50 fs. The SHAKE algorithm261 was used to fix hydrogen atoms allowing a 2 fs timestep.
The Particle Mesh Ewald (PME) algorithm262 was utilized to take total electrostatic interactions
into account, with full periodic boundary conditions. The cut-off for van der Waals interactions
was 12 Å with a smooth switching function at 10 Å. Bonded atoms were excluded from non-bonded
atom interactions using a scaled 1-4 value. After equilibration, all random systems were
transferred to Anton2263 for production runs. During production runs on Anton2, the timestep
was changed to 2.5 fs. The short-range electrostatics was calculated every timestep, while the longrange electrostatics was calculated every three timesteps. The Gaussian Split Ewald method264
was used to accelerate the electrostatic calculations. All other parameters were used as suggested
by the Anton2 website (wiki.psc.edu/twiki/viewauth/Anton/WebHome). A production run of 18
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µs was performed for the ‘mCPT-buSS-Tau’-POPC system and 25 µs for the ‘qCPT-buSS-Tau’POPC system.

Umbrella Sampling
Here, we use Umbrella Sampling (US)265 to determine the interaction free energy of the
‘mCPT-buSS-Tau’ nanofilament and the ‘qCPT-buSS-Tau’ nanotube with the POPC membrane.
US is a widely used method to calculate free energy for various biophysical properties such as –
protein folding266,

267,

peptide-peptide interactions268,

269,

peptide-DNA interactions270, and

peptide-membrane interactions271. The reaction coordinate (rc) is the z-distance between the
center of the nanofilament/nanotube center and the membrane, divided into multiple windows.
For each US window, a biasing harmonic potential (𝑤! ) is applied such that the states sampled
near the center of the window. The 𝑤! in each window is defined as
𝑤! =

𝐾
[𝑄 − 𝑞! ]%
2

,

where k is the spring constant, 𝑞! is the center and 𝑄 is the actual difference of rc for the initial
and final state. The biased distribution function for every ith window is defined as
〈𝑝(𝜉)〉=!K;9L
= 𝑒 '²! ({)/)" * 〈𝑝(𝜉)〉〈𝑒 '²!({)/)" * 〉'#
!

,

and the unbiased PMF is defined as
𝑊! (𝜉) = −𝑘" 𝑇 × 𝑙𝑛〈𝑝(𝜉)〉−𝑤! + −𝐹!

,

where 𝐹! is the unknown free energy constant, defined as
𝑒 ¨! /)" * = 〈𝑒 ²! /)" * 〉

,

Next, the weighted histogram analysis method (WHAM)196 is used to determine 𝐹! . This uses
an iterative process by making an initial guess of 𝐹! to estimate unbiased probability distribution
as
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〈𝑝(𝜉)〉 = ^ 𝑛! 〈𝑝(𝜉)〉! þ^ 𝑛+
!

(² ({)'¨! )
' !
)" *
𝑒
!

'#

,

+

The resulting probability is then used to get a new set of 𝐹! values,
𝑒 '¨! /)" * = j 𝑑 𝜉𝑒 '(²!({)'¨! )/)" * 〈𝑝(𝜉)〉

.

Here, we performed steered MD213 (SMD) simulations to pull the nanofilament and the
nanotube with 7 kcal/mol force towards the POPC membrane to generate the initial positions in
each window. Thus, the nanofilament interaction with the membrane has 38 windows 1Å apart
with rc varying 70.5 Å to 33.5 Å (Figure 52). Similarly, the nanotube interaction with the
membrane has 49 windows 1Å apart with rc varying 84.5 Å to 36.5 Å (Figure 53). Each
configuration is harmonically constrained with a spring constant of 20kcal/mol.

These

simulations have periodic boundary conditions; thus, infinitely long nanofilament/nanotube is
interacting with an infinitely wide cell membrane. For the nanostructure-membrane systems, the
same MD parameters as that for random drug amphiphile-membrane systems are used.

Results
Low Drug Loading and Interaction with a POPC Membrane.
Long-time molecular dynamics can assess if the DA structure affects the translocation
across and interaction with the cellular membrane. To begin with, studies on Anton2263 indicate
that the interaction of ‘mCPT-buSS-Tau’ with model cellular membranes is repulsive. That
suggests small aggregates of the DAs do not interact with or disturb the membrane, as shown in
Figure 44, even after 18 µs simulation time. As shown in Figure 44, the DAs slowly start to
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cluster over the 18 µs timeframe. However, they do not penetrate or disturb the membrane. 54
‘mCPT-buSS-Tau’ molecules (39.3 mM) are placed initially randomly above and below a model
POPC

(1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine)

membrane.

Notably,

this

concentration is about 80-fold higher than the experimental concentration reported by Cui et al.79

Figure 44. (A–F) Snapshots along the 18 microsecond trajectory showing nanoclusters of ‘mCPTbuSS-Tau’ interacting with the model POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine)
membrane. CPT (Camptothecin) are in magenta with ‘Licorice’ representation, peptides are
yellow with a ‘Secondary Structure’ representation. The linkers are in black. POPCs is shown in
cyan, red, and white in a ‘Licorice’ representation. The water is shown with a transparent box.
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At a concentration of 0.05 mM, ‘mCPT-buSS-Tau’ forms nanofilaments with a 6.7 nm width in
solution79. In Figure 44 A-F, snapshots show that ‘mCPT-buSS-Tau’ nanoclusters form at the
early state of the simulation (within the first 0.01 µs) and persist throughout the simulation. It is
known that the 𝛑 − 𝛑 interaction of the aromatic rings on CPT dictates the early nucleation of the
DA nanoclusters, according to Kang et al.204 We quantify the average size of nanoclusters as
∑>?D7495 3C5DE,>?D7495
3>?D7495

. However, ‘mCPT-buSS-Tau’ contains an average of only five drugs per

nanocluster, as shown in Figure 45 A. Moreover, the distribution of sizes of ‘mCPT-buSS-Tau’
nanoclusters is persistently lower than ‘qCPT-buSS-Tau’ as shown in Figure 46. In other words,
‘mCPT-buSS-Tau’ prefers to stay in smaller size nanoclusters. Figure 46 A-B shows an average
of 10 ‘CPTs’ per nanocluster. Furthermore, we also observe that the CPT nanoclusters gradually
reach an equilibrium size after 6 µs, with an average of ~10-15 monomers in 3-6 nanoclusters. At
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6 and 13 µs, we observe the formation of a ‘percolated’ nanocluster with all 54 CPTs, but it is not
stable and dissolves into smaller size nanoclusters.

Figure 45. “(A) The average size of ‘mCPT-buSS-Tau’ and ‘qCPT-buSS-Tau’ nanoclusters
based on drug aggregation is shown after three time points for ‘mCPT-buSS-Tau’
(magenta) (1 ms, 9 ms, and 18 ms) and ‘qCPT-buSS-Tau’ (purple): ‘Initial’ (0 ms), ‘Insertion’
(88 ns), and ‘Permeation’ (18 ms). The lowest, middle, and top lines of the boxes are 25,
50, and 75 percentiles, respectively. The top and bottom lines are maxima and minima,
with the outliers as black diamonds. (B) The sphericity index as a function of normalized
size. The error bars are shown as straight lines. Linear regressions with 95% confident
interval are shown.”
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We define the normalized cluster size as a fraction between 0 and 1 as

3C5DE,>?D7495
3C5DE7,4<46?

. We group

the DA molecules that stay within the rcut-off of 4.5 Å. To quantify the shape of each defined
nanocluster, we align each nanocluster's principal axes along x, y, and z-direction. The radius of
gyration, R, is derived from the principal moment of inertia, 𝐼 = 𝑚𝑅% , along one direction of each
nanocluster where m is the total mass in grams of each nanocluster. The ratio of minimum radius
of gyration, Rmin, to the maximum radius of gyration, Rmax, was used to quantify the shape of
œ

each nanocluster as the sphericity index, œ G!1 . Using this index, a spherical aggregate will have a
G60

Figure 46. “Average cluster sizes and number of clusters for A-B. ‘mCPT-buSS-Tau’ and C-D.
‘qCPT-buSS-Tau’. Average cluster size is the number of hydrophobic drugs (CPTs) per cluster.”
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value close to 1. In Figure 45 B, small to medium nanoclusters, which corresponds to ~ 0.25
normalized size, have a sphericity index of 0.5. This indicates that small nanoclusters are almost
ellipsoidal. Interestingly, larger nanoclusters, which reach a normalized size of 0.75, elongate
horizontally. This trend is predicted to hold even larger nanoclusters since the linear regression
shows a negative slope. The anisotropic growth of ‘mCPT-buSS-Tau’ nanoclusters is supported by
Cheetham et al. 79 and Kang et al. 204 studies.
Furthermore, we also characterize the 2D free energy surface that correlates the ‘mCPTbuSS-Tau’ nanocluster sizes and the relative distance, dz, from the center of mass (COM) of the
POPC membrane to the closest point (or closest atom within each nanocluster) of each of the
nanoclusters. The 2D Potential of Mean Force (PMF) profiles are derived from the distribution
probability using the following equation, ∆𝐺 = −𝑅𝑇𝑙𝑛 8S

S

G60

temperature T is in Kelvin and

S
SG60

; where R is the gas law constant,

is the ratio between the probability of a single event to the

highest probability event. Figure 4 A, small to medium ‘mCPT-buSS-Tau’ nanoclusters (~ 0.1-0.4
normalized nanocluster size) is placed randomly at least 20 Å above the POPC membrane.
Throughout 18 µs, those small to medium nanoclusters move further away from the membrane,
as shown in Figure 47 B-C. The free energy minimum is located around 75 to 90 Å, with the
closest dz at 30 Å away. More comparative observations show two peaks along with the
normalized size direction corresponding to two distinctive dz’s. The first peak with maximum
normalized size at 0.4 always stays closer to the membrane, at ~ 45 Å, while the second peak with
maximum normalized size at 0.6 is staying further away from the membrane, at ~ 105 Å.
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Figure 47. “2D Potential of Mean Force (or PMF) profiles that shows the relationship between
normalized nanocluster size and the relative distance, dz, between the lowest points of ‘mCPTbuSS-Tau’ ((A–C) 0–18 µs) and ‘qCPT-buSS-Tau’ ((D–F) 0–25 µs) nanoclusters and the center
of mass of the model POPC membrane.”

Although the overall normalized size mostly remains the same for the two peaks, the trend
indicates that small to medium nanoclusters tend to get closer to the membrane. We hypothesize
that the positively charged lysines on the amphiphilic peptides, when aggregating in larger groups
will repulse the membrane's positively charged choline head groups. This repulsion can hinder
the normalized size of the nanocluster and may also prevent their approach to the membrane
surface. This could also correlate to the lowest in vitro efficiency of ‘mCPT-buSS-Tau’ in cell
culture79. However, a definitive answer requires more insightful studies.
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Higher Drug Loading and Interaction with a POPC
membrane.
Another DA is ‘qCPT-buSS-Tau’ (Figure 43 B), which carries four times the number of
drugs per peptide (four times the drug loading). However, in this case, due to the increased

Figure 48. (A–C) Snapshots show ‘nanoclusters’ of ‘qCPT-buSS-Tau’ interacting with the model POPC
membrane at the (A) initial (0 ns), (B) insertion (88 ns), and (C) permeation (25 ms) timepoints.
Camtothecin (CPT) are in purple with Licorice presentation, peptides are yellow with secondary
structure presentation. POPCs are shown in default colors (cyan, red, white) in ‘Licorice’ representation.
Water is represented by a transparent box. CPT that inserts itself in the outer hydrophobic core of the
membrane is highlighted in magenta. (D–F) 2D electrostatic potential maps after the initial (0 ns),
insertion (88 ns), and permeation (25 ms) timepoints demonstrating the positively charged surface of
the POPC membrane. The +ve potential and -ve potential are shown in blue and red respectively.
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relative accessibility of the CPT, the drug starts to interact with and penetrate the membrane just
after 88 ns (Figure 48 B). After 25 µs, we see that the drug builds up in a stacking configuration
in the outer hydrophobic core of the membrane, starting to bend the membrane, pulling the
positively charged peptide groups towards the membrane (Figure 48 C).
The electrostatic potential at and surrounding the membrane, before contact with the drugs,
during initial drug penetration of the membrane, and after 25 µs, is also shown in Figure 48 DF. 54 qCPT molecules or 54.7 mM are placed randomly above and under the POPC membrane,
same as previously described for the ‘mCPT-buSS-Tau’-membrane system. Again, this
concentration is approximately 80-fold higher than the concentration that forms 9.5-nm-width
nanotubes in TEM and cryo-TEM experiments79. Over a 25-µs simulation, we find a more
significant interaction of the ‘qCPT-buSS-Tau’ with the model POPC membrane than with the
‘mCPT-buSS-Tau’ nanoclusters. Indeed, we find that the ‘qCPT-buSS-Tau’ nanoclusters penetrate
and insert in the membrane at ~ 100 ns, with the drugs eventually stacking up at the membrane
surface and permeating the membrane, as shown in Figure 48. Here, we identify two critical
events: Insertion at 88 ns and deeper partitioning of the drug into the membrane or Permeation
at 25 µs.
In contrast to ‘mCPT-buSS-Tau,’ after 6 µs, we do not observe an equilibrium state of the
‘qCPT-buSS-Tau’ nanoclusters average size or number of molecules per cluster, as shown in
Figure 46 C-D. Indeed, the average size still decreases after 25 µs as the number of nanoclusters
is increasing. After the insertion event at 88 ns, the original larger nanoclusters dissolve into
smaller nanoclusters which are shown as a decrease of the average size from 10 to 6 in Figure 45
A. Also, the sphericity, which describes the overall shapes of the ‘qCPT-buSS-Tau’ nanoclusters,
follows a different trend compared to ‘mCPT-buSS-Tau’.
As shown in Figure 45 B, small to medium nanoclusters of ‘qCPT-buSS-Tau’ have a similar
sphericity index of ~ 0.5 as for the ‘mCPT-buSS-Tau.’ In other words, the overall shape of the
small to medium drug-amphiphilic peptides are ellipsoidal regardless of their chemical
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structures. Nevertheless, when qCPT nanoclusters reach more than ~ 0.5 normalized size, their
sphericity index rapidly approaches 1.0, indicated they become rounder/more spherical. A
positive linear regression predicts this trend to be followed when a normalized size of 1 is reached.
We postulate that such a spherical shape in larger qCPT nanoclusters may nucleate nanotube
formation, observed in experiments79. However, it is unclear what role a membrane interface may
play in facilitating self-assembly.
Next, we characterize the 2D free energy surface to investigate the relationship between the
‘qCPT-buSS-Tau’ nanocluster sizes and the relative distance, dz, between the nanocluster and the
COM of the POPC bilayer. As mentioned, dz measures from the lowest point of each nanocluster
(or closest atom to the membrane in the nanocluster) to the COM of the membrane to characterize
the penetration, or nearest point of approach, of the drugs. From Figure 47 D, we observe two
‘qCPT-buSS-Tau’ nanocluster populations: the first dominant population with ~ 0.1 normalized
size (small to medium sizes) and the second population with ~ 0.5 normalized size (larger sizes).
Initially, the first population is concentrated mainly at ~36 Å (0 kcal/mol), and ~72 Å (1 kcal/mol)
with its minimum dz is at 24 Å while the second population is located at ~72 Å (~2.5 kcal/mol).
Moreover, ‘qCPT-buSS-Tau’ nanoclusters are 12 Å closer to the membrane compared to ‘mCPTbuSS-Tau’. One may argue that the initial random configurations favor a closer distance for
‘qCPT-buSS-Tau’ than ‘mCPT-buSS-Tau’, as shown in Figure 44 A and Figure 48 A,
respectively.
Nevertheless, the ‘Insertion’ event at 88 ns has the minimum dz of the first population of
drugs that penetrate the membrane as deep as 12 Å. At the end of the simulation, the penetration
is at its deepest, which is only 6 Å away from the COM of the membrane, as shown in Figure 47
E-F. Visual inspection of Figure 5 B shows that only 8 CPT drugs, colored in magenta, diffuse past
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the outer head group layer. While the membrane is bending after 25 µs simulation (Figure 48
C), the local membrane thickness and the x-y positions of the drugs that position themselves in
the outer hydrophobic core of the membrane are only weakly correlated, as shown in Figure 49.

Figure 49. “(A-C) Local thickness profiles of the POPC membrane at three critical events: Initial
(0 ns), Insertion (88 ns) and Permeation (25 microsecond). The black boxes shows the positions
of the 8 drug-portions on the thickness profiles. (D-F) Tracking positions of 8 drug-portions that
penetrate the membrane the deepest. To smooth out the average, only the last 20 frames of each
event are considered. Larger size shows ending of the trajectory.”

As mentioned, ‘qCPT-buSS-Tau’ nanoclusters break into smaller sizes after insertion, but
their clustering propensity is still high. In other words, after breaking apart, ‘qCPT-buSS-Tau’
nanoclusters reorganize and form aggregates again. We hypothesize that there are competing free
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energy contributions between the inter-and intra- nanocluster interactions. In other words, the
enthalpic interactions between the POPC and the ‘qCPT-buSS-Tau’ nanoclusters, specifically the
camptothecin9, are more favorable than the mainly hydrophobic and stacking interactions that
hold the ‘qCPT-buSS-Tau’ nanoclusters together. As a result, the POPC membrane allows the
‘qCPT-buSS-Tau’ nanoclusters inside, leading via the hydrophobic CPT, breaking the larger
aggregates.
When the DAs insert into the membrane, drug parts first, we hypothesize that the insertion
may affect the overall electrostatics at the membrane interface. Since the peptides contain
multiple positively charged Lysines, we expect to see a shift in the electrostatic potential along the
z-direction of the membrane as the peptides are pulled closer to the membrane surface. The
choline and phosphate phospholipid head groups at the interface give the membrane surface a
net dipole moment, with the positively charged cholines on the surface.
Figure 48 D-F shows the electrostatic potential (EP) map calculated from the PMEPot272
plugin in Visual Molecular Dynamics (VMD)272 using fast Fourier transformations to solve
Poisson's equation numerically. A detailed explanation can be found in Aksimentiev et al. 273. Only
a slice through the simulation box at the insertion site above and below the CPT drugs' membrane
is shown. We find that the membrane is more positive than the surrounding water, which contains
Cl- ions and is net negatively charged. The hydrophobic CPT drugs are buried inside the
amphiphilic peptides. There is a net positive region (0.1 – 0.5 V) in the initial configuration that
appears in the surrounding water. This is attributed to the positively charged Lysines, which are
mostly buried.
However, after 25 µs, more Lysines are pointing outwards as multiple more positive regions
(~ 1V) appear around the membrane in the surrounding water. However, this would, in effect, put
a positively charged ‘coat’ on the qCPT nanoclusters. As a result, the net positive charge of the
membrane surface may repulse this positively charged ‘coat’ on the qCPT nanoclusters. The
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interaction between the membrane surface and larger self-assemblies will be quantified in more
detail in the next section.
We next observe that ‘qCPT-buSS-Tau’ nanoclusters anchor themselves above the
membrane, while ‘mCPT-buSS-Tau’ nanoclusters fail to do so. Hydrogen bonds between the
peptides and the membrane surface may play a crucial role in this anchoring step. In Figure 50

Figure 50. (A) Total hydrogen bonds after the initial (0 ns), insertion (88 ns), and permeation (25
ms) timepoints. The lowest, middle, and top lines of the boxes are 25, 50, and 75 percentiles,
respectively. The top and bottom lines are maxima and minima, with the outliers as black
diamonds (B). The average hydrogen bonds between ‘qCPT-buSS-Tau’ and the POPC bilayer
during 25 ms trajectory. The transparent line shows the raw data and the opaque line shown the
running average over the previous 100 frames. (C) The amino acid involved and the lifetime of
the associated hydrogen bonds between nanoclusters of the ‘qCPT-buSS-Tau’ and the POPC
membrane.
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B, an average of 5-10 hydrogen bonds persistently exists between ‘qCPT-buSS-Tau’ nanoclusters
and the membrane. At the same time, there is an average of only one hydrogen bond between
‘mCPT-buSS-Tau’ and the membrane (as shown in Figure 51). The multi-fold difference in
hydrogen bonds between mCPT and qCPT reemphasizes the critical role of the hydrogen bonds
in forming an anchor for the nanoclusters above the membrane surface.

Figure 51. “Hydrogen bonds over time in mCPT-buSS-Tau/membrane system.”

Additionally, Figure 50 shows a significant increase in hydrogen bonds formed during
insertion, most of them lasting 25 µs. As a result, we calculate the lifetimes of hydrogen bonds
between ‘qCPT-buSS-Tau’ nanoclusters and the POPC membrane. Hydrogen bond analysis was
performed using the Cpptraj package217 from AmberTools package. The cut-off angle between the
hydrogen donor-hydrogen atom-hydrogen acceptor was 120°, and the cut-off distance between
the hydrogen donor-hydrogen acceptor was 3 Å. We considered all atoms on ‘qCPT-buSS-Tau’
and POPCs. In Figure 6 C, K517, K556, K557 have the most extended lifetimes spanning 30-50%
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of the 25 µs trajectory. G510 occurs during 10% of the trajectory. V511, Q662, Y505 are the least
significant. K517 and G510 are on the same DA. K556 and K557 are on the same DA. V511, Q662,
and Y505 are on different DAs. Both K517 and K557 are outer lysines in the peptide sequence.
The rest of the residues, which are not shown, form extremely short lifetime hydrogen bonds with
the membrane. Surprisingly, we find a high density of persistent hydrogen bonds near the
insertion site between the hydrophobic CPT and the membrane. We hypothesize that ‘qCPTbuSS-Tau’ nanoclusters initially form scattered stable hydrogen bonds with the POPC membrane
surface, effectively anchoring the nanoclusters to the surface of the membrane. Then, more stable
hydrogen bonds aggregate, which can facilitate a high-density hydrogen bonding region on the
surface of the nanoclusters. Eventually, the free energy tips such that it becomes more favorable
to break the nanoclusters apart, followed by the reformation of such nanoclusters as several
molecules leave and insert themselves in the membrane.

Umbrella Sampling
Next, we perform umbrella sampling (US) to determine the interaction energy of
preassembled ‘mCPT-buSS-Tau’ nanofilaments and ‘qCPT-buSS-Tau’ nanotubes with the POPC
model membrane. Figure 52 A, B, C shows snapshots of three windows from the US of the
nanofilament interaction with the POPC membrane for reaction coordinates (rc) of 70.5 Å, 52.5 Å,
and 33.5 Å respectively. These three snapshots represent three events during US –when the
nanofilament is away from the membrane, approaching the membrane, and in contact with the
membrane. These snapshots indicate the changing structure of the membrane as the
nanofilament approaches it –initially, the membrane bends and then wraps the nanofilament. We
do not observe any penetration of the membrane by the nanofilament suggesting a robust
repulsive interaction between the membrane and the nanofilament. Next, we look at the
electrostatic potential (EP) map during the three events mentioned above (Figure 52 C, D, E).
The EP map is calculated in VMD272 for the last 10 ns of the 28 ns simulation of each US window.
In these maps, we observe the solvent is negatively charged (red), the nanofilament and the
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membrane are both positively charged (blue), and the surrounding water solution is neutral
(white). The nanofilament is positively charged with protonated Lysines surrounding the
periphery of the nanofilament. The system has been neutralized by Cl- ions. Thus, it makes the

Figure 52. “Snapshots from umbrella sampling calculations showing nanofilament interaction
with the membrane at three reaction coordinates (rc) selected when nanofilament is (A) away
from the membrane (rc = 70.5 Å) (B) approaching the membrane (rc = 52.5 Å) and (C) in
contact with the membrane (rc = 33.5 Å) . 2D Electrostatic potential maps for nanofilament
interaction with the membrane when nanofilament is (D) away from the membrane (E)
approaching the membrane and F. in contact with the membrane. The +ve potential and -ve
potential are shown in blue and red respectively.”

solvent more negatively charged compared to the membrane and the nanofilament. The POPC
membrane is composed of zwitterionic phosphatidylcholines, and we observe the membrane is
positively charged compared to its surroundings. The electrostatic potential maps for three events
shift as the nanofilament approach the membrane. We find that the nanofilament is most positive
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when it is approaching the membrane (Figure 52 E) compared to when the filament is away
(Figure 52 D) or in contact (Figure 52 F) with the membrane.
Similarly, Figure 53 shows the snapshots of the ‘qCPT-buSS-Tau’ nanotube interaction
with the membrane and the corresponding EP maps. The rc’s of the three events when the
nanotube is away from the membrane, approaching the membrane, and in contact with the
membrane are 84.5 Å, 60.5 Å, and 36.5 Å respectively (Figure 53 A, B, C). Like the nanofilament
scenario, we find that as the nanotube approaches, the membrane starts bending and then wraps

Figure 53. Snapshots from umbrella sampling calculations showing the nanotube interaction with
the membrane at three reaction coordinates (rc) selected when nanofilament is (A) away from the
membrane (rc = 84.5 Å) (B) approaching the membrane (rc = 60.5 Å) and (C) in contact with the
membrane (rc = 36.5 Å) . Electrostatic potential maps for nanotube interaction with the membrane
when nanotube is (D) away from the membrane (E) approaching the membrane and (F) in contact
with the membrane. The +ve potential and -ve potential are shown in blue and red respectively.
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the nanotube. Furthermore, the EP maps of the nanotube interaction with the membrane
complement the trend of nanofilament interaction with the membrane. We find the nanotube and
the membrane are positively charged (blue), and the solvent is negatively charged (Figure 53 D,
E, F).
Figure 54 shows the resulting PMF profile determined by US for the interaction of the
nanofilament and the nanotube with the membrane. We find similar trends for both systems –
the interaction energy increases as the nanofilament/nanotube approaches the membrane.
However, it is energetically less costly for the nanofilament than the nanotube to interact with the
membrane. This suggests that the nanofilament succeeds in making a higher number of favorable
interactions with the membrane than the nanotube. We find that hydrogen bonds between the

Figure 54. Free energy profile, ΔG (kcal/mol), calculated by umbrella sampling for
the interaction of nanofilament (magenta) and nanotube (orange) with the POPC
model membrane. The reaction coordinate (rc) is the difference between center of
mass (COM) of the membrane and the nanotube or the nanofilament, respectively.
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Figure 55. “Interaction of Lysines of the (A) nanofilament (magenta) and (B) nanotube
(orange) with model POPC membrane (head groups shown in gray and tail groups shown in
cyan). (C) Average no. of H-bonds formed by Lysines and Tyrosines of the nanofilament
(magenta) and the nanotube (orange) with POPC membrane during last 10 ns of 28 ns
simulation in the closest umbrella sampling window. (D) Hydrogen bonds between the amine
of the Lysine and Phosphate of the POPC head groups.”

nanofilament/nanotube with the membrane are significant intermolecular interactions. Each DA
has two lysines that form the outer periphery of the nanofilament and the nanotube, creating
direct contact between lysines and the membrane (Figure 55 A, B). Since the nanofilament has
a smaller radius ~4.5 nm than the nanotube of radius ~5.0 nm, the outer surface area per 10 nm
length for the nanofilament ~283 nm2 is smaller than the surface area of the nanotube ~321 nm2.
Thus, lysines are packed much more closely for the nanofilament than for the nanotube. The
density profile (Figure 56) of the last window from the US further indicates that the phosphate
head groups of the membrane and the Lysines of the nanofilament and the nanotube overlap.
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Using VMD, we calculate the number of hydrogen bonds between the nanofilament and the
nanotube with the membrane for two events –when approaching and when in contact with the
membrane.

Figure 56. Density of water, lysines of the nanostructures and phosphates of the membrane
across Z-direction along the middle section (~30 Å) of (A) ‘mcpt-buSS-Tau’ filament (B) ‘qcptbuSS-Tau’ nanotube calculated for the last 10ns of the 28ns simulation when the nanofilament
and the nanotube is in contact with the membrane.

As shown in Figure 57, the average number of hydrogen bonds increases as the
nanofilament/nanotube approaches and then contacts the membrane. For both events, the
average number of hydrogen bonds is significantly more significant for the nanofilamentmembrane interaction than nanotube-membrane interaction. Next, we characterize the residues
from the nanofilament/nanotube forming hydrogen bonds with the membrane. We find the
number of hydrogen bonds for different residues of the nanofilament/ nanotube with the
membrane is directly related to their position for both systems. As shown in Figure 55 C, the
average number of hydrogen bonds between lysines of the nanofilament and the nanotube with
the membrane is significantly higher compared to tyrosines. Lysines being at the outer periphery
of the nanofilament and the nanotube directly contact the membrane resulting in higher hydrogen
bonds between lysines and the membrane. Tyrosine is the next inner residue after lysines in the
DAs. Since tyrosine has less access to the membrane than lysines, the average number of hydrogen

121

Figure 57. “Average H-bonds when the (A) nanofilament and the membrane (B) nanotube
and the membrane when nanotube/nanofilament is approaching the membrane and in
contact with the membrane calculated for the last 10ns of the 28ns simulation.”

bonds between tyrosines and the membrane is significantly lower than the hydrogen bonds
between lysines and the membrane. The fourth inner residue valine has negligible (~1) hydrogen
bonds with the membrane for both systems. In Figure 55 D, we show the representative
hydrogen bonds between lysine and membrane phosphate head groups. The greater hydrogen
bonds of the nanofilament-membrane compared to nanotube-membrane supports the lower PMF
for the nanofilament-membrane interaction compared to the nanotube-membrane interaction.
Next, we characterize structural changes in the membrane as the nanofilament/nanotube
approaches the membrane surface. Figure 52 and Figure 53 clearly show the membrane
bending as the nanofilament/nanotube approaches. We calculated the change in thickness and
surface area of the membrane during the three events previously described. The calculations are
discussed in the methods section. We find that the thickness of the membrane along the Y-axis
decreases as the nanofilament/nanotube approaches and makes contact with the membrane.
Figure 58 A, B shows the original membrane thickness of ~ 38 Å when the
nanofilament/nanotube is far away from the membrane, which significantly decreases to the
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Figure 58. Thickness of the membrane during interaction with the (A) nanofilament and
(B) nanotube. Average surface area of the membrane during interaction with the (C)
nanofilament and (D) nanotube. These values are calculated for the last 10ns of the 28 ns
simulation of the selected umbrella sampling windows. The thickness and average surface
area for these systems are calculated at three timepoints–when the nanofilament/nanotube
is away from the membrane, approaching membrane, and in contact with the membrane
with decreasing rc values as shown above.

thickness of ~ 28 Å, the nanofilament/nanotube makes contact with the membrane. The change
in thickness is dominant where the nanofilament/nanotube is directly contacting the membrane
(~ 10 Å thinner). Next, we calculate the surface area of the membrane during these three events
(Figure 58 C, D). We find the surface area of the membrane is greater for the membrane when
in

contact

with

the

nanofilament/nanotube

than

when

not

in

contact

with

the

nanofilament/nanotube, with an increase of ~ 2000 Å2. The difference for the thickness and the
surface area of the membrane is most significant between two end events – the
nanofilament/nanotube away from the membrane and the nanofilament/nanotube in contact

123

with the membrane. For the inner window, when the nanofilament/nanotube is approaching the
membrane, the values of the membrane thickness are similar to the corresponding values when
the nanotube/nanofilament is further away from the membrane. In contrast, the surface area of
the membrane has already increased. This suggests that the membrane first bends, without any
contact with the nanofilament/nanotube, and then only thins upon contact.
Overall, we determined the interaction free energy of DA nanofilament and nanotube with
the POPC cell membrane using umbrella sampling. The processes of bending of the membrane
and then wrapping the nanostructures have been previously observed in coarse-grained
simulations of spherical nanoparticles and spherocylinders by Frenkel et al.123 We find the
interaction energy between the nanostructures and the membrane is very high (> 400 kcal/mol),
suggesting the process is energetically costly. A previous study by Liu et al. has reported the
clathrin-mediated endocytosis is easier for a softer membrane than a rigid membrane. The study
conducted with varying membrane rigidity found it is difficult for a rigid membrane to deform
and form the vesicle for the endocytosis274. We assume the bending rigidity 𝒌𝒄 for a model POPC
𝟏

membrane and estimate the bending energy of the membrane, 𝑭𝒃𝒆𝒏𝒅 = 𝟐 𝒌𝒄 𝑯𝟐 , where 𝑯 is the
mean curvature of the membrane. The bending energy of the membrane, 𝑭𝒃𝒆𝒏𝒅 , costs ~ 1/3 of the
total interaction energy (~130 kcal/mol for the nanofilament system, and ~ 100 kcal/mol for the
nanotube system), as described in the methods section. However, this is a simplistic
representation of the system and composition of the membrane compared with a realistic
membrane composition of the plasma membrane of the cancer cell. Notably, molecular dynamics
simulations are moving towards more realistic phospholipid compositions to mimic real cells275.
A significant difference has been observed in the interaction of cationic nanoparticles with
zwitterionic vs. charged membrane. A study by Cui et al. has reported the cationic gold
nanoparticles have a lower affinity to the zwitterionic membrane but readily bind to 9:1
zwitterionic:anionic membrane model276. Thus, including a range of anionically charged

124

Phosphatidylserine (PS) to mimic the negative charge found in cancerous cells277 may significantly
modulate the degree of repulsion.
To summarize, the high interaction free energy, electrostatic potential maps, and the
bending phenomena of the membrane indicate strong repulsive interaction between the
nanostructures and the membrane. We find the interaction free energy of the nanofilament and
the membrane is lower than the interaction free energy of the nanotube and the membrane. We
suggest that one factor contributing to this difference is the number of hydrogen bonds each
nanostructure makes with the membrane. The nanofilament, having a smaller radius than the
nanotube, has a higher lysine density on its surface, facilitating more hydrogen bonds between
the nanofilament and the membrane. We did not observe pore formation in the membrane nor
significant deformation of the nanostructures during the simulations. This suggests
nanostructures are very stable structures, and breaking nanostructures into DAs will be
energetically costly. Previous long-timescale all-atom and coarse-grained simulations of these
anticancer nanostructures have shown these structures remain intact throughout the simulation
with pi-pi interactions as a crucial interaction between the DAs.86, 204, 260, 278 Thus, nanostructures
will not disassemble and release DAs and rather interact and traverse through the membrane as
one entity. Our observation of membrane bending and wrapping of the nanostructures suggests
endocytosis as the possible mechanism for these nanostructure internalizations by the membrane.
It is improbable for the nanostructures to break apart and release DAs outside of the cell
membrane; thus, the nanostructures as a whole entity needs to be internalized by the membrane.
A possible mechanism for this process may be endocytosis.

Conclusions
In this article, we computationally investigate the dynamic self-assembly and stability of
peptide-drug amphiphiles (DAs) and characterize their interactions with a model cellular
membrane. We find that with increased drug loading, singular DAs penetrate the membrane at
short time scales due to their increased hydrophobicity and increased accessibility of the drug.
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Using advanced sampling methods in molecular dynamics, we find that self-assembled DA
nanostructures—nanofilament and nanotube—repel the model membrane, forcing the membrane
to be thin and bend. This computational approach can be extended to molecularly design further
self-assembled drug carriers and predict the method of drug transport across the cellular
membrane. With the additional molecular design, control of the self-assembly shape and
interaction with and transport across the cellular membrane of these DA’s can then be optimized.
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EXPLORING THE NUCLEATION PATHWAY
FOR THE SELF-ASSEMBLY OF DRUG AMPHIPHILES
Phu K. Tang, Vincenzo Carnevale, Sharon M. Loverde

Abstract
Nucleation is a delicate process in Nature that guides both liquid-liquid phase separation
and crystallization. It is an essential phenomenon because just a subtle change in the nucleation
pathway can significantly change the macrostructure. For example, regulating pharmaceutical
products' production and purity requires a strong understanding of the nucleation process. Since
this process occurs at molecular dimensions, it is experimentally challenging to probe its initiation
steps. , Here we present a case study using molecular dynamics (MD) simulations, in combination
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with free energy techniques, to enrich configurational sampling of the self-assembly pathway of a
model drug amphiphile called Tubustecan－ a group of Camptothecin analogs that forms microns
long tubular morphologies with diameter ~ 8 nanometers in solution. Our conventional MD
simulations show that the PEGylated tails of Tubustecans disrupt the intrinsic 𝜋 − 𝜋 stacking of
Camptothecin in solution. Moreover, our choice of reaction coordinates for Metadynamics
promotes the reorganization of Camptothecin and high-density droplet forms after the formation
of ordered droplets. The results suggest that the nucleation of self-assembly of drug amphiphiles
adopts the "Two-Step Mechanism" instead of the "Classical Nucleation Theory."

Introduction
Crystallization is a spontaneous phenomenon that forms one of the most ordered structures
on Earth. This process can take place from picoseconds to millions of years. There are two
sequential steps in the process: nucleation and growth. It is the former step that governs how the
final crystalline structure materializes. For example, in "The Cave of Crystals" near Naica, Mexico,
giant crystals formed ages ago with the slowest ever measured crystallization rate.279 Besides
mineralogy, crystallization is also vital to many disciplines, such as chemistry, biochemistry, and
pharmaceuticals.280 Crystallization is the essential step that controls the polymorphism of
crystalline drugs281, exhibiting new physical282, 283 and chemical284, 285 properties in their different
forms. For example, Ritonavir's form II is a notorious case where conformational polymorphism
dramatically changes the crystals' solubility, causing manufacturing termination.286 Moreover, it
also strongly impacts drug purification.287 Nucleation is the critical process and thus responsible
for the resulting polymorphism.
Drug amphiphiles (DAs) are “one-component” delivery systems, developed by the
laboratory of Honggang Cui, that the delivered cargos also contribute to the self-assembly
process.79, 288-290 Computational studies by Kang et al. ratify that the 𝜋 − 𝜋 stacking of anticancer
drug Camptothecin (CPT) is the main driving force of chirality formation in the self-assembly of
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the DAs.291 Structurally, DAs have three components; hydrophobic drugs are conjugated to
amphiphilic peptides or polymers via reducible linkers. The polymorphism of the DAs has a direct
impact on their efficiency and functions. For example, the difference in drug:peptide ratio in
mCPT (one CPT to one peptide) and qCPT (four CPT to one peptide) induce the polymorphism in
these vesicles. Cheetham et al. reveal that mCPTs arrange into filaments and express lower
cytotoxicity in dosage response studies against human MCF-7 breast cancer and rat 9L
gliosarcoma cells while qCPTs form nanotubes and demonstrate higher cytotoxicity.79
Furthermore, long-time simulations from P. K. Tang and A. Manandhar et al. shows small size
aggregates of mCPT are repulsive to the cell membrane while larger size of those of qCPT
penetrate it.292 Therefore, understanding the nucleation of self-assembly of DAs have a profound
effect on novel designing and refining the DAs.
Gibbs developed classical nucleation theory (CNT) to describe the kinetics of nucleation
process. According to the CNT, the free energy of the nuclei formation ΔGnucleation can be
decomposed into the following two terms, ΔGvolume and ΔGsurface. The first term favors the growth
of nuclei, while the latter favors the dissolution. When the nucleus radius is less than that of the
critical radius rc, ΔGsurface is dominant, and because it is always positive, ΔGnucleation is unfavorable.
When the radius surpasses the critical radius rc, ΔGnucleation is dominated by the negative ΔGvolume.
As a result, the nuclei grow into crystals. Although CNT provides an excellent explanation in
simple cases, it occasionally fails to characterize the nucleation processes of complex systems as
reviewed in detail elsewhere.293, 294
As an upgraded version of the CNT, the "two-step mechanism" or TSM, developed by ten
Wolde and Frenkel, suggests that the nucleation process have more than one activation
energies.295 According to the TSM, fluctuations in density near the critical radius rc facilitate the
formation of high-density amorphous liquid-like droplets. Next, reorganization inside these highdensity droplets gives rise to the final states or the growth state. Theoretical and molecular
dynamics (MD) simulation studies provide results supporting the TSM.296-302 For example,
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Salvalaglio et al. finds that urea nucleation follows the TSM closely that includes the competition
of two crystalline polymorphisms.303 TSM theory is also experimentally validated.304-313 Given that
characterization of nucleation is nontrivial experimentally, molecular dynamics (MD) simulation
is an alternative choice to study such a process. Brute-force MD is usually not the first choice
because a nucleation process is a rare event. Thus, advanced sampling methods in molecular
dynamics314-318,

such

as

reaction-coordinate-based

(Umbrella

sampling265,

295,

319,

Metadynamics143, 193, 320, 321), and path-based sampling314, 322-325 are favored over brute-force MD
simulation.
Tubustecan (TT) is a class of Camptothecin (CPT) analogs that can self-assemble into
nanotubes in solution. These molecules exhibit potent anti-cancer therapeutics8. In general,
among the analogs, TT1, which has two PEGylated tails, produces the best yield in maximum
tolerated dose, survival chance. Although TEM images show the final self-assembled nanotubes,
the nucleation of the TT1 remains undetermined.
Herein, this chapter explores the nucleation pathway for the self-assembly of drug
amphiphile TT1 using free energy techniques. CD spectroscopic studies observe bisignate signals
at 266 and 367 nm indicating strong conjugation of 𝜋 − 𝜋 stacking of CPT inside the nanotube.8
However, there is no experimental data to define the orderliness of CPTs within the nanotube
structure. To accelerate the sampling on such orderliness, we employ MD simulations with
Metadynamics to enhance configurational sampling for the stacking of CPTs. Since the 𝜋 − 𝜋
stacking of CPT is the main driving force in self-assembly of DAs,8 we use and develop reaction
coordinates to drive the nucleation of TT1 (the total coordination number of the largest cluster
𝑠š ,321 and relative shape anisotropy 𝜅 % ) and also describe the orderliness of CPT (stacking index
ΞZ ) at the same time. 𝑠š and 𝜅 % are readily implemented in PLUMED－an open-source package
allowing flexible designing and easy usage of complicated and complex reaction coordinates.146,
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Through examination of radial mass density profiles, we observe high-density droplet after

ordered droplet formation. Furthermore, coarse-grained MD simulations also suggests large and
high-density nucleus formation of DAs that is stable for ~1.1 microseconds. Our results indicate
that the nucleation of self-assembly of TT1 endorses the TSM theory, as illustrated in Figure 59.
In other words, random distribution of TT1 must access the first high energetic state to form high-

Figure 59. A proposed nucleated mechanism of TT1 using the two-step nucleation theory. When
the degrees of drug orderliness increase, TT1s self-assemble from a random state to a highdensity amorphous state, following by reorganization within that state. More intermediates are
sampled during reorganization, depicted as light-blued arrows until the final state is accomplished.
Camptothecin drugs are highlighted in lime. PEGylated tails are highlighted in dark blue. Δ𝐸•# and
Δ𝐸•% are the activation energies.

density droplets via local density fluctuation. This is barricaded by the first activation energy Δ𝐸•# .
Then, internal reorganization occurs within the high-density droplets pushing for drug
orderliness until the thermostable configurations are achieved, hindered by the second activation
energy Δ𝐸•% , and initiate the growing phase of the DAs.
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Methods
Simulation Parameters
Table 5 provides a summary of all simulated systems. The systems were generated by
Packmol97 and parameterized in the GAFF as implemented in AmberTools18112. The systems were
minimized for 1000 steps using the steepest descent algorithm in AMBER18. Then, they were
heated to 300 K using Langevin dynamics125 for 10 ps at constant volume. Following this, the
volume was allowed to fluctuate spontaneously with a Langevin collision frequency of γ= 1.0 ps−1,
and isotropic Berendsen116 regulation (1 atm) with a time constant of 2 ps. Bonds involving
hydrogen were constrained using the SHAKE algorithm326, allowing a 2 fs timestep with TIP3P
water. Particle Mesh Ewald (PME) was used to treat all electrostatic interactions with a real space
cut-off of 10 Å.262 The trajectories was saved every 2 ps for analysis.

CPT-Only system
It has 72,582 atoms with 24 molecules of CPT (~50 mM) solvated in 23,853 TIP3P water.
The system was minimized following the equilibration recipe for the TT1 system. The box
dimension is 96 Å × 97 Å × 96 Å.

TT1 Equilibrated Run
It has 27,888 atoms with 12 molecules of TT1 (51 mM) and solvated in 8180 TIP3P water.
After 10 ns simulation, we extracted the last frame from the trajectory to initiate the three
following systems. The box dimension is 92 Å × 67 Å × 66 Å.

System I
The last frame from the equilibration run was extracted and used as the initial configuration
for system I. Using conventional MD, the system I was simulated for 100 ns in 300 K.

System II
The last frame from the equilibration run was extracted and used as the initial configuration
for system II. Using Metadynamics, system II was simulated for 100 ns at 300 K. The Gaussian
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width 𝜎 10 and the Gaussian height parameter 𝑊 was 2 kcal/mol, respectively. The reaction
coordinates were the total coordination numbers of the largest cluster S· . Detailed description is
provided in “Metadynamics” section. The frequency of depositing Gaussian biasing force 𝜏‹ was
0.2 ps.

System III
The last frame from the equilibration run was extracted and used as the initial configuration
for system III. Using Metadynamics, system III was simulated for 100 ns at 300 K. The reaction
coordinates were the total coordination numbers of the largest cluster S· and the relative shape
anisotropy 𝜅 % . Detailed description is provided in “Metadynamics” section. The Gaussian widths
𝜎 were 10 and 1, respectively. The Gaussian height parameter 𝑊 was 1.5 kcal/mol for both reaction
coordinates. The frequency of depositing Gaussian biasing force 𝜏‹ was 0.5 ps.

Metadynamics
Metadynamics is a history-dependent free energy method that prevents a system from
revisiting sampled phases by periodically adding a Gaussian bias potential 𝑉=!K; to a coarsegrained reaction coordinate 𝜉. Thus, the system with additional 𝑉=!K; can explore higher energy
states which can be difficult to sample in conventional MD. Laio and Parrinello143 first defined
𝐴(𝜉)=!K; , the biasing potential, as
𝐴(𝜉)=!K; = 𝐴(𝜉) + 𝑉=!K;
|𝜉 − 𝜉) |%
𝐴(𝜉)=!K; = 𝐴(𝜉) + 𝑊 ^ 𝑒𝑥𝑝 –
›
2 𝛿𝜎 %
)—:

,

where 𝜉) is the instantaneous reaction coordinate 𝜉 at time k, 𝑊 is the height of the Gaussian and
𝛿𝜎 is the Gaussian width. The deposition rate 𝜏‹ at every timestep (pace) are set before starting
simulations. The deposited 𝑉=!K; are stored on a grid327 in PLUMED 2.0146. After a sufficiently long
time, the total of the deposited 𝑉=!K; can be considered as a "negative image" of the free energy
profile, −𝐹(𝜉), which can be estimated as
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−𝐹(𝜉) = 𝑙𝑖𝑚 𝑊 ^ 𝑒𝑥𝑝 –
I7!G →B

)—:

|𝜉 − 𝜉) |%
›
2𝛿𝜎 %

.

The two dimensional 𝐹(𝜉) surface as a function of 𝑠š and 𝑐 can be reconstructed using postprocessing tool called sum_hill in PLUMED 2.0.146

Reaction Coordinates
The total coordination number of the largest cluster, 𝑺𝑳 .
Tribello et al. demonstrate that using the total coordination number of the largest cluster
𝑺𝑳 as the reaction coordinate in well-tempered Metadynamics can accelerate nucleation and
growth of crystalline urea146. Similarly, we define 𝑺𝑳 using the following scheme:
i.

We select two N atoms, one on each CPT, to represent one TT1 molecule. Thus, we have
a total group of 24 atoms for 12 TT1s or 24 CPTs.

ii.

We calculate the self-coordination number 𝑠! of each N atom within the 24-atom-group
within the cut-off 𝑟$ = 3.5 Å as

𝑠! = ^

𝑟!+ ]
1 − 8𝑟 ;
$

𝑟!+ #%
! ¹+ 1 − 8 ;
𝑟$

iii.

.

A 24 × 24 symmetric adjacency matrix328 𝑀!+ is then constructed based on each 𝑠! as
below
1
𝑀!+ = 0 𝑠(𝑖)
0

𝑟!+ < 3.5 Å
𝑟!+ = 3.5 Å
𝑟!+ > 3.5 Å

,

where 𝑠(𝑖) is a rational switching function to ensure that 𝑀!+ is continuous. The horizontal sum
of this matrix is the coordination numbers for the ith N atom.
iv.

The depth-first search (DFS) graph reduction algorithm328 was used to find the largest
cluster from the 𝑀!+ matrix and sum up its coordination numbers, 𝑺𝑳 .

134

3H 3H

𝑆š = ^ ^ 𝑀!+

.

!4# +4#

Relative Shape Anisotropy
To characterize the cluster shape, we employ the "shape descriptor" developed by Suter et
al. to quantify the geometric shape of linear polymers.329 The gyration tensor can be defined as
∑𝑥!%
𝑆 = þ∑𝑥! 𝑦!
∑𝑥! 𝑧!

∑𝑥! 𝑦!
∑𝑦!%
∑𝑦! 𝑧!

∑𝑥! 𝑧!
∑𝑦! 𝑧! !
∑𝑧!%

,

and its diagonalized matrix is the principal moments of the gyration tensor
𝑆

L!KN

𝑆#
= b0
0

0
𝑆%
0

0
0d
𝑆U

,

where S# > 𝑆% > 𝑆U . Implemented in PLUMED, we calculate the relative shape anisotropy κ% as
𝜅% = 1 − 3

𝑆# 𝑆% + 𝑆# 𝑆U + 𝑆% 𝑆U
𝑆# + 𝑆% + 𝑆U

.

𝜅 % can have values from 0 to 1. While 𝜅 % = 0 indicates that the cluster is a perfect sphere,
𝜅 % = 1 means that the shape highly anisotropic. Although not used as a reaction coordinate in
Metadynamics, we also calculate the acylindricity 𝑐 as
𝑐 = 𝑆% − 𝑆U

.

A high value of 𝑐 indicates high deviation from the cylindrical shape.

Stacking Index
𝜋 − 𝜋 stacking is an important factor in self-assembly of drug amphiphile, thus it is crucial
to characterize such interaction.278, 291, 292, 330, 331 In terms of geometry, 𝜋 − 𝜋 stacking can have
three distinct orientations: T-shaped, offset, and sandwich stacked.332 Thus, the orientation of
CPT is crucial in describing the 𝜋 − 𝜋 stacking. Using atom C on the A ring and atom O on the E
ring, ¢¢¢¢¢¢¢¢¢¢¢¢¢¢⃗
𝑂19𝐶6 and ¢¢¢¢¢¢¢¢¢¢¢¢¢¢⃗
𝑂7𝐶31 represents two CPTs that belong to one TT1 molecule. In total, there are
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24 CPT vectors. The atoms were numbered arbitrarily following the generated PDB. A group of
vectors was defined with their center of mass within 3.5 Å from each other. Within the group, the
𝜃 angles between all pairs of vectors were calculated using the dot product. Then, the calculated
angles were subjected to the following grading scheme,
10,
⎧
⎪ 5,
⎪ 0,
𝛯! =
0,
⎨
⎪ 5,
⎪10,
⎩

0° ≤
30° ≤
85° ≤
90° ≤
90° ≤
150° ≤

𝜃 < 30°
𝜃 < 85°
𝜃 < 90°
𝜃 < 95°
𝜃 < 150°
𝜃 < 180°

.

Parallel or anti-parallel stacked CPTs have higher values, according to the above grading
schematic. Finally, the stacking index is defined as
𝛯Z = ^ 𝛯!
!

.
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Table 5. Summary of Simulated Systems
System

CPT-Only

I

II

III

96 × 97 × 96 ÅU

92 × 67 × 66 ÅU

Atoms

72,582

27,888

Waters

23,853

8,180

TT1 molecules

24

12

Concentration

50 mM CPT

51 mM TT1

Box dimension

Temperature
MD Type

300 K
Conventional

Run Time

Metadynamics
100 ns

Reaction
Coordinate
N/A
Parameter

S·

S· & 𝜅 %

σ = 10
W= 2 kcal/mol
𝜏‹ = 100 steps

σ = 10,1
W = 1.5 kcal/mol
𝜏‹ = 500 steps

Results
PEGylated tail modifies the intrinsic π-π stacking of
Camptothecin
Here, we demonstrate that the PEGylated tail interrupts the intrinsic packing of CPT using
conventional MD with a CPT-Only system and system I. To characterize this phenomenon more
closely, we calculate the radial distribution function (RDF) between the CPTs in these two systems
as shown in Figure 60.
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The RDF profile of the CPT-Only system shows more peaks while all TT1 systems, regardless
of the simulation methods, show a disappearance of the peaks at 1 Å. The CPT-Only system RDF
indicates a crystalline structure while the RDF for the TT1 suggest a liquid-like structure. The loss
of the peak at 1 Å can be caused by the PEGylated tails physically hindering the signature 𝜋 − 𝜋
stacking of CPT. To have a thorough look, we monitor the clustering trends of CPTs between free
CPTs (CPT-Only system) and PEGylated CPTs (system I) over time by conventional MD method.

Figure 60. The radial distribution function between the drug parts of TT1.

In the CPT-Only system, the stacking index Ξ» is significantly higher, as shown in Figure 61 A,
than system I. At the same time, Figure 61 B shows that the distribution of S· in the CPT-Only
system is also at a higher value than system I. There is a substantial reduction of the 𝜋 − 𝜋 stacking
and close contact between the CPTs in system I. Whether the PEGylated tails nucleating or else
stabilizing the final nanotube structure of TT1, as shown in TEM,8 is another question altogether.
Moreover, there is no kinetic study of these self-assemblies.
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To further characterize the configurational profiles of free CPTs, we calculate the 2D PMF
profiles of the total coordination numbers of the largest cluster S· with the stacking index ΞZ . A
glance at Figure 62 A and Figure 63 A shows that the CPT-Only system samples broader ranges
of S· and ΞZ , in comparison to the system I. Moreover, free CPTs with high value of stacking index
(~400) also achieves better orderliness as its 𝑆š reaches value of 10. These results emphasize that

Figure 61. Clustering trends of 4 systems (CPT-Only, I, II, III) at the first 10% (blue)
and at the last 10% (orange) of simulated times. All systems are simulated for 100 ns.
(A) Stacking Index 𝜩𝝅 (B) Total coordination number of the largest cluster 𝑆š (C)
Acylindricity c (D) Relative Shape Anisotropy 𝜅 % . The dashed lines represent the
distribution quartiles, with the long-dashed line being the average and the shortdashed line is the other quartiles.
the PEGylated tails restrict the self-assembly of TT1 by impeding the 𝜋 − 𝜋 stacking of CPTs.
Changing the molecular shape and properties can lead to macroscopic alterations of selfassembly. For instance, cryo-TEM and coarse-grained simulations reveal that amphiphilic Janus
dendrimers with various degrees of hydrophobicity form many shapes such as cubic (or
cubosomes), disklike, tubular, and helical ribbons.7 Thus, it is within our expectation that the
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PEGylated tails will alter the elongation trend of free CPT molecules, which tends to form rod-,
needle-333, sheet-like334 shaped nanocrystals under various solvent conditions.
A closer look at the 2D PMF profiles of system I, in Figure 63 A－C, reveal that, for 100
ns, the ranges of SL are certainly stable since the minimum peaks are significant and have
minimum free energies of 0.6 kcal/mol. The low intensity of SL concurs with previous data,

Figure 62. Characteristics of CPT-Only System (conventional MD). 2D PMF profiles between the
total coordination number of the largest cluster S· and (A) Stacking Index ΞZ (B) Acylindricity 𝑐 (C)
Relative Shape Anisotropy κ% . Only the maximum signal from the radial mass density profile of
each highlighted peak is plotted. The circle represents the drug part, and the cross represents the
PEGylated tail part.

indicating that the PEGylated tail is explicitly obstructing the 𝜋 − 𝜋 stacking between the CPTs
and indeed hindering this stacking due to the excluded volume of the attached PEGylated tail.
Furthermore, Figure 63 A－C shows that system I obtains energetically favorable peaks at c = 4
and at 𝜅 % =0.7. To track the position/density of the CPTs, we calculate the radial mass density
profiles for each identified peak. For clarification purposes, we only plot the maximum values
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from the radial mass density profile. In Figure 63 D－E, the density peaks indicates that CPTs
in TT1 are further away from the center of mass of the cluster. We hypothesize that CPTs move
outward and act as an interface between the PEGylated tails and the solvent to minimize the
surface tension. Another concern here is whether the chosen force field can describe the
PEGylated tail correctly. This should be validated in future study.

PEGylated tails promote cylindrical cluster formation
To illustrate the morphology of the CPT clusters more thoroughly, we calculate the
acylindricity 𝑐, also from the principal moment of gyration tensor, which quantifies how close a
shape is to a cylinder. In Figure 61 C, we observe that PEGylated system I, II, and III are prone

Figure 63. Characteristics of System I (conventional MD). 2D PMF profiles between the total
coordination number of the largest cluster S· and (A) Stacking Index ΞZ (B) Acylindricity 𝑐 (C)
Relative Shape Anisotropy κ% . Only the maximum signal from the radial mass density profile of
each highlighted peak is plotted. The circle represents the drug part, and the cross represents the
PEGylated tail part.

to form cylindrical shape while the CPT-Only system is diverging from forming one. This concurs
with experimental TEM images displaying that while TT1s form nanotubes in solution,

8

CPTs
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form different shapes.333, 334 We hypothesize that the PEGylated tail promotes cylindrical shape
formation in TT1s. Figure 61 D shows an increase of the Relative Shape Anisotropy 𝜅 % in CPTOnly system, after 100 ns. This indicates that CPT gradually elongates linearly; this trend is also
very prominent for all PEGylated systems. An important observation in Figure 61 is that the
sampling efficiency by conventional MD method is inadequate. For example, the profiles of
system I are consistent, for 100 ns. Furthermore, visual inspection of system I shows the
PEGylated tails experience hydrophobic collapse at the very beginning of the trajectory. We
hypothesize that the addition of PEGylated tails modifies the CPT’s hydrophobicity and kinetically
trap the system after hydrophobic collapse. This presents a high activation energy of transforming
the current state of system I. Thus, we utilize Metadynamics on 𝑆š (system II) and both 𝑆š and 𝜅 %
(system III) to enhance the configurational sampling of CPT orderliness and cluster shape.

Metadynamics promotes reorganization of CPTs in TT1
cluster
After 10 ns of equilibration, TT1s aggregate into one cluster with their PEGylated tails
collapsing into the cluster core. However, this spontaneous hydrophobic collapse can potentially
trap the TT1 in an undesired energy basin. In Figure 61, system I continuously acquires
consistent peaks in all clustering trend’s characteristics which suggests a high activation energy
of transforming the current configuration to another state. Metadynamics is an excellent method
to enhance sampling on complex reaction coordinates quickly to overcome such high activation
energies. Since CPT is the main driving force of self-assemblies in solution,8, 290, 291 enhancing
configurational sampling on the CPT stacking can salvage the system from the current state. Thus,
we utilize Metadynamics on the total coordination number of the largest cluster S· , demonstrated
by Tribello et al,321 to augment the innate π − π stacking of CPTs presented in system II.
After 100 ns, SL is sampled, in system II, up to 5 times higher than system I. In Figure 64
A－C S· reaches a value of 30, which implies that the CPTs in TT1s are being more ordered within
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the cut-off of 3.5 Å. Interestingly, following the positions of the low acylindricity peaks from B1
to B4 in Figure 64 B D, we observe density fluctuation of CPTs in TT1 which endorse the TSM
theory. Moreover, the cylindrical propensity of CPTs in TT1 cluster is consistent as the CPT
orderliness increases. Attempting to utilize the Methodology in Kang et al.291, we set up and
simulated a pre-assembled nanotube of TT1 with CPTs positioned inside the core. For the initial
conditions we chose, we found spontaneous breaking down of pre-assembled TT1 nanotube into
micelles after 20 ns of equilibration (not shown here). Thus, we hypothesize that these additional
parameters, 𝑆š and 𝜅 % , need to be considered in building a better pre-assembled nanotube model
in future studies of the DAs.
Moreover, in Figure 64 the high-density C7 peak has the highest values of 𝑆š and 𝜅 %

Figure 64. Characteristics of System II (1D Metadynamics). 2D PMF profiles between the
total coordination number of the largest cluster S· and (A) Stacking Index ΞZ (B) Acylindricity
𝑐 (C) Relative Shape Anisotropy κ% . Only the maximum signal from the radial mass density
profile of each highlighted peak is plotted. The circle represents the drug part, and the cross
represents the PEGylated tail part.

indicating CPTs in TT1 cluster achieve highly ordered and linear configuration. Interestingly, the
radial mass density profile in Figure 64 D shows that the C7 peak has similar position to that
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of the B4 peak which is at the interface between the solvent and the TT1 cluster. Furthermore,
Figure 64 D E shows that CPTs localize at the interface with the solvent while the PEGylated
tails are buried deep inside the TT1 cluster.
As mentioned in the method section, 𝜅 % is the relative shape anisotropy which is sensitive
to the cluster shape. In other words, it shows the likelihood that a cluster will elongates in a linear
fashion. Next, we apply Metadynamics on both S· and 𝜅 % presented in system III. After 100 ns,
the 2D PMF profiles of system III in Figure 65 A－C are, indeed, extended versions of the 2D
PMF profiles of system II in Figure 64 A－C. For example, the total coordination number of the
largest cluster S· in system III is sampled in a higher range (close to the 40s). Moreover, higher
range of acylindricity 𝑐 and lower range of the relative shape anisotropy κ% are also visited after
using 2D Metadynamics. In comparison with the Figure 64 A the 2D PMF profile of Ξ» and S·
in Figure 65 A appears to be shifted from a vertical peak to a spherical peak. This shift changes
the 2D PMF profile of Ξ» and S· from high Ξ» and low S· to the opposite trend; this agrees with
the comparison between system I (Figure 63) and CPT-Only system (Figure 62). In other
words, the 𝜋 − 𝜋 stacking is anti-correlated to the orderliness of the CPTs in TT1 cluster. Thus,
what is experimentally anticipated as the CPT orderliness is not simply the inherent 𝜋 − 𝜋
stacking. Moreover, the paralleled or anti-parallel conformations of aromatic 𝜋 − 𝜋 stacking (low
Ξ» ) are suppressed when conformational orderliness increases. We hypothesize that after density
fluctuations, observed with Metadynamics only, the C4 peak represents a highly ordered cluster
(S· =30) with the highest calculated mass density (C4 = 5.0 g/mL), as shown in Figure 65.
Contradicting the observation of the high-density C7 peak in Figure 64, the C4 peak here also
indicates that CPTs confines to the COM of the TT1 cluster while its PEGylated tails are moving
outward, as shown in Figure 65 D-E.
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Figure 65. Characteristics of System III (2D Metadynamics). 2D PMF profiles between the total
coordination number of the largest cluster S· and (A) Stacking Index ΞZ (B) Acylindricity 𝑐 (C)
Relative Shape Anisotropy κ% . Only the maximum signal from the radial mass density profile of
each highlighted peak is plotted. The circle represents the drug part, and the cross represents the
PEGylated tail part.

In conclusion, evidence of density fluctuations with the appearances of high-density
amorphous droplets in Metadynamics MD simulations (system II and III) supports the TSM
theory. However, no stable state is identified questioning the convergence of the simulations. It is
interesting to determine whether there is a correlation between this exchange of movement
between the CPTs and the PEGylated tails with the high-density droplet formation. Is one the
outcome of the other? Is this phenomenon transferable to other self-assembly systems where 𝜋 −
𝜋 stacking is the driving force? The answers to these questions require more sophisticated studies
in the future.
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Discussion
Self-assembly is an interesting and complex process in Nature. There are many applications
of self-assemblies, but our understandings of how these molecules reach their final assembled
state is still very primitive. This article attempts to study the nucleation of self-assembly of TT1, a
drug delivering vehicle, using Metadynamics with complex and complicated PLUMED reaction
coordinates. Our data implies that the nucleation of self-assembly of the TT1 follows the "two-step
nucleation" theory where a high-density droplet is the precursor to nucleation. While the most
prominent clusters form spontaneously, it is possible that this is just a kinetically trapped state
driven solely by the hydrophobic collapse of the PEGylated tails. Our Metadynamics results
suggest that the CPTs tend to shield the PEGylated tails away from the hydrophilic solvent, such
as water, encouraging the TT1 cluster to rearrange internally. Until the orderliness, gauged by SL,
reaches a high value, such as 40 as observed in Figure 65, then the CPTs will move inwards to
be closer to the COM of the TT1 cluster. As stated above, whether this inward movement is being
caused by or causing the high-density droplet formation is unknown and will require more studies
to reach the final answer. Additionally, we learn that the orderliness, measured by SL, is the
configuration orderliness rather than the innate 𝜋 − 𝜋 stacking; thus, we suggest that the stacking
index Ξ» is a potential reaction coordinate that can quantifies the spatial orientation of the 𝜋 − 𝜋
stacking. Moreover, implementation of the Ξ» in PLUMED is effective in analyzing nucleation of
self-assemblies which contains aromatic components as in the DAs.
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Concluding Remarks and Future Directions
The overall theme of this Dissertation is self-assemblies, including natural and synthetic
systems. Self-assembly is a process in which monomers self-assemble into functional
macromolecules via non-covalent linkages. This process is ubiquitous in many natural
phenomena, such as the cell membrane. It is a fantastic example of Mother Nature showing us
what could be achieved by successfully controlling the self-assembly process. It is the definition
and the guardian of the cell. Although synthetic self-assemblies are still newborn, they already
show great potential in many disciplines, especially drug delivery. For example, drug amphiphiles
show great potential in delivering the anticancer drug Camptothecin. Given their undoubted
importance, researchers have studied these self-assemblies, natural or synthetic systems, to a
great extent. Yet, the knowledge of mastering self-assembly is still hidden away. This Dissertation
wants to contribute to the finding of such knowledge by molecular dynamics simulations. To be
more specific, we used long-time simulations and free energy techniques to investigate the
interactions between the self-assemblies and other molecules. More precisely, our results provide
theoretical aspects into
(i)

The interactions between Camptothecin and POPC bilayers

(ii)

The interactions between drug amphiphiles and POPC bilayers

(iii)

The nucleation of the self-assembly of drug amphiphiles

Chapter 3 presents the characterization of the interactions between Camptothecin and
three interfaces, including octanol bilayers, octanol slab, and POPC bilayers. We apply the
Adaptive Biasing Force method to enhance conformational sampling of Camptothecin along the
normal direction of the membrane. Using the calculated PMF profiles, our calculated partition
coefficients logP agree with experimental values. Moreover, the PMF profiles with minima at the
interfacial regions suggest the interfacial activity of Camptothecin. Also, the choice of water model
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influences transferring free energy. We advise using polarizable force fields for a higher accurate
description of membrane permeation.
Furthermore, we find that the orientation of the drug with respect to each model interface
is correlated to some degree due to the strength of hydrogen bonding at each respective interface.
Due to the intrinsic 𝜋 − 𝜋 stacking, we show that these strong aromatic interactions lead to
crystalline drug formation across the membrane at higher concentrations. The crystalline drug
formation mediates the interaction of the drug with the phospholipid bilayer, modifying the
orientation of the drug with respect to the membrane, changing the membrane permeation
pathway. The PMF profile of the POPC is not converged, suggesting hidden reaction coordinates
that are not addressed in the Adaptive Biasing Force simulations. For future studies, we'd like to
use machine learning approaches to characterize hidden variables further. We also note that these
models do not emphasize drug-drug interactions, which is also essential in the study the
membrane permeation. We advise a methodology uniquely suitable for exploring the contribution
of drug-drug interactions on membrane permeability is rational coarse-grained methods.
Chapter 4 reports the computational investigations of the dynamics and stability of
peptide-drug amphiphiles and characterizes their interactions with a model cellular membrane.
Using long-time simulations on Anton2, we find that with increased drug loading, singular DAs
have higher hydrophobicity and penetrate the membrane at shorter time scales. Using Umbrella
Sampling, we find that pre-assembled nanofilament and nanotube of the DAs are repulsive with
respect to the membrane, forcing the membrane to deform. Our computational approach and
analysis can be extended to molecularly optimize different self-assembled drug carriers and
predict drug transport pathways across the cellular membrane.
In chapter 5, we study the nucleation of self-assembly of TT1 － a drug-delivering vehicle
that self-assembles into nanotube － using Metadynamics with complex and complicated
PLUMED reaction coordinates such as the total coordination number of the largest cluster S· and
the relative shape anisotropy 𝜅 % . We also developed the stacking index Ξ» to quantify the spatial
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orientation of the 𝜋 − 𝜋 stacking, which is dominant in aromatic molecules. Our data imply that
the additional PEGylated tails impede the 𝜋 − 𝜋 stacking of Camptothecin and promoting
cylindrical shape clusters.
Moreover, our Metadynamics simulations with chosen reaction coordinates promote drug
orderliness and drug reorganization. As a result, these effects rescue the system from being
trapped kinetically. With the observation of the high-density droplet, we hypothesize that the
nucleation of self-assembly of the TT1 endorses the "two-step nucleation" theory. To be more
specific, our 2D Metadynamics simulations with the total coordination number of the largest
cluster S· and the relative shape anisotropy 𝜅 % show that the Camptothecin drugs form an ordered
cover for the hydrophobic PEGylated tails. When the drug orderliness is high (S· ~40) and the
relative shape anisotropy 𝜅 % is above 0.70, the drug cover forms a high-density droplet, and it
dissolves into the core and exposes the hydrophobic tails. As stated, whether this inversion of the
cluster is being caused by or causing the high-density droplet formation is unknown and will
require more studies to reach the definitive answer.
Additionally, thanks to the stacking index Ξ» we find that the total coordination number of
the largest cluster S· cannot represent the intrinsic 𝜋 − 𝜋 stacking of aromatic molecules. Thus,
we'd like to develop this reaction coordinate in PLUMED to yield better results in future studies
of aromatic molecules using free energy techniques.
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